Timing of Aphasia Treatment in Stroke Patients : Early Interventions and Outcome by Nouwens, F. (Femke)
  
 
 
Timing of Aphasia Treatment     
in Stroke Patients 
Early Interventions and Outcome  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Rotterdam Aphasia Therapy Study (RATS) – 3 was funded by a fellowship granted to L.M.L. de 
Lau by the Brain Foundation Netherlands (project number: 2011(1)-20). This thesis could not 
have been realized without grants from Zabawas Fund, Coolsingel fund, Dura fund, Blokland 
fund, and the Erasmus MC Care Research Fund. 
 
 
 
 
 
 
Financial support for publication of this thesis was kindly provided by the Dutch Aphasia 
Foundation (Stichting Afasie Nederland), The Erasmus University and the Dutch Heart 
Foundation.  
 
 
 
 
Cover design: Maarten Timmer  
Printed by: Gildeprint  
ISBN: 978-94-6233-652-0 
 
© 2017 Femke Nouwens  
No part of this thesis may be reproduced, stored in a retrieval system or transmitted in any form 
or by any means, without permission of the author or, when appropriate, of the publishers of the 
publications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Timing of Aphasia Treatment     
in Stroke Patients 
Early Interventions and Outcome 
 
 
Timing van taaltherapie voor afasie 
ten gevolge van een beroerte 
Vroege interventies en uitkomsten 
 
 
 
Proefschrift 
 
ter verkrijging van de graad van doctor aan de 
Erasmus Universiteit Rotterdam 
op gezag van de 
rector magnificus 
 
prof.dr. H.A.P. Pols  
 
en volgens besluit van het College voor Promoties. 
 
De openbare verdediging zal plaatsvinden op 
5 juli 2017 om 11.30 uur 
 
 
Door 
 
Femke Nouwens 
geboren te ‘s-Hertogenbosch  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Rotterdam Aphasia Therapy Study (RATS) – 3 was funded by a fellowship granted to L.M.L. de 
Lau by the Brain Foundation Netherlands (project number: 2011(1)-20). This thesis could not 
have been realized without grants from Zabawas Fund, Coolsingel fund, Dura fund, Blokland 
fund, and the Erasmus MC Care Research Fund. 
 
 
 
 
 
 
Financial support for publication of this thesis was kindly provided by the Dutch Aphasia 
Foundation (Stichting Afasie Nederland), The Erasmus University and the Dutch Heart 
Foundation.  
 
 
 
 
Cover design: Maarten Timmer  
Printed by: Gildeprint  
ISBN: 978-94-6233-652-0 
 
© 2017 Femke Nouwens  
No part of this thesis may be reproduced, stored in a retrieval system or transmitted in any form 
or by any means, without permission of the author or, when appropriate, of the publishers of the 
publications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Timing of Aphasia Treatment     
in Stroke Patients 
Early Interventions and Outcome 
 
 
Timing van taaltherapie voor afasie 
ten gevolge van een beroerte 
Vroege interventies en uitkomsten 
 
 
 
Proefschrift 
 
ter verkrijging van de graad van doctor aan de 
Erasmus Universiteit Rotterdam 
op gezag van de 
rector magnificus 
 
prof.dr. H.A.P. Pols  
 
en volgens besluit van het College voor Promoties. 
 
De openbare verdediging zal plaatsvinden op 
5 juli 2017 om 11.30 uur 
 
 
Door 
 
Femke Nouwens 
geboren te ‘s-Hertogenbosch  
 
  
 
 
 
PROMOTIECOMMISSIE 
 
 
Promotor  Prof.dr. D.W.J. Dippel 
                                           
 
 
Overige leden       Prof.dr. Y.R.M. Bastiaanse 
   Prof.dr. J.J.V. van Busschbach 
   Prof.dr. G.M. Ribbers 
 
Copromotoren Dr. L.M.L. de Lau 
   Dr. E.G. Visch-Brink 
 
 
 
 
 
 
 
 
The time is now 
 
You're my last breath, 
you're a breath of fresh air to me 
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So tell me you care for me 
 
You're the first thing 
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APHASIA 
 
According to the World Heart Federation each year 15 million people suffer from a stroke.1 
One possible consequence of stroke is the acquired language deficit aphasia. Aphasia occurs 
in approximately 30% of stroke patients.2 This amounts to 4.5 million new stroke patients 
with aphasia each year across the world.  
The language system is predominantly located in the left hemisphere. Thus, aphasia is 
usually caused by a left hemisphere stroke, either hemorrhagic or ischaemic.3 Aphasia may 
affect all language modalities, i.e. auditory comprehension, speaking, reading and writing.4 
Also, one or more linguistic components such as semantics (meaning), phonology (sound), 
syntax (grammar) and morphology (form) can be affected. All of these deficits influence 
language processing differently; hence aphasia can manifest itself in numerous different 
ways.   
As aphasia affects language processing, it affects verbal communication. People with 
aphasia may find themselves not being able to participate adequately in conversations, and 
often they are incapable of understanding route directions, or unable to read a book. 
Aphasia has a large impact on daily life. Therefore, early recognition and diagnosis of aphasia 
in stroke patients is of importance both for prognostication and providing adequate 
treatment, aimed at improving patients’ wellbeing and quality of life.   
 
DIAGNOSIS OF APHASIA 
 
Usually, in the acute stage after stroke patients are assessed by a neurologist or stroke 
physician for focal neurological deficits, including aphasia.5, 6 Early after stroke it is often not 
feasible to diagnose individual aphasia characteristics in detail, as extensive examinations 
may be too burdensome for the often seriously ill patients. Furthermore, speech and 
language therapists (SL-therapists) are not always available for performing specific linguistic 
testing in this phase. Yet, timely evaluation of presence and severity of aphasia is crucial for 
adequate treatment, and by rapid recognition of language deficits medical staff is able to 
promptly adapt to the communication problems.7 It has been shown that when adequate 
communication strategies are applied by medical staff, this may prevent patients from 
developing maladaptive strategies occurring in response to the language deficits.8, 9 Early 
recognition of problems with language processing is also of importance to educate the social 
environment of the patient to avert communication distress.    
Hence, it is crucial to have a brief and easy screening test for aphasia that may be 
administered by SL-therapists as well as other health professionals shortly after aphasia 
onset and is also appropriate for vulnerable stroke patients.5, 6  
 
PROGNOSIS OF APHASIA 
 
After a stroke, patients and their relatives are faced with uncertainties and patients may ask 
themselves whether they will be able to fulfil their professional and household tasks and 
social activities again. Consequently, providing patients with aphasia due to stroke and their 
proxies with a well-defined prognosis is of great importance.  
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However, prediction of functional outcome in patients with aphasia is complicated. 
Rehabilitation physicians and neurologists often use prognostic models, derived from data 
collected in large groups of patients to distinguish relevant factors in predicting recovery.10, 
11 To date, not all factors influencing recovery following a stroke are identified and new 
models are being composed. It is important that these models are adequate and valid, and 
generalize well to the patients with aphasia in order to optimize individual care.12   
 
RECOVERY OF LANGUAGE 
 
Spontaneous recovery 
In the first period after stroke, aphasia is often fairly severe, due to direct damage to the 
neural networks dedicated to language, but also because of diaschisis; a state of global 
functional breakdown of widespread cortical networks involved in language processing, 
which are not directly damaged by the stroke.13 Diaschisis can resolve relatively quickly, 
when perfusion is restored and edema is reduced. As a consequence, in the hours to days 
after stroke language recovery is capricious, and language function can be instable and 
change rapidly. A patient, who is unable to verbally communicate hours after stroke, may be 
talking fluently the next day.   
After the acute stage, during which spontaneous recovery is mostly attributed to saving 
the perilesional region and resolution of diaschisis, spontaneous language recovery is still 
ongoing.13, 14 It is unclear which exact mechanisms are at play during this stage of recovery, 
but at least it involves widespread neural networks.13, 15 It has been speculated that speech 
and language therapy (SLT) may interfere with these processes.13, 16-19 Hence, we need to 
understand the recovery mechanisms and the effect of SLT on these processes better, in 
order to generate maximal gains from SLT.    
 
Treatment induced recovery 
Most stroke patients with aphasia receive SLT. SLT is a diverse intervention, and comprises 
many components, e.g. type of treatment, treatment intensity, timing and duration of 
treatment.4 Furthermore, specific therapeutic principles may be implemented, such as 
massed practice, a highly intensive and repetitive treatment regimen or errorless learning, 
by which only correct responses are enforced in order to reduce errors.19  
SLT can be roughly divided into impairment-based treatment and communicative 
treatment. The first is focused on repairing language deficits, thus aimed at restoration of 
language function, while the latter focuses on regaining the capability to communicate in 
whatever way possible.18, 20  
Impairment-based SLT is based on language processing models and may include specific 
exercises for the different language modalities; auditory or visual comprehension and oral or 
written production. Treatment may also target linguistic components, such as semantics, 
phonology or syntax; i.e. cognitive-linguistic treatment (CLT).21, 22 In the Netherlands, two 
CLT therapy programs, BOX and FIKS, are applied frequently. Both programs aim to improve 
word finding deficits, a common problem in aphasia; BOX through semantic exercises and 
FIKS through phonological exercises.23-25  
Communicative treatment is not based on language processing models or linguistic 
models, but on communication in its broadest form. The goal is to improve everyday 
communication by using residual verbal capacities and alternative ways of communication, 
 
e.g. a communication aid or gestures. Consequently, this treatment approach is more 
directed at compensation, rather than restoration of premorbid language function. Well-
known communicative treatment approaches are the Conversational Coaching26 and the 
Promoting Aphasics’ Communication Effectiveness (PACE)27 method.   
Hypotheses on the underlying processes explaining the effectiveness of these different 
treatment approaches are manifold. Some have argued that impairment-based treatment, 
including CLT, is to be preferred in the acute and post-acute stage, because the greatest 
benefits are achieved when recovery of language function occurs, due to plasticity of the 
brain.18, 19, 28 Furthermore, it has been argued that this cognitive-linguistic approach alters 
neural processing, thus inducing permanent improvement.29 Others claim that the focus of 
SLT should be on regaining the ability to communicate by stimulating communication in its 
broadest sense, because that is the main goal of language processing and prevents social 
isolation.30 Hereby, new neural pathways may be created, dedicated to the new way of 
communicating.   
 
EFFICACY OF SPEECH AND LANGUAGE THERAPY 
 
Determining the efficacy of language treatment in aphasia due to stroke is substantial, as 
ineffective treatment programs or ineffective modes of delivery are a waste of time, 
patients’ precious energy and costly resources. Obviously, when treatments have been 
proven efficacious, effectiveness research may be carried a step forward and results can be 
implemented, which may benefit many of the 4.5 million new stroke patients with aphasia 
each year worldwide.   
The authors of the latest update of the Cochrane review on the efficacy of SLT for 
aphasia due to stroke conclude that SLT is more effective than no intervention, and that 
there are potential benefits of intensive treatment over regular therapy.4 However, there 
were more dropouts, either from intervention or follow-up, in studies with high-intensity 
treatment, indicating that not all stroke patients with aphasia tolerate frequent treatment. 
Insufficient evidence was found to prefer one type of treatment over another or to 
recommend an optimal treatment regimen. Despite the authors acknowledging that aphasia 
research has improved since the first Cochrane review dated 1999 and that the evidence 
base for SLT is getting more solid, the optimal i.e. proven effective treatment approach is still 
not established.  
Nowadays imaging techniques are used more and more to study whether specific types 
of treatment have an impact on neural processes, but results have been inconclusive.29, 31 
 
Timing of treatment 
An important, yet unanswered clinical question is whether there is an optimal time window 
after stroke in which treatment should be initiated.32 In rehabilitation medicine early 
intensive treatment for motor deficits is often promoted with statements such as “Use it or 
lose it” and “The sooner, the better”.33 Some researchers and clinicians advocate starting 
impairment-based SLT for aphasia as soon as possible after stroke, to make use of the 
supposed hyperexcitable brain as a result of increased brain plasticity, while it may be better 
to wait until the brain has stabilized.15, 19 Most clinicians agree that guidance and counseling 
by an SL-therapist aimed at prevention of communication distress are essential early after 
stroke, but they are also faced with very tired and ill patients who do not tolerate intensive 
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rehabilitation therapies.34 As yet, there is little evidence supporting a relationship between 
timing of treatment and its efficacy.35 
 
The Rotterdam Aphasia Therapy Studies (RATS) 
Studying the efficacy of CLT has been the aim of the prior two Rotterdam Aphasia Therapy 
Studies.20, 36 In RATS-1 the hypothesis was tested that semantic treatment is more effective 
for recovery of aphasia than phonological treatment, as it has long been assumed that 
semantic treatment is more effective than phonological treatment for restoring word 
finding, the most frequently occurring deficit in aphasia.36 In RATS-1 we studied whether 
lexical semantic treatment with the Dutch treatment program BOX was more effective for 
recovery of aphasia than phonological treatment with the program FIKS, when initiated 
more than three months after stroke.36 We found no difference in treatment effect on 
everyday verbal communication, measured with the Amsterdam-Nijmegen Everyday 
Language Test (ANELT)37. However, findings suggested a therapy specific treatment effect, as 
patients that were treated with semantic therapy improved more on semantic tests than the 
group that received phonological treatment, and patients receiving phonological treatment 
improved more on phonological tests than those in the semantic treatment group. This 
therapy specific treatment effect in both groups was correlated with improvement on the 
ANELT, ruling out the effect of spontaneous recovery.   
Since most patients with aphasia have both a semantic and phonological deficit, we 
subsequently hypothesized that combining impairment-based lexical semantic and 
phonological treatment, i.e. CLT, would be profoundly effective in the sub-acute phase 
compared to other treatment approaches, also because of the supposed interaction of CLT 
with spontaneous neural recovery.18   
These hypotheses were tested in RATS-2.20 In this multicenter randomized controlled 
trial (RCT), patients received six months of either CLT or communicative treatment starting 
within three weeks of stroke onset. Communicative treatment was chosen as control 
condition, as this non-linguistically based method contrasts maximally with CLT. After six 
months there were no differences between groups with regard to everyday verbal 
communication as measured with the ANELT, refuting that CLT in the sub-acute phase would 
have a greater impact on aphasia recovery than communicative treatment. Yet, we did find 
differences in favor of CLT on linguistic tests, still suggesting that CLT may positively affect 
language recovery.    
 
OUTLINE OF THIS THESIS 
 
The aim of this thesis is to study various aspects of language rehabilitation in stroke patients 
with aphasia, with a major focus on the relationship between the timing of CLT and its 
efficacy. In this thesis three questions are addressed: 
 
How accurately can we diagnose the presence of aphasia in the early stage after stroke 
onset? 
In Chapter 2, a systematic review is presented aimed at identifying linguistic screening tools 
to detect aphasia early after admittance to hospital. Vital elements of adequate language 
screening tests are sensitivity, i.e. the ability to pick up language deficits; and specificity, i.e. 
the ability to distinguish language deficits from other deficits.38  Several aspects of the 
 
selected screening tools are addressed, together with a detailed appraisal of the tests, taking 
into account these vital elements. 
 
Which factors are of importance for an accurate prediction of aphasia outcome in 
stroke? 
The most common cause of aphasia is cerebral infarction, which may be treated with a form 
of endovascular intervention to improve perfusion to the affected brain area. This treatment 
affects the prognosis of recovery, because it is aimed at saving as much brain tissue as 
possible. In Chapter 3.1, we present the results from a post-hoc analysis of the MR CLEAN 
trial, a large phase III RCT evaluating the effectiveness of intra-arterial treatment with 
retrievable stents in ischemic stroke.39 We selected all patients with aphasia from this trial 
and evaluated whether usual care plus endovascular treatment was more effective than 
usual care alone for the early recovery from aphasia in acute ischemic stroke. Furthermore, 
we evaluated whether the effect of endovascular treatment on early aphasia recovery 
differed from the effect on early recovery of motor function. In Chapter 3.2 the external 
validity of a prognostic model for the outcome of aphasia, derived from an observational 
prospective study, is determined using data from another RCT: RATS-3. The original model 
consisted of a number of factors that can easily be recorded from newly admitted patients 
to the stroke ward. The discriminative power and calibration properties of the model are 
assessed to verify the validity of the model. 
 
Is there a relationship between the timing of aphasia treatment and its efficacy? 
In the narrative review in Chapter 4.1 we discuss that there is little evidence for a 
relationship between the timing of SLT and its efficacy, as there are no RCT’s directly 
comparing early initiated treatment to deferred treatment. Evidence from the field of animal 
studies and motor rehabilitation is explored to provide insights into a possible relationship 
between timing of treatment and its efficacy.    
The design and methods of the third Rotterdam Aphasia Therapy Study, RATS-3, are 
introduced in Chapter 4.2. The results of this randomized controlled trial on the efficacy of 
early initiated CLT are presented and discussed in Chapter 4.3.  
As initial aphasia severity is thought to be related to recovery potential, we compare 
recovery profiles according to three levels of baseline aphasia severity in Chapter 4.4. The 
impact of CLT and communicative treatment on the recovery of aphasia in these three 
severity groups are compared also.  
 
The principal findings of the studies discussed in the chapters of this thesis, and their clinical 
implications, as well as directions for future research are discussed in Chapter 5. A summary 
of the main findings is provided in Chapter 6. 
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rehabilitation therapies.34 As yet, there is little evidence supporting a relationship between 
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OUTLINE OF THIS THESIS 
 
The aim of this thesis is to study various aspects of language rehabilitation in stroke patients 
with aphasia, with a major focus on the relationship between the timing of CLT and its 
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The design and methods of the third Rotterdam Aphasia Therapy Study, RATS-3, are 
introduced in Chapter 4.2. The results of this randomized controlled trial on the efficacy of 
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impact of CLT and communicative treatment on the recovery of aphasia in these three 
severity groups are compared also.  
 
The principal findings of the studies discussed in the chapters of this thesis, and their clinical 
implications, as well as directions for future research are discussed in Chapter 5. A summary 
of the main findings is provided in Chapter 6. 
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ABSTRACT  
 
Background 
Aphasia has a large impact on quality of life and adds significantly to the costs of stroke care. 
Early recognition of aphasia in stroke patients is important for prognostication and well-
timed treatment planning.  
 
Objective 
We aimed to identify available screening tests for differentiating between aphasic and non-
aphasic stroke patients, and to evaluate test accuracy, reliability, and feasibility.  
 
Methods 
We searched PubMed, EMbase, Web of Science, and PsycINFO for published studies on 
screening tests aimed at assessing aphasia in stroke patients. The reference lists of the 
selected articles were scanned and several experts were contacted to detect additional 
references. Of each screening test, we estimated the sensitivity, specificity, likelihood ratio 
of a positive test, likelihood ratio of a negative test, and diagnostic odds ratio (DOR), and 
rated the degree of bias of the validation method.  
 
Results 
We included ten studies evaluating eight screening tests. There was a large variation across 
studies regarding sample size, patient characteristics, and reference tests used for 
validation. Many papers failed to report on consecutiveness of patient inclusion, time 
between aphasia onset and administration of the screening test, and blinding. Of the three 
studies that were rated as having an intermediate or low risk of bias, the DOR was highest 
for the Language Screening Test and ScreeLing.  
 
Conclusion 
Several screening tools for aphasia in stroke are available, but many tests have not been 
verified properly. Methodologically sound validation studies of aphasia screening tests are 
needed in order to determine their usefulness in clinical practice. 
 
 
INTRODUCTION 
 
For people aged 65 years or more, the worldwide prevalence of stroke ranges from 46 to 73 
per 1000 people.1 This number is likely to increase in the coming years due to aging of the 
population. Approximately 30% of stroke survivors have aphasia in the acute phase of 
stroke, a condition affecting daily communication and thus quality of life.2 Aphasia adds 
significantly to the costs of patient care after stroke due to a longer hospital stay, and 
patients with aphasia are more frequently discharged to a rehabilitation center than those 
without.3, 4 Initial severity of aphasia is an important factor determining the prognosis of 
patients with aphasia due to stroke.5, 6 It has repeatedly been suggested that treatment of 
aphasia should be initiated as soon as possible after stroke, although consistent evidence for 
a beneficial effect of early language therapy has not been published yet.7  
Altogether, it is pivotal that presence and severity of aphasia are adequately evaluated in 
patients who suffered a stroke. A large number of diagnostic instruments is available to 
examine the type and degree of aphasia. As many of these diagnostic test batteries are fairly 
demanding and time-consuming, they may be too cumbersome for stroke patients in the 
acute phase. Given that aphasia characteristics are generally instable shortly after stroke and 
can change rapidly, extensive testing may be a waste of time and resources. Also, a speech 
and language therapist (SL-therapist) is not always sufficiently available in the first days after 
stroke to obtain a detailed linguistic profile. Hence, a short and simple screening test, easy to 
administer by various disciplines, is essential for referring patients for additional assessment 
and adequate language therapy. Furthermore, advice regarding communication may be 
better personalized using results from screening tests.  
The aim of this review was to identify available screening tests for differentiating 
between aphasic and non-aphasic patients after stroke, and to evaluate the accuracy, 
reliability, and feasibility of those tests.  
 
METHODS  
 
Search strategy 
We searched PubMed, EMbase, Web of Science, and PsycINFO for published studies on 
screening tests aimed at assessing presence and/or severity of aphasia in patients who 
suffered an ischemic or hemorrhagic stroke. The following search string was used for NLM 
PubMed-Medline and was adapted for the other databases: 
(cerebrovascular disorders[mesh:noexp] OR brain ischemia[mesh] OR intracranial embolism 
and thrombosis[mesh] OR intracranial hemorrhages[mesh] OR stroke[mesh:noexp] OR 
vertebral artery dissection[mesh:noexp] OR stroke*[tw] OR poststroke*[tw] OR cva[tw] OR 
cvas[tw] OR cerebrovasc*[tw] OR cerebral vasc*[tw] OR ((cerebr*[tw] OR intracerebr*[tw] 
OR cerebell*[tw] OR brain*[tw] OR vertebrobasilar*[tw] OR intracran*[tw]) AND 
(infarct*[tw] OR ischem*[tw] OR ischaem*[tw] OR hemorrh*[tw] OR haemorrh*[tw] OR 
hematom*[tw] OR haematom*[tw] OR thrombos*[tw] OR thrombot*[tw] OR 
thromboembol*[tw] OR thrombol*[tw] OR apoplex*[tw] OR emboli*[tw] OR bleed*[tw]))) 
AND (aphas*[tw] OR logastheni*[tw] OR logagnos*[tw] OR logamnes*[tw] OR alogi*[tw] OR 
anepia*[tw] OR dysphasi*[tw] OR lichtheim*[tw]) AND (test[tw] OR tests[tw] OR 
testing*[tw] OR screen*[tw] OR tool*[tw] OR instrument*[tw] OR assessment*[tw]) AND 
(accura*[tw] OR sensitiv*[tw] OR specificit*[tw] OR psychometr*[tw] OR psycho-metr*[tw] 
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OR cerebell*[tw] OR brain*[tw] OR vertebrobasilar*[tw] OR intracran*[tw]) AND 
(infarct*[tw] OR ischem*[tw] OR ischaem*[tw] OR hemorrh*[tw] OR haemorrh*[tw] OR 
hematom*[tw] OR haematom*[tw] OR thrombos*[tw] OR thrombot*[tw] OR 
thromboembol*[tw] OR thrombol*[tw] OR apoplex*[tw] OR emboli*[tw] OR bleed*[tw]))) 
AND (aphas*[tw] OR logastheni*[tw] OR logagnos*[tw] OR logamnes*[tw] OR alogi*[tw] OR 
anepia*[tw] OR dysphasi*[tw] OR lichtheim*[tw]) AND (test[tw] OR tests[tw] OR 
testing*[tw] OR screen*[tw] OR tool*[tw] OR instrument*[tw] OR assessment*[tw]) AND 
(accura*[tw] OR sensitiv*[tw] OR specificit*[tw] OR psychometr*[tw] OR psycho-metr*[tw] 
24  |  Chapter 2.1
 
OR predictive value*[tw]). We applied no search limits. The reference lists of the selected 
articles were checked and experts in the field of aphasia research were contacted to detect 
additional published studies. The initial search was carried out in March 2012 and updated in 
May 2015 with a search in PubMed. 
 
Selection of studies 
Eligible for inclusion were full-text articles, written in Dutch, English, French, German or 
Spanish, on cohort or cross-sectional studies of stroke patients who underwent a screening 
test to detect aphasia. A screening test was defined as a diagnostic test designed to assess 
presence and/or severity of aphasia, requiring a short turnaround time that is at most 15 
minutes. Studies evaluating patients with aphasia due to other causes than stroke or with an 
unspecified etiology were not included. We also excluded studies in which test scores of 
aphasic stroke patients were compared with those from healthy controls instead of stroke 
patients without aphasia, as we specifically aimed to evaluate screening tests suitable for 
use in clinical practice.  
Articles had to report the results of the screening test for aphasia as well as those from a 
reference test or gold standard. Data should be described in such a way that sensitivity and 
specificity of the screening test could be calculated. If sensitivity and specificity were given 
without reporting the original data the authors of the paper were contacted. In case authors 
were not able to provide the requested data the study was excluded from this review.  
First, titles and abstracts of the retrieved studies were checked and obviously irrelevant 
articles were excluded. If a decision could not be made based on the information in the title 
and abstract, then the full-text article was checked for the above mentioned in- and 
exclusion criteria.   
 
Data extraction  
From the selected studies we recorded clinical characteristics of the patient sample (age, 
sex, stroke type, number of patients with and without aphasia). The following features of the 
validation method were collected: consecutiveness of patient inclusion, the type of 
reference test that was used, and blinding of the test assessors. All estimates of test 
accuracy reported in the studies had to be based on exact numbers of patients and were 
recalculated in order to check for errors and non-verification (that is whether only patients 
who could be assessed with the reference as well as with the screening test were included 
and reported which indicates selection bias). We collected the following data on the 
screening tests: the language in which the validation study was conducted, subtests, score 
range, time needed for administration, type of patients for which the test was initially 
developed, and reported suitability for bedside use. 
 
Data analysis 
We expressed the results of the validation studies of each screening test in 2x2 tables and 
estimated the sensitivity, specificity, likelihood ratio of a positive test (LR+), and the 
likelihood ratio of a negative test (LR-). Sensitivity was estimated by the number of aphasic 
patients who were correctly classified with the screening test divided by the total number of 
patients with aphasia. Specificity was estimated by the number of patients without aphasia 
who were correctly classified divided by the total number of patients without aphasia. LR+ 
was estimated by the sensitivity divided by 1-specificity. LR- was estimated by dividing 1-
 
sensitivity by the specificity.8 The diagnostic odds ratio (DOR) was used as a single measure 
of test accuracy and was calculated by dividing the LR+ by the LR-.9 
We evaluated the methodological quality of the selected studies by scoring three items: 
consecutiveness of patient inclusion, representativeness of the patient sample, and blinding. 
Consecutive patient inclusion is essential to eliminate selection bias and to ensure that the 
full range of aphasia types and severities is represented in the patient sample. Furthermore, 
the patient sample should be representative for the general stroke population, since this is 
the population in which the screening test will be used. Blinding is of importance to minimize 
expectation bias. The assessor of the screening test should not be aware of the results of the 
reference test, and vice versa.8  
The score assigned for the representativeness of the patient sample in the validation 
study was 0 = not representative or not reported, 1 = fairly representative or partially not 
reported, or 2 = very representative. This was based on the size of the cohort, available data 
on stroke type, and mean age and sex of the patient sample. Consecutiveness was scored as 
either 0 = no consecutive inclusion or consecutiveness not reported or 2 = consecutive 
inclusion of patients. The degree of blinding was rated as 0 = when assessment was not 
blinded or blinding was not reported on; 1 = in case of blinding for the screening test only, or 
blinding without further specification; or 2 = in case of blinding for both the reference and 
the screening test.  
Finally, we assigned a score for the risk of bias based on the three above mentioned 
items. A total score of ≤2 was classified as high risk of bias, a total score of 3 or 4 as 
intermediate risk of bias, and a total score of ≥5 as low risk of bias. 
  
RESULTS  
 
The electronic search resulted in 1004 records. We identified 13 additional articles after 
hand-searching the reference lists and another four by asking experts in the field. After 
screening all titles and abstracts, 956 records were excluded (Figure 1). Sixty-five full-text 
articles were assessed for eligibility, of which 14 were selected. There were no articles 
excluded because of the administration time of the test. In three articles the sensitivity and 
specificity were reported, but the exact numbers of evaluated patients were lacking. After 
contacting the publication authors we retrieved the data for one of these papers. The other 
two studies were excluded as the requested data were not available.10, 11 One article 
reported on the aphasia item of the Scandinavian Stroke Scale (SSS). This study did not meet 
the inclusion criteria, since the SSS is a post-hoc scoring system and not a screening test. 
Eventually we included 11 articles, including one review.12 In total, eight screening tests for 
aphasia were evaluated. 
 
Included studies  
Table 1 shows the characteristics of the patient samples of the ten included validation 
studies (the table does not contain the review article12) ordered alphabetically by screening 
test. One paper reported on the validation of two screening tests13, a full version and a short 
version of the same test, and two tests were evaluated in more than one study.13-18 Sample 
sizes ranged from 3719 to 19416 patients. Only two studies provided details concerning the 
type of stroke (i.e. ischemic versus hemorrhagic).18, 20 In two papers information on age and 
sex of the patient sample was lacking,14, 15 and another three evaluated a rather young 
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OR predictive value*[tw]). We applied no search limits. The reference lists of the selected 
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presence and/or severity of aphasia, requiring a short turnaround time that is at most 15 
minutes. Studies evaluating patients with aphasia due to other causes than stroke or with an 
unspecified etiology were not included. We also excluded studies in which test scores of 
aphasic stroke patients were compared with those from healthy controls instead of stroke 
patients without aphasia, as we specifically aimed to evaluate screening tests suitable for 
use in clinical practice.  
Articles had to report the results of the screening test for aphasia as well as those from a 
reference test or gold standard. Data should be described in such a way that sensitivity and 
specificity of the screening test could be calculated. If sensitivity and specificity were given 
without reporting the original data the authors of the paper were contacted. In case authors 
were not able to provide the requested data the study was excluded from this review.  
First, titles and abstracts of the retrieved studies were checked and obviously irrelevant 
articles were excluded. If a decision could not be made based on the information in the title 
and abstract, then the full-text article was checked for the above mentioned in- and 
exclusion criteria.   
 
Data extraction  
From the selected studies we recorded clinical characteristics of the patient sample (age, 
sex, stroke type, number of patients with and without aphasia). The following features of the 
validation method were collected: consecutiveness of patient inclusion, the type of 
reference test that was used, and blinding of the test assessors. All estimates of test 
accuracy reported in the studies had to be based on exact numbers of patients and were 
recalculated in order to check for errors and non-verification (that is whether only patients 
who could be assessed with the reference as well as with the screening test were included 
and reported which indicates selection bias). We collected the following data on the 
screening tests: the language in which the validation study was conducted, subtests, score 
range, time needed for administration, type of patients for which the test was initially 
developed, and reported suitability for bedside use. 
 
Data analysis 
We expressed the results of the validation studies of each screening test in 2x2 tables and 
estimated the sensitivity, specificity, likelihood ratio of a positive test (LR+), and the 
likelihood ratio of a negative test (LR-). Sensitivity was estimated by the number of aphasic 
patients who were correctly classified with the screening test divided by the total number of 
patients with aphasia. Specificity was estimated by the number of patients without aphasia 
who were correctly classified divided by the total number of patients without aphasia. LR+ 
was estimated by the sensitivity divided by 1-specificity. LR- was estimated by dividing 1-
 
sensitivity by the specificity.8 The diagnostic odds ratio (DOR) was used as a single measure 
of test accuracy and was calculated by dividing the LR+ by the LR-.9 
We evaluated the methodological quality of the selected studies by scoring three items: 
consecutiveness of patient inclusion, representativeness of the patient sample, and blinding. 
Consecutive patient inclusion is essential to eliminate selection bias and to ensure that the 
full range of aphasia types and severities is represented in the patient sample. Furthermore, 
the patient sample should be representative for the general stroke population, since this is 
the population in which the screening test will be used. Blinding is of importance to minimize 
expectation bias. The assessor of the screening test should not be aware of the results of the 
reference test, and vice versa.8  
The score assigned for the representativeness of the patient sample in the validation 
study was 0 = not representative or not reported, 1 = fairly representative or partially not 
reported, or 2 = very representative. This was based on the size of the cohort, available data 
on stroke type, and mean age and sex of the patient sample. Consecutiveness was scored as 
either 0 = no consecutive inclusion or consecutiveness not reported or 2 = consecutive 
inclusion of patients. The degree of blinding was rated as 0 = when assessment was not 
blinded or blinding was not reported on; 1 = in case of blinding for the screening test only, or 
blinding without further specification; or 2 = in case of blinding for both the reference and 
the screening test.  
Finally, we assigned a score for the risk of bias based on the three above mentioned 
items. A total score of ≤2 was classified as high risk of bias, a total score of 3 or 4 as 
intermediate risk of bias, and a total score of ≥5 as low risk of bias. 
  
RESULTS  
 
The electronic search resulted in 1004 records. We identified 13 additional articles after 
hand-searching the reference lists and another four by asking experts in the field. After 
screening all titles and abstracts, 956 records were excluded (Figure 1). Sixty-five full-text 
articles were assessed for eligibility, of which 14 were selected. There were no articles 
excluded because of the administration time of the test. In three articles the sensitivity and 
specificity were reported, but the exact numbers of evaluated patients were lacking. After 
contacting the publication authors we retrieved the data for one of these papers. The other 
two studies were excluded as the requested data were not available.10, 11 One article 
reported on the aphasia item of the Scandinavian Stroke Scale (SSS). This study did not meet 
the inclusion criteria, since the SSS is a post-hoc scoring system and not a screening test. 
Eventually we included 11 articles, including one review.12 In total, eight screening tests for 
aphasia were evaluated. 
 
Included studies  
Table 1 shows the characteristics of the patient samples of the ten included validation 
studies (the table does not contain the review article12) ordered alphabetically by screening 
test. One paper reported on the validation of two screening tests13, a full version and a short 
version of the same test, and two tests were evaluated in more than one study.13-18 Sample 
sizes ranged from 3719 to 19416 patients. Only two studies provided details concerning the 
type of stroke (i.e. ischemic versus hemorrhagic).18, 20 In two papers information on age and 
sex of the patient sample was lacking,14, 15 and another three evaluated a rather young 
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cohort (i.e. mean age of 5413, 18 and 5517 years). In one study, the screening test was 
validated in the chronic stage,17 and in three studies the time since stroke onset was not 
reported.13, 21, 22 
 
Table 1. Characteristics of the study cohorts of the validation studies 
Study Screening 
test 
n Stroke type 
(n/n) 
Mean age 
(years)  
Male sex  
n (%)  
Time since 
onset (days) 
Al-Khawaja, 199613 FAST 50 n.r. 54 32 (64%) n.r. 
Enderby, 198714 FAST 50 n.r. n.r. n.r. 1-36 
O’Neill, 199015 FAST 54 n.r. n.r. n.r. 1 
Flamand-Roze, 201121 LAST 102 n.r. 62 52 (51%) n.r. 
Choi, 201518 MAST* 60 41/19 54 47(78%) 2-8 
Kostalova, 200816 MAST 194 n.r. 68/71 97 (50%) 1-46 
Romero, 201117 MAST 58 10/19 55 32 (55%) 277 
Doesborgh, 200320 ScreeLing 63 54/9 62 43 (68%) 2-11 
Al-Khawaja, 199613 SST 50 n.r. 54 32 (64%) n.r. 
Kim, 201122 SVF 53 27/n.r. 66 36 (68%) n.r. 
Thommessen, 199919 UAS 37 n.r. 76 15 (41%) 3-8 
Abbreviations: n = number; FAST = Frenchay Aphasia Screening Test; LAST = Language Screening Test; MAST*= 
Mobile Aphasia Screening Test; MAST = Mississippi Aphasia Screening Test; SST = Sheffield Screening Test for 
Acquired Language Disorders; SVF = Semantic Verbal Fluency; UAS = Ullevaal Aphasia Screening Test; n.r. = not 
reported.  
 n (ischemic stroke) / n (hemorrhagic stroke);  8 patients with traumatic brain injury were included in the 
study;  median, subjects with aphasia/controls with right hemisphere stroke;  mean. 
 
Screening tests included in the review 
We included validation studies for nine screening tools: the full and the short version of the 
Frenchay Aphasia Screening Test (FAST),13-15 Language Screening Test (LAST),21 Mississippi 
Aphasia Screening Test (MAST),16, 17, 23 the mobile aphasia screening test (also abbreviated as 
MAST),18 ScreeLing,20 Sheffield Screening Test for Acquired Language Disorders (SST),13 
Semantic Verbal Fluency (SVF),22 and Ullevaal Aphasia Screening test (UAS).19 Characteristics 
of the screening tests, including language, subtests, score range, administration time, type of 
patients the test was originally designed for, and applicability as a bedside screening tool are 
given in Table 2. Two of the validation studies were conducted in English, two were 
conducted in Korean, one in Norwegian, one in French, one in Czech, one in Spanish and one 
in Dutch.13-15, 23, 24 All tests can be administered within 15 minutes and most of them are 
judged to be suitable for bedside use. The SVF was originally designed for patients with 
dementia.22, 24 The SST and the MAST were not developed specifically for stroke patients, but 
to assess language deficits in general.13, 23 The mobile aphasia screening test is a tablet 
application based on the Korean version of the FAST and explicitly designed with no tool 
requirements so to be used for patients in remote locations easily.18 
 
Figure 1. Flowchart of the search results 
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Methodological quality of the validation studies 
Table 3 provides information on methodological features for each validation study, including 
reference test used, test assessors and blinding of test assessors, and consecutiveness of 
patient inclusion. In more than half of the studies, patients were not included 
consecutively;13, 16-18, 21, 22 and for one study this information was missing.14 The diagnostic 
test that was applied as the gold standard varied from an informal evaluation by an SL-
therapist to extensive aphasia test batteries. In most studies, the reference diagnosis was 
made by an SL-therapist,13-16, 19 in two studies this information was not reported,21, 22 or not 
exactly specified.17 The screening tests were carried out by various disciplines. Most studies 
did not provide information on the time interval between the assessment of the reference 
test and the screening test,13-15, 20-22 as was the case with respect to the order in which the 
assessments were conducted.13, 14, 16, 17, 22 
One study lacked blinding,17 in one study blinding was reported to be secured, but it was 
not specified how,21 and seven studies did not describe whether or not test assessors were 
blinded.13-16, 18, 22 Three studies reported on cut-off scores for the screening test indicating 
presence or absence of aphasia that were stratified for age,13, 16, 18 and in one study no cut-
off score was reported.19 In three studies the cut-off value for the screening test was based 
on previous studies comparing subjects with aphasia and healthy controls.13, 15, 16  
Table 4 shows the diagnostic properties of the identified aphasia screening tests 
(sensitivity, specificity, LR+, LR-, and DOR). In all studies, each patient was reported to be 
assessed with the reference test as well as with the screening test. Four studies included a 
larger group of patients with aphasia than without aphasia,13, 16, 21, 22 and two included 
groups of equal sample size.17, 18 In five studies the DOR was infinite, because either LR- was 
nil or LR+ was infinite.13, 14, 17, 21  
In Table 5 the estimated degree of bias is given based on scores for blinding of test 
assessors, consecutiveness of inclusion, and representativeness of the patient sample. Seven 
studies were judged as having a high risk of bias, two as having an intermediate risk of bias, 
and in one study the risk of bias was judged low. Four screening tools seemed to perform 
very good (Table 4), with sensitivity and specificity of 100% and 90% respectively (short 
version of FAST14), 98% and 100% (LAST21), 86% and 96% (ScreeLing20), and 90% and 100% in 
one (MAST17) and 96% and 89% in another study (MAST16). However, the validation studies 
for the FAST short version and both validation studies for the MAST were considered as 
having a high risk of bias. Of the three studies with an intermediate or low risk of bias, the 
calculated DOR was highest for the LAST21 and Screeling20.  
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Methodological quality of the validation studies 
Table 3 provides information on methodological features for each validation study, including 
reference test used, test assessors and blinding of test assessors, and consecutiveness of 
patient inclusion. In more than half of the studies, patients were not included 
consecutively;13, 16-18, 21, 22 and for one study this information was missing.14 The diagnostic 
test that was applied as the gold standard varied from an informal evaluation by an SL-
therapist to extensive aphasia test batteries. In most studies, the reference diagnosis was 
made by an SL-therapist,13-16, 19 in two studies this information was not reported,21, 22 or not 
exactly specified.17 The screening tests were carried out by various disciplines. Most studies 
did not provide information on the time interval between the assessment of the reference 
test and the screening test,13-15, 20-22 as was the case with respect to the order in which the 
assessments were conducted.13, 14, 16, 17, 22 
One study lacked blinding,17 in one study blinding was reported to be secured, but it was 
not specified how,21 and seven studies did not describe whether or not test assessors were 
blinded.13-16, 18, 22 Three studies reported on cut-off scores for the screening test indicating 
presence or absence of aphasia that were stratified for age,13, 16, 18 and in one study no cut-
off score was reported.19 In three studies the cut-off value for the screening test was based 
on previous studies comparing subjects with aphasia and healthy controls.13, 15, 16  
Table 4 shows the diagnostic properties of the identified aphasia screening tests 
(sensitivity, specificity, LR+, LR-, and DOR). In all studies, each patient was reported to be 
assessed with the reference test as well as with the screening test. Four studies included a 
larger group of patients with aphasia than without aphasia,13, 16, 21, 22 and two included 
groups of equal sample size.17, 18 In five studies the DOR was infinite, because either LR- was 
nil or LR+ was infinite.13, 14, 17, 21  
In Table 5 the estimated degree of bias is given based on scores for blinding of test 
assessors, consecutiveness of inclusion, and representativeness of the patient sample. Seven 
studies were judged as having a high risk of bias, two as having an intermediate risk of bias, 
and in one study the risk of bias was judged low. Four screening tools seemed to perform 
very good (Table 4), with sensitivity and specificity of 100% and 90% respectively (short 
version of FAST14), 98% and 100% (LAST21), 86% and 96% (ScreeLing20), and 90% and 100% in 
one (MAST17) and 96% and 89% in another study (MAST16). However, the validation studies 
for the FAST short version and both validation studies for the MAST were considered as 
having a high risk of bias. Of the three studies with an intermediate or low risk of bias, the 
calculated DOR was highest for the LAST21 and Screeling20.  
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Table 5. Risk of bias in evaluated validation studies  
Study Screening 
test 
Score for 
blinding 
Score for 
consec. 
Score for 
repres. 
Risk of bias 
Al-Khawaja, 199613 FAST 0 0 1 high 
Enderby, 198714 FAST 0 0 0 high 
O’Neill, 199015 FAST 0 2 0 high 
Flamand-Roze, 201121 LAST 1 0 2 intermediate 
Choi, 201518 MAST* 0 0 2 high 
Kostalova, 200816 MAST 0 0 2 high 
Romero, 201117 MAST 0 0 1 high 
Doesborgh, 200320 ScreeLing 2 2 2 low 
Al-Khawaja, 199613 SST 0 0 1 high 
Kim, 201122 SVF 0 0 2 high 
Thommessen, 199919 UAS 1 2 1 intermediate 
Abbreviations: consec. = consecutiveness; repres. = representativeness. 
 0 = assessment was not blinded or blinding was not reported on; 1 = blinding for the screening test only, or 
blinding without further specification; 2; blinding for both the reference and the screening test.  
 0 = no consecutive inclusion or consecutiveness not reported; 2 = consecutive inclusion of patients. 
 Based on the size of the cohort, available data on stroke type, and mean age and sex of the study population, 
0 = not representative or not reported; 1 = fairly representative or partially not reported; 2 = very 
representative.  
 Total score ≤2 = high, total score ≥3 and ≤4 = intermediate, total score ≥5 = low. 
 
DISCUSSION 
 
Given the impact of aphasia on quality of life, rehabilitation after stroke and the costs of 
stroke care, it is of great importance that aphasia in stroke patients is immediately 
recognized, allowing for adequate referral and treatment as soon as possible.25 Hence, it is 
crucial to have a brief and easy screening test for aphasia that may be administered by SL-
therapists as well as other health professionals shortly after aphasia onset and is also suited 
for ill stroke patients for whom an extensive test battery is too demanding. A simple 
screening tool for aphasia may also be of use for research purposes, in order to identify 
patients with aphasia in stroke trials.  
In this systematic review, we evaluated ten studies reporting on the validation of eight 
screening tests for aphasia after stroke, with emphasis on methodological quality of the 
validation study. Nearly all included screening tools usually reflect the approach taken in 
traditional aphasia test batteries that assess language modalities such as spontaneous 
speech, auditory and written comprehension, reading and writing in addition to naming and 
repetition, except the ScreeLing and the SVF. The ScreeLing comprises tasks directly aimed at 
the basic linguistic components (semantics, phonology and syntax). The SVF addresses 
semantic verbal fluency only. Although it is not always explicitly mentioned in the test 
descriptions, all tests are suitable to be administered at bedside, a requirement for the use 
in the acute stage.   
Several issues have to be taken into account when appraising studies that claim to 
validate a screening test against a reference test.8 Clearly, the patient sample of the 
 
 
validation study should be representative for the population in which the screening test will 
be applied. This means that a screening tool for aphasia due to stroke should be verified in a 
cohort representative for the general stroke population. For this reason we only included 
validation studies performed on stroke patients with and without aphasia, and excluded 
studies investigating test performance by examining aphasic stroke patients and healthy 
controls. We attempted to assign a score for representativeness to each included study 
based on the available information on patient characteristics. Unfortunately, data on age 
and sex of the patient sample were not reported for all studies. Furthermore, in more than 
half of the validation studies patients were not included consecutively, or this information 
was missing. Consecutive inclusion increases the likelihood that the full spectrum of aphasia 
severity is represented in the study cohort and minimizes the risk of selection bias. The 1:1 
ratio of patients with and without aphasia in some of the validation studies however 
suggests that patients were not recruited consecutively but rather selected.17, 18, 22 One study 
that reported consecutive inclusion only enrolled patients already suspected to have 
aphasia, resulting in a study cohort containing a majority (i.e. 90%) of stroke patients with 
aphasia.13 In all studies the number of non-verified patients was nil, which indicates that 
selection bias may have been present to some extent. It is possible that only patients who 
were able to undergo the screening test as well as the reference test were enrolled, while 
patients for whom the burden of the reference test (which is likely to be more time-
consuming and more difficult) was too high were not included. In addition, administration of 
the reference test should not be restricted to patients in whom the screening test was 
positive, in order to avoid workup bias. In each study included in this review, all patients 
were reported to be assessed both with the screening test and the test used as the gold 
standard.  
For many of the screening tools the cut-off value below or above which the test result is 
considered abnormal (i.e. the patient is diagnosed as having aphasia) was derived from 
studies performed in stroke patients with aphasia and healthy control subjects, while cut-off 
values based on a general stroke population are preferred. Finally, the assessor of the 
screening test should be blind for the result of the reference test and the other way around. 
Many of the evaluated studies did not report whether or not blinding was secured, making it 
difficult to estimate the risk of expectation bias. Altogether, most of the validation studies 
had serious methodological limitations, thus hampering firm conclusions about utility of the 
aphasia screening tools for clinical practice. 
Of the four studies with an intermediate or low risk of bias, the LAST21 and ScreeLing20 
seem to have the best diagnostic properties. An advantage of the LAST is the short 
administration time. The ScreeLing, a measure for the patients’ functioning in the main 
linguistic levels semantics, phonology and syntax, gives more detailed information for 
language treatment. It is notable that the SVF, a very short screening test that was initially 
developed for use in patients with dementia, also performs quite reasonably as a screening 
test for aphasia in stroke patients.22  
Besides the screening tools evaluated in this review, there are several well-known 
screening tests for aphasia that are widely used in clinical practice. For the Acute Aphasia 
Screening Protocol,26 the Aachen Aphasia Bedside Test,27 and the Bedside Western Aphasia 
Battery,28 strikingly we were unable to find any peer-reviewed articles in which these tests 
were validated in stroke patients with and without aphasia. The Token Test29 is one of the 
first recommended screening tests for the detection of aphasia in patients with neurological 
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aphasia screening tools for clinical practice. 
Of the four studies with an intermediate or low risk of bias, the LAST21 and ScreeLing20 
seem to have the best diagnostic properties. An advantage of the LAST is the short 
administration time. The ScreeLing, a measure for the patients’ functioning in the main 
linguistic levels semantics, phonology and syntax, gives more detailed information for 
language treatment. It is notable that the SVF, a very short screening test that was initially 
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Battery,28 strikingly we were unable to find any peer-reviewed articles in which these tests 
were validated in stroke patients with and without aphasia. The Token Test29 is one of the 
first recommended screening tests for the detection of aphasia in patients with neurological 
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damage and therefore exists in a lot of variations.30-32 However, although this test is 
generally considered very useful in clinical practice it could not be included because etiology 
of aphasia was too diverse or unspecified in the validation studies for this test. Finally, 
general stroke scales quantifying stroke severity in the acute stage contain specific subparts 
for speech and language, such as the NIH Stroke Scale (NIHSS),33 the Canadian Neurological 
Scale (CNS)34 and the European Stroke Scale (ESS)35. These standardized scales are often 
used in clinical practice to identify stroke patients with aphasia, but have not been 
systematically validated as such.   
 
CONCLUSION 
 
In conclusion, several screening tools for aphasia in stroke are available, but many tests have 
not been verified in a proper way. Future studies should focus on a better validation of the 
available aphasia screening tests in large stroke populations. The design should include a 
reliable reference diagnosis, a consecutive inclusion of stroke patients to make them 
representative of a general stroke population, a secured blinding of the assessments, details 
on the numbers of patients with and without aphasia correctly classified, and a good 
description of the subtests of the screening test, in order to eliminate the risk of bias as 
much as possible.    
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ABSTRACT 
 
Objective  
To investigate the effect of intra-arterial treatment (IAT) on early recovery from aphasia in 
acute ischemic stroke. We hypothesized that the early effect of IAT on aphasia is smaller 
than the effect on motor deficits.  
 
Methods  
We included patients with aphasia from the Multicenter Randomized Clinical Trial of 
Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN), in which 
500 patients with a proximal anterior circulation stroke were randomized to usual care plus 
IAT (<6 hours after stroke, mainly stent retrievers) or usual care alone. We estimated the 
effect of IAT on the shift on the NIH Stroke Scale (NIHSS) item language and the NIHSS item 
motor arm at 24 hours and one week after stroke with multivariable ordinal logistic 
regression as a common odds ratio, adjusted for prognostic variables (acOR). Differences 
between the effect of IAT on aphasia and on motor deficits were tested in a multilevel model 
with a multiplicative interaction term. 
 
Results  
Of the 288 patients with aphasia, 126 were assigned to IAT and 162 to usual care alone. The 
acOR for improvement of language score at 24 hours was 1.65 (95% confidence interval, CI: 
1.05 to 2.60), and at one week 1.86 (95% CI: 1.18 to 2.94). The acOR for improvement of 
motor deficit at 24 hours was 2.44 (95% CI: 1.54 to 3.88), and at one week 2.32 (95% CI: 1.43 
to 3.77). The effect of IAT on language deficits was significantly different from the effect on 
motor deficits at 24 hours and one week (p = 0.01 and p = 0.01). 
 
Conclusion  
IAT results in better early recovery from aphasia than usual care alone. The early effect of 
IAT on aphasia is smaller than the effect on motor deficits. This study provides Class II 
evidence that for patients with acute ischemic stroke IAT increases early recovery from 
aphasia and that the early effect on aphasia, as measured by the NIHSS, is smaller than the 
effect on motor deficits.  
 
 
INTRODUCTION 
  
Recently, several randomized clinical trials showed that intra-arterial treatment (IAT) with 
retrievable stents for patients with acute ischemic stroke (AIS) caused by a proximal 
intracranial occlusion in the anterior circulation is safe and improves functional outcome at 
90 days.1-5  
Aphasia is diagnosed in 15% to 40% of patients at ischemic stroke onset.6-11 Stroke 
patients with aphasia have increased mortality,7 decreased functional recovery,12 and 
reduced probability to return to work,13 and they have a higher risk of depression,8 
compared to those without aphasia.9 Clinical observations and previous studies suggest that 
language deficits in AIS do not respond as rapidly to reperfusion therapy as other neurologic 
deficits, especially upper limb paresis.14-16 To our knowledge, no study thus far has assessed 
the effect of IAT on aphasia. 
Our first aim was to determine whether usual care plus IAT would be more effective than 
usual care alone for the early recovery from aphasia in patients with AIS. The second aim 
was to evaluate whether the effect of IAT on early aphasia recovery differed from the effect 
on early motor deficit recovery. 
 
METHODS 
 
Study design 
For this study, we used data from the Multicenter Randomized Clinical Trial of Endovascular 
Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN),1 a randomized, 
pragmatic phase III, multicenter clinical trial with a Prospective Randomized Open Blinded 
Endpoint (PROBE) design,17 among 500 AIS patients with a proximal intracranial arterial 
occlusion of the anterior circulation. In this trial, usual care plus IAT (mainly with retrievable 
stents) was compared with usual care alone. Usual care in MR CLEAN could include 
intravenous administration of alteplase. The MR CLEAN study design has been described in 
detail elsewhere.18  
 
Participants 
Patient characteristics and intervention details for MR CLEAN have been extensively 
described previously.1 For this study, we selected all patients with aphasia at baseline, 
affirmed with a deficit on the item language (item 9) of the NIH Stroke Scale (NIHSS). 
Patients who were comatose at baseline (defined as a score of 3 on the item orientation, 
item 1A of the NIHSS) were excluded. 
 
Clinical and radiologic assessment 
All patients underwent clinical assessment at baseline, which included demographics, risk 
factors, medical history, pre-stroke modified Rankin Scale score (mRS), and NIHSS score. 
Assessment of the NIHSS score was repeated after 24 hours and at one week (range 5 to 7 
days) or discharge. Investigators were trained to conduct the NIHSS. The NIHSS consists of 
standardized items, with good interrater reliability.19, 20 The imaging committee evaluated 
the baseline vessel images (CT angiography, magnetic resonance angiography, or digital 
subtraction angiography) to ascertain the location of the occlusion. 
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Outcomes 
The first outcome was the score on the item language of the NIHSS at 24 hours and at one 
week. This item was scored by asking the patient to name items, perform a complex picture 
description task (cookie theft), and perform a repetition task, according to the NIHSS 
manual.21 Scores on the language item range from 0 to 3, with a score of 0 indicating no 
aphasia; 1 = mild to moderate aphasia; 2 = severe aphasia; and 3 = mute or global aphasia.  
To evaluate the difference with the effect of IAT on motor arm deficits, we used the 
NIHSS item motor arm at 24 hours and at one week. The item motor arm (item 5) was 
measured by determining motor arm strength contralateral to the affected hemisphere. The 
patient was asked to extend the arms 90° and hold this for ten seconds. Scores on this item 
range from 0 to 4, with a score of 0 indicating no drift; 1 = drift; 2 = some effort against 
gravity; 3 = no effort against gravity; and 4 = no movement. 
 
Statistical analyses 
Missing values for baseline variables that were used to adjust the regression models were 
imputed with mean or mode, as applicable. Single missing values of items on the NIHSS at 24 
hours and at one week were imputed by mode. The percentage of single imputed data was 
0.28%. There were no single missing values on the items language and motor arm at 24 
hours and at one week. Patients who died within seven days after stroke onset were given 
the worse score for missing values on the items language (score 3) and motor arm (score 4). 
Patients who were lost to follow-up because of early discharge and did not die within seven 
days after stroke onset were not included in the analyses. 
All analyses were based on the intention-to-treat principle. The primary effect estimate 
was the adjusted common odds ratio (acOR) for a shift in the direction of a better outcome 
on the item language. The acOR estimates the likelihood that IAT would lead to lower NIHSS 
scores, as compared with usual care alone (shift analysis).22 This ratio was estimated with 
multivariable ordinal logistic regression. Estimates were adjusted for age, stroke severity 
(total NIHSS score) at baseline, history of ischemic stroke, atrial fibrillation, diabetes mellitus, 
carotid top occlusion, and time from stroke onset to randomization. The acOR for the effect 
of IAT on the item motor arm was estimated similarly.  
In order to summarize the data, we plotted proportions of patients with good outcome 
at 24 hours and one week. Good outcome was defined, both for aphasia and for motor arm 
deficit, as a score of 0 or 1 on the NIHSS item. For further analyses, the total distribution of 
scores was used. 
To evaluate whether there is a differential effect of IAT on language versus motor arm 
recovery, two records per patient were created in the database, one with the language 
outcome and one with the motor arm outcome. We then fitted a multilevel model with a 
random intercept for patient, to account for the correlation within patients, and a 
multiplicative interaction between outcome type and treatment. Since common odds ratios 
were used, the scales with different ranges could be accurately compared, because they 
represent weighted averages of odds ratios for each possible dichotomization of the ordinal 
scale. This analysis was conducted with and without imputed data. 
The adjusted and unadjusted odds ratios are reported with 95% confidence intervals 
(95% CI) to indicate statistical precision. All analyses were performed using Stata/SE 
statistical package, version 13.1 (StataCorp, College Station, TX). 
 
 
 
Standard protocol approvals, registrations, and patient consents 
This study is a post-hoc study of MR CLEAN. The trial protocol has been approved by a 
central medical ethics committee and the research board of each participating center.18 MR 
CLEAN is registered in the Dutch trial register (NTR1804) and in the ISRCTN register 
(ISRCTN10888758). Written informed consent was obtained from all participants or their 
legal representatives before randomization. 
 
RESULTS 
 
Study population 
We identified 289 patients with a language score of >0 at baseline. One comatose patient 
was excluded. In total, 288 patients were selected for analyses, of whom 126 (44%) had 
been assigned to the intervention group and 162 (56%) to the control group. One patient 
received IAT after being assigned to the control group. IAT was never initiated in 12 patients 
(9.5%) assigned to the intervention group. Baseline characteristics were similar in the two 
treatment groups (Table 1). 
 
Imputation 
After 24 hours and one week, respectively, nine and 37 patients had died and were imputed 
with a maximum score of 3 on the item language and 4 on the item motor arm. Seven 
patients at 24 hours and 16 patients at one week were lost to follow-up and were not 
included in the analyses. 
 
Effect of IAT on language function  
There was a shift in the distribution of language scores in favor of IAT at both 24 hours and 
one week. The acORs for improvement were 1.65 at 24 hours (95% CI: 1.05 to 2.60) and 1.86 
at one week (95% CI: 1.18 to 2.94) (Table 2). The shift towards better outcomes in favor of 
the intervention was consistent for all categories of the item language (Figure 1). At 24 
hours, 13% of the patients in the intervention group had no aphasia versus 4% in the control 
group (acOR: 3.51, 95% CI: 1.28 to 9.67) and at one week these percentages were 21% 
versus 10% (acOR: 2.45, 95% CI: 1.17 to 5.10) (Table 2). 
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Table 1. Baseline characteristics of the study population  
Characteristics Intervention  
(n = 126) 
Control 
 (n = 162) 
Age in years, median (IQR)  65 (56-76) 66 (58-76) 
Male sex, n (%) 75 (60%) 105 (65%) 
Total NIHSS score, median (IQR) 20 (16-23) 21 (16-23) 
NIHSS score item language, n (%)   
    1 15 (12%) 13 (8%) 
    2 41 (33%) 54 (33%) 
    3 70 (56%) 95 (59%) 
NIHSS score item motor arm, n (%)   
    0 3 (2%) 4 (3%) 
    1 10 (8%) 14 (9%) 
    2 19 (15%) 14 (9%) 
    3 14 (11%) 24 (15%) 
    4 80 (64%) 106 (65%) 
Pre-stroke modified Rankin score, n (%)   
    0 104 (83%) 128 (79%) 
    1 10 (8%) 18 (11%) 
    2 8 (6%) 9 (6%) 
    >2 4 (3%) 7 (4%) 
History of ischemic stroke, n (%) 13 (10%) 17 (11%) 
Atrial fibrillation, n (%) 34 (27%) 51 (25%) 
Diabetes mellitus, n (%) 24 (19%) 20 (12%) 
Systolic blood pressure, mm Hg, mean (SD) 147 (28) 145 (23) 
Location of stroke in left hemisphere, n (%) 114 (91%) 148 (91%) 
Carotid top occlusion, n (%) 34 (27%) 43 (27%) 
Treatment with IV alteplase, n (%) 112 (89%) 142 (88%) 
Time from stroke onset to start of IV alteplase, min   
    Median (IQR) 94 (70-108) 100 (65-116) 
Time from stroke onset to randomization, min   
    Median (IQR) 208 (158-249) 212 (159-264) 
Time from stroke onset to IAT, min   
    Median (IQR) 266 (215-315) n.a. 
Abbreviations: n = number; IQR = interquartile range; n.a. = not applicable; NIHSS = NIH Stroke Scale; SD = 
standard deviation; IV = intravenous. 
 Scores on the NIHSS (a 15-item scale) range from 0 to 42, with higher scores indicating more severe 
neurologic deficits. 
 NIHSS score on the item motor arm was measured on the arm contralateral to the affected hemisphere. 
 Scores on the modified Rankin scale of functional disability range from 0: no symptoms to 6: death. A score of 
2 or less indicates functional independence. 
 
 
 
Table 2. Effect of IAT on language function 
Outcome Intervention Control Effect variable Unadjusted 
value  
[95% CI] 
Adjusted 
value  
[95% CI] 
NIHSS item language 
at 24 h 
n = 126 n = 155 Common odds 
ratio 
1.58  
[1.02 – 2.44] 
1.65  
[1.05 – 2.60] 
 Score of 0, n (%) 16 (13%) 6 (4%) Odds ratio 3.61  
[1.37 – 9.53]  
3.51  
[1.28 – 9.67] 
 Score of 0 to 1, n (%) 33 (26%) 28 (18%) Odds ratio 1.61  
[0.91 – 2.85] 
1.59  
[0.85 – 2.98] 
 Scores of 0 to 2, n (%) 76 (60%) 79 (51%) Odds ratio 1.46  
[0.91 – 2.35] 
1.54  
[0.92 – 2.59] 
NIHSS item language 
at 1 week 
n = 121 n = 151 Common odds 
ratio 
1.78  
[1.15 – 2.76] 
1.86  
[1.18 – 2.94] 
 Score of 0, n (%) 25 (21%) 15 (10%) Odds ratio 2.36  
[1.18 – 4.71] 
2.45  
[1.17 – 5.10] 
 Score of 0 to 1, n (%) 52 (43%) 41 (27%) Odds ratio 2.02  
[1.22 – 3.36] 
2.21  
[1.25 – 3.94] 
 Scores of 0 to 2, n (%) 81 (67%) 87 (58%) Odds ratio 1.49  
[0.91 – 2.45] 
1.55  
[0.89 – 2.70] 
Abbreviations: IAT = intra-arterial treatment; 95% CI = 95% confidence interval; n = number; NIHSS = NIH Stroke 
Scale. 
 The NIHSS score was not available for seven patients who were lost to follow-up at 24 hours and did not die 
within seven days after stroke. 
 The NIHSS score was not available for 16 patients who were lost to follow-up at one week and did not die 
within seven days after stroke. 
 
Prognosis of aphasia: Early effect of intra-arterial treatment |  47
3
 
 
Table 1. Baseline characteristics of the study population  
Characteristics Intervention  
(n = 126) 
Control 
 (n = 162) 
Age in years, median (IQR)  65 (56-76) 66 (58-76) 
Male sex, n (%) 75 (60%) 105 (65%) 
Total NIHSS score, median (IQR) 20 (16-23) 21 (16-23) 
NIHSS score item language, n (%)   
    1 15 (12%) 13 (8%) 
    2 41 (33%) 54 (33%) 
    3 70 (56%) 95 (59%) 
NIHSS score item motor arm, n (%)   
    0 3 (2%) 4 (3%) 
    1 10 (8%) 14 (9%) 
    2 19 (15%) 14 (9%) 
    3 14 (11%) 24 (15%) 
    4 80 (64%) 106 (65%) 
Pre-stroke modified Rankin score, n (%)   
    0 104 (83%) 128 (79%) 
    1 10 (8%) 18 (11%) 
    2 8 (6%) 9 (6%) 
    >2 4 (3%) 7 (4%) 
History of ischemic stroke, n (%) 13 (10%) 17 (11%) 
Atrial fibrillation, n (%) 34 (27%) 51 (25%) 
Diabetes mellitus, n (%) 24 (19%) 20 (12%) 
Systolic blood pressure, mm Hg, mean (SD) 147 (28) 145 (23) 
Location of stroke in left hemisphere, n (%) 114 (91%) 148 (91%) 
Carotid top occlusion, n (%) 34 (27%) 43 (27%) 
Treatment with IV alteplase, n (%) 112 (89%) 142 (88%) 
Time from stroke onset to start of IV alteplase, min   
    Median (IQR) 94 (70-108) 100 (65-116) 
Time from stroke onset to randomization, min   
    Median (IQR) 208 (158-249) 212 (159-264) 
Time from stroke onset to IAT, min   
    Median (IQR) 266 (215-315) n.a. 
Abbreviations: n = number; IQR = interquartile range; n.a. = not applicable; NIHSS = NIH Stroke Scale; SD = 
standard deviation; IV = intravenous. 
 Scores on the NIHSS (a 15-item scale) range from 0 to 42, with higher scores indicating more severe 
neurologic deficits. 
 NIHSS score on the item motor arm was measured on the arm contralateral to the affected hemisphere. 
 Scores on the modified Rankin scale of functional disability range from 0: no symptoms to 6: death. A score of 
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Table 2. Effect of IAT on language function 
Outcome Intervention Control Effect variable Unadjusted 
value  
[95% CI] 
Adjusted 
value  
[95% CI] 
NIHSS item language 
at 24 h 
n = 126 n = 155 Common odds 
ratio 
1.58  
[1.02 – 2.44] 
1.65  
[1.05 – 2.60] 
 Score of 0, n (%) 16 (13%) 6 (4%) Odds ratio 3.61  
[1.37 – 9.53]  
3.51  
[1.28 – 9.67] 
 Score of 0 to 1, n (%) 33 (26%) 28 (18%) Odds ratio 1.61  
[0.91 – 2.85] 
1.59  
[0.85 – 2.98] 
 Scores of 0 to 2, n (%) 76 (60%) 79 (51%) Odds ratio 1.46  
[0.91 – 2.35] 
1.54  
[0.92 – 2.59] 
NIHSS item language 
at 1 week 
n = 121 n = 151 Common odds 
ratio 
1.78  
[1.15 – 2.76] 
1.86  
[1.18 – 2.94] 
 Score of 0, n (%) 25 (21%) 15 (10%) Odds ratio 2.36  
[1.18 – 4.71] 
2.45  
[1.17 – 5.10] 
 Score of 0 to 1, n (%) 52 (43%) 41 (27%) Odds ratio 2.02  
[1.22 – 3.36] 
2.21  
[1.25 – 3.94] 
 Scores of 0 to 2, n (%) 81 (67%) 87 (58%) Odds ratio 1.49  
[0.91 – 2.45] 
1.55  
[0.89 – 2.70] 
Abbreviations: IAT = intra-arterial treatment; 95% CI = 95% confidence interval; n = number; NIHSS = NIH Stroke 
Scale. 
 The NIHSS score was not available for seven patients who were lost to follow-up at 24 hours and did not die 
within seven days after stroke. 
 The NIHSS score was not available for 16 patients who were lost to follow-up at one week and did not die 
within seven days after stroke. 
 
48  |  Chapter 3.1
 
 
Figure 1. Distribution of scores on the item language of the NIH Stroke Scale (NIHSS) in the intention-
to-treat population 
 
 
Distribution of scores on the item language of the NIHSS at 24 hours (A) and one week (B) after stroke. Scores 
range from 0 to 3. At 24 hours, 4% of the patients in the control group had a score of 0. 
 
 
 
Effect of IAT on aphasia versus motor arm deficits 
We visualized the effects of treatment by plotting proportions of patients with good 
outcome (score 0 or 1 on the items motor arm and language) at 24 hours and one week. At 
baseline, the proportions of patients with little or no language or motor deficits in the 
intervention group were similar. At 24 hours, more patients had a good outcome on the item 
motor arm than on the item language, but at one week these proportions were again equal 
(Figure 2).  
 
Figure 2. Good outcome scores of language and motor arm 
Proportions of patients with good outcome (score 0 or 1) on the item language and on the item motor arm at 
24 hours and at one week.  
Proportions displayed at day six are based on the NIH Stroke Scale (NIHSS) scores measured at five to seven 
days or discharge if earlier. 
 
We observed a shift in the distribution of all scores for the NIHSS item motor arm in favor 
of IAT. Figure 3 shows acORs for the language item and the motor arm item. At 24 hours, the 
acOR was 1.65 (95% CI: 1.05 to 2.60) for the item language and 2.44 (95% CI: 1.54 to 3.88) 
for the item motor arm, in favor of the intervention, meaning that chances of improvement 
of one or more points on the NIHSS are larger for motor function than for aphasia. The 
difference between these two ratios was statistically significant (p = 0.01). At one week after 
stroke, the acOR was 1.86 (95% CI: 1.18 to 2.94) for the item language and 2.32 (95% CI: 1.43 
to 3.77) for the item motor arm. This difference was also significant (p = 0.01). Treatment 
effects on the NIHSS item motor leg were similar (data not shown).  
 
Prognosis of aphasia: Early effect of intra-arterial treatment |  49
 
 
Figure 1. Distribution of scores on the item language of the NIH Stroke Scale (NIHSS) in the intention-
to-treat population 
 
 
Distribution of scores on the item language of the NIHSS at 24 hours (A) and one week (B) after stroke. Scores 
range from 0 to 3. At 24 hours, 4% of the patients in the control group had a score of 0. 
 
 
 
Effect of IAT on aphasia versus motor arm deficits 
We visualized the effects of treatment by plotting proportions of patients with good 
outcome (score 0 or 1 on the items motor arm and language) at 24 hours and one week. At 
baseline, the proportions of patients with little or no language or motor deficits in the 
intervention group were similar. At 24 hours, more patients had a good outcome on the item 
motor arm than on the item language, but at one week these proportions were again equal 
(Figure 2).  
 
Figure 2. Good outcome scores of language and motor arm 
Proportions of patients with good outcome (score 0 or 1) on the item language and on the item motor arm at 
24 hours and at one week.  
Proportions displayed at day six are based on the NIH Stroke Scale (NIHSS) scores measured at five to seven 
days or discharge if earlier. 
 
We observed a shift in the distribution of all scores for the NIHSS item motor arm in favor 
of IAT. Figure 3 shows acORs for the language item and the motor arm item. At 24 hours, the 
acOR was 1.65 (95% CI: 1.05 to 2.60) for the item language and 2.44 (95% CI: 1.54 to 3.88) 
for the item motor arm, in favor of the intervention, meaning that chances of improvement 
of one or more points on the NIHSS are larger for motor function than for aphasia. The 
difference between these two ratios was statistically significant (p = 0.01). At one week after 
stroke, the acOR was 1.86 (95% CI: 1.18 to 2.94) for the item language and 2.32 (95% CI: 1.43 
to 3.77) for the item motor arm. This difference was also significant (p = 0.01). Treatment 
effects on the NIHSS item motor leg were similar (data not shown).  
 
3
50  |  Chapter 3.1
 
 
Figure 3. Effect of IAT on aphasia versus motor arm deficits 
 
Adjusted common odds ratios for improvement, expressed by a shift on the overall categories of the items 
language and motor arm at 24 hours and at one week, between intervention and control group.  
Abbreviations: NIHSS = NIH Stroke Scale. 
 p-value for interaction between treatment and outcome (language or motor arm) at 24 hours.  
 p-value for interaction between treatment and outcome (language or motor arm) at one week.  
 
Repeated analyses without imputed data yielded slightly more significant differential 
effects (differential effect between scores on items language and motor arm at 24 hours: p = 
0.00, and at one week: p = 0.01). 
 
DISCUSSION 
 
This study shows that in patients with AIS caused by a proximal intracranial arterial occlusion 
of the anterior circulation, greater improvement of aphasia in the first week can be 
accomplished when IAT is added to usual care within six hours after stroke onset. Second, 
we showed that early recovery of aphasia was less than the early recovery of motor 
function. 
In the acute phase, rapid recovery can be attained within hours to days by rapid 
reperfusion of brain tissue.23 Subacute recovery follows and is thought to be primarily due to 
neural reorganization, which is complex and can take several weeks to months.23  
With the addition of IAT to usual care, recovery of aphasia is accelerated. This is 
important because aphasia can be severely socially disabling and can affect daily life 
 
 
tremendously.7-9, 12, 13 Faster recovery will also reduce the substantial costs associated with 
post-stroke care and communication rehabilitation. The 1-year cost of caring for stroke 
patients with aphasia was on average $1,700 more than the cost of caring for stroke patients 
without aphasia.24 
Visualizing proportions of patients with good outcome on language and motor items 
after IAT shows that the proportions with good outcome are divergent at 24 hours, but at 
one week these proportions are similar. However, analyzing the results by ordinal logistic 
regression, we found that the early effect of IAT on aphasia remains smaller than the effect 
on motor arm deficit both at 24 hours and at one week, taking into consideration all 
categories of deficit. Hence, although the outcome at one week is similar for language and 
motor functioning, the trajectory of recovery differs after IAT from usual care, which is most 
likely an effect of IAT.  
The effect of treatment with intravenous alteplase on early recovery from aphasia 
compared to other neurologic deficits has been examined previously, but treatment effects 
are difficult to compare as these studies present results from different time points and had 
no control group. In a study among 53 patients with an acute middle cerebral artery (MCA) 
stroke syndrome, aphasia recovered more slowly than limb motor deficit during treatment 
with tissue plasminogen activator (tPA).14 In another study in which NIHSS scores were 
measured 120 minutes after intravenous tPA treatment in 113 patients with MCA occlusion 
it was found that aphasia responded less than the other impairments.15 A retrospective 
cohort study among 243 patients showed a better recovery from other neurologic deficits 
than aphasia at 24 hours in patients with severe strokes.16 On the other hand, in another 
study, similar improvement of aphasia and limb motor deficit was found at 24 hours and one 
week after stroke in 109 patients who were mainly treated with intravenous thrombolysis.10 
This last study is difficult to compare with the other studies because of the use of composite 
NIHSS scores by combining the language item with items for cognitive functioning, which 
were not specifically designed to test language.  
There is a tight link between language and motor systems.25-27 The recovery of these two 
systems operates on similar principles,28 so theoretically, aphasia and motor arm deficit 
contralateral to the affected hemisphere would be expected to show the same recovery 
pattern. Clinical observations, however, suggest that language deficits in AIS do not respond 
as rapidly to IAT as motor deficits, which was confirmed by our findings. The most plausible 
explanation is that the recovery of language processing is more complex than the recovery 
of the measured motor functions.23 There is increasing evidence for a neural 
multifunctionality in the recovery from aphasia, i.e. an interaction between the neural 
networks engaged in linguistic and nonlinguistic cognitive and emotional functions.29 Further 
improvement of language deficits may require time and language therapy. It is reassuring, 
however, that the proportions of patients with good outcome are similar for motor and 
language deficits at one week after stroke.  
It is remarkable that 58% of the AIS patients in MR CLEAN (288 of 500) had aphasia, 
compared to 15% to 40% in earlier studies.6-11 A probable explanation is that only patients 
with a proven proximal occlusion were included in the present study, while in other studies 
imaging of intracranial vessels was not routinely performed, resulting in inclusion of patients 
with more distal occlusions. It is known that the more proximal the occlusion, the higher the 
risk of aphasia, especially in case of an occlusion of the MCA.10 
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While other studies have reported left lateralized language functioning in at least 96% of 
the individuals, in the present study only 91% of the aphasic patients had a stroke in the left 
hemisphere.23, 30 This implies an uncommonly high proportion of patients with crossed 
aphasia in our study. However, in the previously cited study among 109 aphasia patients, a 
similar percentage of patients with aphasia due to left hemisphere stroke of 94% was 
found.10 The authors ascribe this to the very early evaluation of their study, as crossed 
aphasia tends to recover more rapidly.31-35 In the current study, language deficits were also 
evaluated in an early stage. 
This study has several methodologic limitations. At first, randomization was slightly 
unbalanced for this post-hoc analysis, because of block size and multiple stratifications in MR 
CLEAN. This resulted in more patients in the control group than in the intervention group. 
Second, in our study the presence of pre-stroke aphasia and pre-stroke motor deficits 
were not documented. Although we could not rule out preexisting aphasia and motor 
deficits, the pre-stroke mRS score of 0 in 80% of the patients and the rate of 90% without 
previous stroke suggests that pre-stroke aphasia and pre-stroke motor deficits were not 
likely. Higher pre-stroke mRS scores were evenly distributed between the intervention and 
control group.  
Third, the follow-up time of at most seven days after stroke is relatively short to study 
recovery of neurologic deficits. However, in this first week great improvement of aphasia 
was observed, especially in patients who were treated with IAT. This therapy induces early 
reperfusion, occurring within the first hours after stroke. The first week after stroke already 
gives a good impression of the effect of IAT on the recovery from aphasia. Differences in 
functioning after this period can be also attributed to adaptation, learning, or rehabilitation, 
which obscures the effect of IAT on these changes. However, as the recovery from language 
deficits can be observed up to several weeks after stroke onset, it would have been 
worthwhile to extend the follow-up period in subsequent studies.36 
Finally, this study was not specifically designed to investigate and compare language and 
motor deficits as it is a post-hoc analysis of a randomized trial. The NIHSS provides a coarse 
categorization for aphasia severity with only four categories, designed to merely detect 
aphasia and roughly assess the severity. Nevertheless, NIHSS examination is proven to be 
reliable in the setting of acute stroke evaluation.19 The assessment of language and motor 
function is among the most reliable test items.20 In addition, more advanced tests are 
difficult to apply in the acute phase after stroke, because these tests are more time-
consuming. However, more specific research of treatment effect on different language 
modalities is needed. A well-known and validated screening tool that can be administered 
without special training is the Frenchay Aphasia Screening Test, measuring comprehension, 
expression, reading, and writing in only ten minutes.37 
Methodologic strengths of this study are the multicenter character, randomized 
treatment group assignments, and open-label treatment. The broad inclusion criteria led to 
a wide generalizability of our results. Research on the implementation of IAT is ongoing. 
Although the positive effect of IAT on functional outcome has been shown, the effects on 
specific domains are unknown. As yet, studies on aphasia recovery are scarce, so these 
results are fairly unique.  
 
 
 
CONCLUSION 
 
We found that IAT within six hours after stroke onset results in better early recovery from 
aphasia than usual care alone in patients with a proximal intracranial arterial occlusion of the 
anterior circulation. Our hypothesis that the very early effect of IAT on aphasia would be 
smaller than the effect on motor deficit was confirmed, supporting the notion that language, 
as a more complex function, recovers more slowly than motor function. 
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ABSTRACT 
 
Objective  
To externally validate the SPEAK model for the prediction of long-term outcome of aphasia 
caused by stroke.   
 
Methods  
We used data from RATS-3, a multicenter RCT with inclusion criteria similar to SPEAK, an 
observational prospective study. Baseline assessment in SPEAK was four days after stroke 
and in RATS-3 eight days. Outcome of the SPEAK model was the Aphasia Severity Rating 
Scale (ASRS) at 1 year, dichotomized into good (score of 4 or 5) and poor outcome (score <4). 
In RATS-3 ASRS scores at one year were not available, but we could use six month ASRS 
scores as outcome. Model performance was assessed with calibration and discrimination.  
 
Results  
We included 131 stroke patients with first-ever aphasia. At six months, 86 of 124 patients 
(68%) had a good outcome, whereas the model predicted 88%. Discrimination of the model 
was good with an AUC of 0.87 (95% CI: 0.81 to 0.94), but calibration was unsatisfactory. The 
model overestimated the probability of good outcome (calibration-in-the-large α = -1.98) 
and the effect of the predictors was weaker in the validation data than in the derivation data 
(calibration slope β = 0.88). We therefore recalibrated the model to correctly predict good 
outcome at six months.  
 
Conclusion  
After further external validation, the updated SPEAK model, SPEAK-6, may be used in daily 
practice to discriminate between stroke patients with good and patients with poor outcome 
of aphasia at six months after stroke. The original model, renamed SPEAK-12, needs further 
external validation. This study provides Class II evidence that the SPEAK model has good 
discriminative properties.  
 
 
 
INTRODUCTION 
 
Aphasia occurs in approximately 30% of stroke patients and has a strong impact on everyday 
communication and daily functioning.1, 2 Shortly after stroke, patients and their family are 
faced with major uncertainties regarding recovery of communication. Consequently, there is 
a need for individual estimation of the expected recovery. Adequate personal prognosis may 
also contribute to optimizing individual care, which is important as medical and paramedical 
care becomes increasingly personalized.3 Prediction of aphasia outcome in aphasia due to 
stroke is often based on models that consist of determinants identified in a single dataset, 
e.g. age, sex, aphasia severity and subtype; site, size and type of the lesion; vascular risk 
factors and stroke severity.4-11 Before a model can be used in daily practice, it should be 
externally validated.3, 12 This means that the generalizability of a model is assessed in 
different cohorts with more recent recruitment (temporal validation), from other institutions 
(geographical validation), and by different researchers.3 To our knowledge, none of the few 
available prognostic models predicting aphasia recovery has been externally validated.13-16   
Previously, our group has constructed a prognostic model for the outcome of aphasia 
due to stroke. The model was derived from the dataset of the Sequential Prognostic 
Evaluation of Aphasia after stroKe (SPEAK) study, and performed well.13 Aim of the current 
study was to externally validate the SPEAK model in an independent, yet comparable cohort 
of stroke patients with aphasia.  
 
METHODS 
 
The SPEAK model 
SPEAK was an observational prospective study in 147 patients with aphasia due to stroke 
conducted between 2007 and 2009 in the Netherlands.13 Demographic, stroke-related and 
linguistic characteristics of 130 participants, collected within six days after stroke, were used 
to construct a model predicting good aphasia outcome one year after stroke, defined by a 
score of 4 or 5 on the Aphasia Severity Rating Scale (ASRS) from the Boston Diagnostic 
Aphasia Examination.17 This scale is often used for rating communicative ability in (semi-) 
spontaneous speech. The ScreeLing, an aphasia screening test designed to assess the core 
linguistic components semantics, phonology and syntax in the acute phase after onset, was 
also used in the model.18-20 For detailed methods, results and discussion we refer to the 
original paper.13 The final SPEAK model contained six baseline variables: ScreeLing 
Phonology score, Barthel Index score, age, level of education (high/low), infarction with a 
cardio-embolic source (yes/no) and intracerebral hemorrhage (yes/no) (Box 1). This model 
explained 55.7% of the variance in the dataset. Internal validity of the model was good, with 
an AUC (area under the receiver operation characteristic (ROC) curve) of 0.89.13  
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Box 1. The SPEAK model 
  
Validation 
For external validation of the SPEAK model we used data from the Rotterdam Aphasia 
Therapy Study (RATS) – 3, a randomized controlled trial (RCT) studying the efficacy of early 
initiated intensive cognitive-linguistic treatment for aphasia due to stroke, conducted 
between 2012 and 2014.21, 22 RATS-3 was approved by an independent medical ethical 
review board. Details about the study design, methods and results have been reported 
elsewhere and a summary will be provided below.21, 22   
 
Participants and recruitment 
A total of 23 hospitals and 66 neurorehabilitation institutions across the Netherlands 
participated in RATS-3. The majority of participating institutions and local investigators (90%) 
differed from those involved in SPEAK. In- and exclusion criteria for both studies are 
presented in Table 1. 
 
 
P (ASRS = 4 or 5) = ey / (1 + ey) 
 
y = 2.04 + 0.27(Phonology score) + 0.10(Barthel score) – 0.06(age) – 0.76(education level) + 
0.27(cardio-embolic infarction) + 2.18(intracerebral hemorrhage)  
e = 2.718 (constant) 
 
Variables: 
Phonology Score: score on ScreeLing subpart Phonology (score range: 0-24) 
Barthel score:  score on Barthel Index (score range: 0-20) 
Age: age at stroke 
Educational level: high = 0 (junior high school or middle vocational education up to university), low 
= 1 (unfinished elementary school up to sophomore high school or lower vocational education) 
Cardio-embolic infarction: yes = 1, no = 0 
Intracerebral hemorrhage: yes = 1, no = 0  
    
 
 
 
 
Table 1. In- and exclusion criteria for participants in RATS-3 and in the SPEAK cohort 
 RATS-3 SPEAK 
Inclusion  First-ever aphasia due to stroke  First-ever aphasia due to stroke  
Aphasia ascertained by a speech and 
language therapist using the 36-item 
Token Test23 and a score <5 on the ASRS 
Aphasia ascertained by a neurologist and 
a speech and language therapist 
Testable with the ScreeLing A score below the cut-off point of the 
Token Test and/or the ScreeLing 
Within two weeks of stroke onset Within two to six days of stroke onset 
Age between 18 and 85 Adult 
Language near-native Dutch Language near-native Dutch  
A life expectancy of >six months  
Able to tolerate intensive treatment  
Exclusion A subarachnoid or subdural hemorrhage  
Success or feasibility of intensive 
language treatment was severely 
threatened by:  
 
 
Presence of one of the following criteria: 
  Severe dysarthria    Severe dysarthria 
  Premorbid dementia   Pre-stroke dementia (suspected or 
confirmed) 
  Illiteracy   Illiteracy 
  Severe developmental dyslexia   Developmental dyslexia  
  Severe visual perceptual disorders    Severe perceptual disorders of 
vision and hearing  
  Recent psychiatric history   Psychiatric history 
 
Prognostic variables 
Patients with aphasia due to stroke were included in RATS-3 within two weeks of stroke. At 
inclusion, the following baseline variables were recorded: age, sex, education level, stroke 
type (cerebral infarction or intracerebral hemorrhage) and ischemic stroke subtype (with or 
without a cardio-embolic source). Level of independence was estimated with the Barthel 
Index, a questionnaire containing ten items about activities of daily life.24 All participants 
were tested with the ScreeLing to detect potential deficits in the basic linguistic 
components.19, 25 Spontaneous speech samples were collected with semi-standardized 
interviews according to the Aachen Aphasia Test manual.26 Aphasia severity was assessed by 
scoring the spontaneous speech samples with the ASRS.  
 
Outcome 
In SPEAK, ASRS scores were used to assess aphasia outcome.17 This six-point scale is used to 
rate spontaneous speech and ranges from 0: “No usable speech or auditory comprehension” 
to 5: “Minimal discernible speech handicaps; the patient may have subjective difficulties 
which are not apparent to the listener”. The SPEAK model predicts the occurrence of ‘good 
outcome’, i.e. an ASRS score of 4 or 5 after one year. In RATS-3 follow-up was at four weeks, 
three and six months after randomization. ASRS scores from the RATS-3 cohort at six months 
after randomization were used as outcome in the analysis, as this was closest in time to the 
original model.  
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Statistical analyses 
Outcome in the RATS-3 cohort was divided in good (ASRS of 4 or 5) or poor (ASRS <4). To 
validate the SPEAK model we assessed discrimination and calibration.3, 12, 27-29 For both 
analyses predicted probability of a good outcome was calculated using the SPEAK model 
(Box 1).  
Discriminative properties of the model were summarized with the c index, similar to the 
AUC. Good discrimination means that the model is able to reliably distinguish patients with 
good aphasia outcome from those with poor outcome.  
We assessed the calibration properties of the model by studying to what extent the 
predicted probability of aphasia outcome corresponded with the observed outcome. To 
construct a calibration plot, we ordered the predicted probabilities of good aphasia outcome 
ascendingly and formed five equally large groups. Per group, the mean probability of a good 
outcome at six months was calculated, resulting in five predicted risk groups. Subsequently, 
in each risk group, proportions were calculated of participants with an observed good 
outcome. These proportions were plotted against the mean probability of a good outcome 
predicted by the SPEAK model. Outcomes of the linear predictor y, calculated with the SPEAK 
model, were used to fit a logistic regression model predicting the dichotomous outcome of 
good versus poor outcome to assess calibration-in-the-large and the calibration slope. If 
calibration of a model is optimal, the calibration-in-the-large α equals 0 and the calibration 
slope β equals 1. In case of insufficient calibration we will recalibrate the prognostic model 
by adjusting the intercept.        
 
Handling of missing data 
For participants with missing outcome scores at six months, scores at three months after 
randomization were used. If no scores were available at three months, patients were 
excluded. Missing data for the other variables were imputed using simple imputation: for 
binary and categorical variables the mode was imputed and means were used for continuous 
variables.    
  
RESULTS 
 
No outcome data at six months were available in 28 of 153 participants, and one participant 
was excluded because aphasia was later found to be caused by a brain tumor. Reasons for 
missing outcome data were death (n = 7), serious illness (n = 4), refusal (n = 16) and 
emigration abroad (n = 1). Of these 28 patients, 21 participants were excluded because 
outcome at three months was also not available. For 7 participants we used ASRS scores at 
three months to impute missing values at six months. Baseline data of patients in the 
validation sample (n = 131), as well as those from the SPEAK cohort (n = 147) are provided in 
Table 2. Groups differed slightly with respect to the baseline variables sex, level of 
education, type of stroke and aphasia severity.  
 
 
 
Table 2. Baseline model parameters of participants in the original SPEAK cohort and in RATS-3  
 SPEAK cohort (n = 147) 
Derivation cohort 
RATS-3 cohort (n = 131) 
Validation cohort 
Age in years, mean (SD)  67 (15) 65 (12) 
Female sex, n (%) 78 (53%) 56 (43%) 
Level of education, n (%)   
 High 55 (42%) 60 (46%) 
Low 74 (57%) 71 (54%) 
Unknown  2 (2%) 0  
Type of stroke, n (%)   
 Non-cardio-embolic infarction 84 (57%) 81 (62%) 
Cardio-embolic infarction 42 (29%) 23 (18%) 
Intracerebral hemorrhage 21 (14%) 24 (18%) 
Unknown 0 3 (2%) 
Time since onset to inclusion  
in days, mean (range)  
4 (2-6) 8 (1-18) 
Barthel Index, median (IQR)  15 (8-20) 16 (6-20) 
ScreeLing Phonology score,  
mean (SD)  
14 (6) 15 (6.5) 
ASRS scores at baseline, n (%)    
 Score 0 18 (12%) 17 (13%) 
Score 1 28 (19%) 21 (16%) 
Score 2 33 (22%) 28 (21%) 
Score 3 26 (18%) 38 (29%) 
Score 4 27 (18%) 27 (21%) 
Score 5 3 (2%) 0 
Missing 12 (8%) 0 
Abbreviations: n = number; SD = standard deviation; IQR = interquartile range; ASRS = Aphasia Severity Rating 
Scale.  
 High = senior vocational education, higher education or university.  
 Low = no/unfinished elementary school, elementary school, unfinished junior secondary vocational education 
or junior secondary vocational education. 
 ScreeLing Phonology scores range from 0 to 24. 
 Imputed scores used for analysis: level of education = low; type of stroke = non-cardio-embolic infarction; 
Barthel Index score (n = 14) = 13.  
 
In the derivation SPEAK cohort (n = 130), 11% of the patients had an ASRS score of 4 or 5 
at baseline (four days after stroke) and 78% had a good outcome after one year. In the RATS-
3 cohort we found a proportion of 21% with a score of 4 or 5 at baseline (eight days after 
inclusion) and 68% at six months. This is comparable to the 74% in SPEAK at six months. The 
course of ASRS scores in the RATS-3 and SPEAK cohort over time is presented in Figure 1.  
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Statistical analyses 
Outcome in the RATS-3 cohort was divided in good (ASRS of 4 or 5) or poor (ASRS <4). To 
validate the SPEAK model we assessed discrimination and calibration.3, 12, 27-29 For both 
analyses predicted probability of a good outcome was calculated using the SPEAK model 
(Box 1).  
Discriminative properties of the model were summarized with the c index, similar to the 
AUC. Good discrimination means that the model is able to reliably distinguish patients with 
good aphasia outcome from those with poor outcome.  
We assessed the calibration properties of the model by studying to what extent the 
predicted probability of aphasia outcome corresponded with the observed outcome. To 
construct a calibration plot, we ordered the predicted probabilities of good aphasia outcome 
ascendingly and formed five equally large groups. Per group, the mean probability of a good 
outcome at six months was calculated, resulting in five predicted risk groups. Subsequently, 
in each risk group, proportions were calculated of participants with an observed good 
outcome. These proportions were plotted against the mean probability of a good outcome 
predicted by the SPEAK model. Outcomes of the linear predictor y, calculated with the SPEAK 
model, were used to fit a logistic regression model predicting the dichotomous outcome of 
good versus poor outcome to assess calibration-in-the-large and the calibration slope. If 
calibration of a model is optimal, the calibration-in-the-large α equals 0 and the calibration 
slope β equals 1. In case of insufficient calibration we will recalibrate the prognostic model 
by adjusting the intercept.        
 
Handling of missing data 
For participants with missing outcome scores at six months, scores at three months after 
randomization were used. If no scores were available at three months, patients were 
excluded. Missing data for the other variables were imputed using simple imputation: for 
binary and categorical variables the mode was imputed and means were used for continuous 
variables.    
  
RESULTS 
 
No outcome data at six months were available in 28 of 153 participants, and one participant 
was excluded because aphasia was later found to be caused by a brain tumor. Reasons for 
missing outcome data were death (n = 7), serious illness (n = 4), refusal (n = 16) and 
emigration abroad (n = 1). Of these 28 patients, 21 participants were excluded because 
outcome at three months was also not available. For 7 participants we used ASRS scores at 
three months to impute missing values at six months. Baseline data of patients in the 
validation sample (n = 131), as well as those from the SPEAK cohort (n = 147) are provided in 
Table 2. Groups differed slightly with respect to the baseline variables sex, level of 
education, type of stroke and aphasia severity.  
 
 
 
Table 2. Baseline model parameters of participants in the original SPEAK cohort and in RATS-3  
 SPEAK cohort (n = 147) 
Derivation cohort 
RATS-3 cohort (n = 131) 
Validation cohort 
Age in years, mean (SD)  67 (15) 65 (12) 
Female sex, n (%) 78 (53%) 56 (43%) 
Level of education, n (%)   
 High 55 (42%) 60 (46%) 
Low 74 (57%) 71 (54%) 
Unknown  2 (2%) 0  
Type of stroke, n (%)   
 Non-cardio-embolic infarction 84 (57%) 81 (62%) 
Cardio-embolic infarction 42 (29%) 23 (18%) 
Intracerebral hemorrhage 21 (14%) 24 (18%) 
Unknown 0 3 (2%) 
Time since onset to inclusion  
in days, mean (range)  
4 (2-6) 8 (1-18) 
Barthel Index, median (IQR)  15 (8-20) 16 (6-20) 
ScreeLing Phonology score,  
mean (SD)  
14 (6) 15 (6.5) 
ASRS scores at baseline, n (%)    
 Score 0 18 (12%) 17 (13%) 
Score 1 28 (19%) 21 (16%) 
Score 2 33 (22%) 28 (21%) 
Score 3 26 (18%) 38 (29%) 
Score 4 27 (18%) 27 (21%) 
Score 5 3 (2%) 0 
Missing 12 (8%) 0 
Abbreviations: n = number; SD = standard deviation; IQR = interquartile range; ASRS = Aphasia Severity Rating 
Scale.  
 High = senior vocational education, higher education or university.  
 Low = no/unfinished elementary school, elementary school, unfinished junior secondary vocational education 
or junior secondary vocational education. 
 ScreeLing Phonology scores range from 0 to 24. 
 Imputed scores used for analysis: level of education = low; type of stroke = non-cardio-embolic infarction; 
Barthel Index score (n = 14) = 13.  
 
In the derivation SPEAK cohort (n = 130), 11% of the patients had an ASRS score of 4 or 5 
at baseline (four days after stroke) and 78% had a good outcome after one year. In the RATS-
3 cohort we found a proportion of 21% with a score of 4 or 5 at baseline (eight days after 
inclusion) and 68% at six months. This is comparable to the 74% in SPEAK at six months. The 
course of ASRS scores in the RATS-3 and SPEAK cohort over time is presented in Figure 1.  
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Figure 1. ASRS scores over time in SPEAK and RATS-3 
 
ASRS scores: 5 = minimal discernible speech handicap, some subjective difficulties that are not obvious to the 
listener; 4 = some obvious loss of fluency in speech or facility of comprehension, without significant limitation 
in ideas expressed or form of expression; 3 = able to discuss almost all everyday problems with little or no 
assistance, reduction of speech and/or comprehension; 2 = conversation about familiar topics is possible with 
help from the listener, there are frequent failures to convey an idea; 1 = all communication is through 
fragmentary expression, great need for inference, questioning and guessing by listener, limited information 
may be conveyed; 0 = no usable speech or auditory comprehension.    
 
Discrimination of the SPEAK model was good, with an AUC of 0.87 (95% confidence 
interval, 95% CI: 0.81 to 0.94). In Figure 2A, the grey line depicts calibration of a 
hypothetically perfect model and the 5 dots represent calibration values in the five 
subgroups of patients, ordered by increasing predicted probabilities and plotted against the 
actual proportions of good outcome. The mean predicted probability of good aphasia 
outcome at one year was 88%, while the observed percentage was 68%, but this was 
measured at six months. The SPEAK model was too optimistic in predicting good aphasia 
outcome, with calibration-in-the-large of α = -1.98. The calibration slope of β = 0.88 
indicated that the predictor effects were slightly weaker in the validation data than in the 
derivation data.  
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Figure 2. Calibration plots of the SPEAK model and updated SPEAK model with predicted probabilities 
and observed proportions of good aphasia outcome  
 
A. Calibration plot of the original SPEAK model, SPEAK-12  
B. Calibration plot of the updated SPEAK model, SPEAK-6 
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As Figure 1 shows that there is still improvement after six months, we assume that the 
poor calibration-in-the-large is at least partly due to the different timing of the outcome 
measurement; six months versus one year. Thus, we updated the SPEAK model to predict 
outcome at six months, instead of one year, by adapting the intercept (Box 2). After revising 
the SPEAK model, the calibration slope remained β = 0.88, but calibration-in-the-large 
improved considerably: α = -0.24 (Figure 2B). We suggest renaming the original SPEAK model 
predicting outcome at one year after stroke into SPEAK-12 and naming the updated model 
SPEAK-6. 
 
Box 2. The updated SPEAK model, SPEAK-6 
 
 
DISCUSSION  
 
We aimed to externally validate the published SPEAK model for the long-term prognosis of 
aphasia due to stroke using data from an independent cohort of stroke patients with 
aphasia, RATS-3. The SPEAK model performed very well in terms of discrimination. However, 
calibration was suboptimal, as it was overoptimistic in predicting good aphasia outcome, 
partly due to the difference in timing of the outcome which was one year in SPEAK and six 
months in RATS-3. Therefore, we proposed an updated version of the SPEAK model for the 
prediction of outcome at six months.  
Prognostic models are used in clinical practice to predict possible outcomes or risks of 
acquiring certain diseases. To our knowledge, apart from the SPEAK model, only three other 
models to predict recovery from aphasia due to stroke have been published.14-16 One logistic 
regression model predicting early clinical improvement in stroke patients with aphasia was 
constructed based on findings from CT-angiography and CT-perfusion.15 Clinical applicability 
of this model is limited, as these detailed CT-data are rarely available in daily practice. 
Another logistic regression model addressed the effect of speech and language therapy (SLT) 
on aphasia recovery.14 The authors found that the amount of SLT, added to baseline aphasia 
severity and baseline stroke disability significantly affected communication four to five 
weeks after stroke. Baseline variables were recorded within two weeks of stroke. Recently, a 
model was published predicting everyday communication ability (Amsterdam-Nijmegen 
Everyday Language Test; ANELT) at discharge from inpatient rehabilitation based on 
 
P (ASRS = 4 or 5) = ey / (1 + ey) 
 
y = 0.06 + 0.27(Phonology score) + 0.10(Barthel score) – 0.06(age) – 0.76(education level) + 
0.27(cardio-embolic infarction) + 2.18(intracerebral hemorrhage)  
e = 2.718 (constant) 
 
Variables: 
Phonology Score: score on ScreeLing subpart Phonology (score range: 0-24) 
Barthel score:  score on Barthel Index (score range: 0-20) 
Age: age at stroke 
Educational level: high = 0 (junior high school or middle vocational education up to university), low 
= 1 (unfinished elementary school up to sophomore high school or lower vocational education) 
Cardio-embolic infarction: yes = 1, no = 0 
Intracerebral hemorrhage: yes = 1, no = 0  
    
 
 
 
 
ScreeLing Phonology and ANELT scores at rehabilitation admission.16 These models predict 
outcome of aphasia recovery only in patients treated with SLT, but do not predict outcome 
before treatment is initiated. Furthermore, in both studies the cohort included only patients 
eligible for intensive treatment.  
In order for a prognostic model to be completely valid and reliable, it is important to 
evaluate the clinical applicability and generalizability of the model.30 Inclusion criteria in 
SPEAK and RATS-3 were not strict, so that both cohorts can be considered representative of 
acute stroke patients with aphasia in general. The SPEAK model is valuable for predicting 
aphasia outcome early after stroke in clinical practice, as it includes easily available baseline 
variables.13 It requires only the Barthel Index score and the ScreeLing Phonology score to be 
collected outside clinical routine. The Barthel Index is commonly assessed in the acute 
phase, allowing for application of this model without much effort.31  
Our study is the first to validate a model for the prognosis of aphasia outcome in an 
independent cohort. Determining whether a model generalizes well to patients other than 
those in the derivation cohort, is crucial for the application of that model in daily practice.12, 
27, 28, 30 We found that the SPEAK model is able to adequately distinguish stroke patients with 
aphasia who will recover well with respect to functional verbal communication from patients 
who will not. The model appears less accurate when it comes to the comparison of predicted 
and actual good outcome.  
A first possible explanation may be the different intervention in the two studies. In 
SPEAK, patients received usual care and researchers did not interfere with the treatment 
provided. In RATS-3, treatment was strictly regulated, as in this RCT patients were randomly 
allocated to four weeks of either intensive cognitive-linguistic treatment or no treatment, 
starting within two weeks after stroke. After this period both groups received usual care, as 
in SPEAK. In RATS-3 we found no effect of this early intervention and both intervention 
groups scored equally on all outcomes. Thus, we believe treatment does not explain the 
poor calibration.     
Second, there was a difference between SPEAK and RATS-3 with respect to the interval 
between stroke onset and inclusion of patients. In SPEAK, patients were included on average 
four days after onset and in RATS-3 after eight days. This seemingly small difference might in 
fact have caused substantial differences in the prognostic effect of the baseline ScreeLing 
and Barthel Index scores. Recovery can occur rapidly early after stroke, as was shown in the 
SPEAK cohort, with a statistically significant improvement on the ScreeLing Phonology score 
between the first and second week after stroke.32 Hence, these predictors might have 
different effects in the RATS-3 cohort, as represented in the suboptimal calibration slope.  
Third and most importantly, calibration may likely have been influenced by a different 
follow-up duration, which was six months in RATS-3 versus one year in SPEAK. In SPEAK, 
ASRS scores improved significantly up to six months after aphasia onset, but no significant 
improvement was found between six and twelve months.32 We used this finding for the 
design of the present study to justify the earlier time point for the outcome in RATS-3. 
Although in SPEAK no statistically significant improvement on the ASRS was found between 
six and twelve months after stroke, some improvement still occurred.32 Of the participants 
from SPEAK 74% had an ASRS score of 4 or 5 at six months after stroke, which is fairly similar 
in RATS-3 at that time point (68%). It is likely that calibration would have been better if the 
outcome was determined at twelve months in the RATS-3 cohort, because of the small, but 
apparent recovery between six and twelve months after stroke. We therefore suggest an 
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As Figure 1 shows that there is still improvement after six months, we assume that the 
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ScreeLing Phonology and ANELT scores at rehabilitation admission.16 These models predict 
outcome of aphasia recovery only in patients treated with SLT, but do not predict outcome 
before treatment is initiated. Furthermore, in both studies the cohort included only patients 
eligible for intensive treatment.  
In order for a prognostic model to be completely valid and reliable, it is important to 
evaluate the clinical applicability and generalizability of the model.30 Inclusion criteria in 
SPEAK and RATS-3 were not strict, so that both cohorts can be considered representative of 
acute stroke patients with aphasia in general. The SPEAK model is valuable for predicting 
aphasia outcome early after stroke in clinical practice, as it includes easily available baseline 
variables.13 It requires only the Barthel Index score and the ScreeLing Phonology score to be 
collected outside clinical routine. The Barthel Index is commonly assessed in the acute 
phase, allowing for application of this model without much effort.31  
Our study is the first to validate a model for the prognosis of aphasia outcome in an 
independent cohort. Determining whether a model generalizes well to patients other than 
those in the derivation cohort, is crucial for the application of that model in daily practice.12, 
27, 28, 30 We found that the SPEAK model is able to adequately distinguish stroke patients with 
aphasia who will recover well with respect to functional verbal communication from patients 
who will not. The model appears less accurate when it comes to the comparison of predicted 
and actual good outcome.  
A first possible explanation may be the different intervention in the two studies. In 
SPEAK, patients received usual care and researchers did not interfere with the treatment 
provided. In RATS-3, treatment was strictly regulated, as in this RCT patients were randomly 
allocated to four weeks of either intensive cognitive-linguistic treatment or no treatment, 
starting within two weeks after stroke. After this period both groups received usual care, as 
in SPEAK. In RATS-3 we found no effect of this early intervention and both intervention 
groups scored equally on all outcomes. Thus, we believe treatment does not explain the 
poor calibration.     
Second, there was a difference between SPEAK and RATS-3 with respect to the interval 
between stroke onset and inclusion of patients. In SPEAK, patients were included on average 
four days after onset and in RATS-3 after eight days. This seemingly small difference might in 
fact have caused substantial differences in the prognostic effect of the baseline ScreeLing 
and Barthel Index scores. Recovery can occur rapidly early after stroke, as was shown in the 
SPEAK cohort, with a statistically significant improvement on the ScreeLing Phonology score 
between the first and second week after stroke.32 Hence, these predictors might have 
different effects in the RATS-3 cohort, as represented in the suboptimal calibration slope.  
Third and most importantly, calibration may likely have been influenced by a different 
follow-up duration, which was six months in RATS-3 versus one year in SPEAK. In SPEAK, 
ASRS scores improved significantly up to six months after aphasia onset, but no significant 
improvement was found between six and twelve months.32 We used this finding for the 
design of the present study to justify the earlier time point for the outcome in RATS-3. 
Although in SPEAK no statistically significant improvement on the ASRS was found between 
six and twelve months after stroke, some improvement still occurred.32 Of the participants 
from SPEAK 74% had an ASRS score of 4 or 5 at six months after stroke, which is fairly similar 
in RATS-3 at that time point (68%). It is likely that calibration would have been better if the 
outcome was determined at twelve months in the RATS-3 cohort, because of the small, but 
apparent recovery between six and twelve months after stroke. We therefore suggest an 
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updated version, SPEAK-6, to predict outcome at six months. More extensive updating could 
imply refitting the models to the new dataset, to obtain new model coefficients. 33-35  
However, as the model discrimination was good, we updated only the intercept to make the 
model applicable to predict outcome at six months, when the average probability of a good 
outcome is lower than at one year. We recommend that the updated SPEAK-6 is validated in 
the future in new independent datasets.  
This study shows again that the external validity of prognostic models in new settings 
should always be carefully assessed. However, it should also be noticed that perfect 
calibration might in fact be impossible, as it implies that a model perfectly predicts outcome 
for all patients.36 
 
Strengths and limitations 
The major limitation of this validation study is the difference in time post onset at which 
predictor and outcome data were collected. Strength is that the RATS-3 and SPEAK cohorts 
are comparable, due to similar inclusion criteria. However, whereas participation in SPEAK 
merely involved periodic language evaluations, RATS-3 was an intervention trial, with either 
early intensive treatment or no early treatment. Due to these experimental interventions 
many patients refused participation. Also, selection criteria for RATS-3 were slightly stricter 
than in SPEAK regarding the potential to receive early intensive treatment. Consequently, 
the SPEAK and RATS-3 cohorts might represent slightly different populations of stroke 
patients with aphasia, albeit closely related.27 Therefore, as in all clinical trials, one must be 
careful in generalizing the results to all stroke patients with aphasia.37 
Although both the derivation cohort and the validation cohort consist of well over a 
hundred participants, sample sizes may be considered rather small for adequate 
modelling.29, 37 This is reflected in the slight imbalance of baseline characteristics between 
both study cohorts. This imbalance may underpin the necessity of larger sample sizes to 
better reflect the population of stroke patients with aphasia.      
A much debated issue is the potential lack of sensitivity of rating scales for analyses of 
spontaneous speech in aphasia.38 In the current study, we dichotomized outcome, further 
reducing sensitivity. It can be argued that the definition of “good outcome” with an ASRS of 
4 or 5 is somewhat optimistic. A score of 4, or sometimes even 5, does not imply full 
recovery. Patients with a score of 4 still experience difficulties with word finding or 
formulating thoughts into language. 
The ScreeLing is currently only available in Dutch, which severely limits the applicability 
of the prediction model. However, translation into other languages should not be very 
complicated as the ScreeLing Phonology subscale contains well-known tasks to measure 
phonological processing, e.g. repetition, discrimination of minimal pairs, and 
phoneme/grapheme conversion.20 
Finally, the RATS-3 database contained several missing values. Of the participants who 
refused evaluation at six months, three had fully recovered, which may have introduced a 
slight bias. Missing values for other variables in the model mostly resulted from 
inconsistencies in reporting the scores. We used generally accepted methods for imputation 
of the data and for most variables few data were missing (<5%).28 For the Barthel Index 10% 
had to be imputed, which is a fairly large proportion. There were no clear reasons for these 
missing values, other than clinicians sometimes just forgot to fill out the score form, which in 
our view justifies imputation.   
 
 
CONCLUSION 
 
The original SPEAK model, renamed SPEAK-12, performs well in predicting language recovery 
after one year in patients with aphasia due to stroke. As calibration was initially 
unsatisfactory, we propose an updated version of SPEAK-12 for the prediction of the 
probability of good language outcome at six months: SPEAK-6. Further external validation of 
SPEAK-12 and SPEAK-6 is recommended. Special attention should be given to timing, as time 
after stroke onset at which predictors and outcome data are collected appears crucial for 
adequate model validation. Our results show that SPEAK-6 may be used in daily practice to 
discriminate between stroke patients with good and patients with poor language recovery at 
six months after stroke. 
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updated version, SPEAK-6, to predict outcome at six months. More extensive updating could 
imply refitting the models to the new dataset, to obtain new model coefficients. 33-35  
However, as the model discrimination was good, we updated only the intercept to make the 
model applicable to predict outcome at six months, when the average probability of a good 
outcome is lower than at one year. We recommend that the updated SPEAK-6 is validated in 
the future in new independent datasets.  
This study shows again that the external validity of prognostic models in new settings 
should always be carefully assessed. However, it should also be noticed that perfect 
calibration might in fact be impossible, as it implies that a model perfectly predicts outcome 
for all patients.36 
 
Strengths and limitations 
The major limitation of this validation study is the difference in time post onset at which 
predictor and outcome data were collected. Strength is that the RATS-3 and SPEAK cohorts 
are comparable, due to similar inclusion criteria. However, whereas participation in SPEAK 
merely involved periodic language evaluations, RATS-3 was an intervention trial, with either 
early intensive treatment or no early treatment. Due to these experimental interventions 
many patients refused participation. Also, selection criteria for RATS-3 were slightly stricter 
than in SPEAK regarding the potential to receive early intensive treatment. Consequently, 
the SPEAK and RATS-3 cohorts might represent slightly different populations of stroke 
patients with aphasia, albeit closely related.27 Therefore, as in all clinical trials, one must be 
careful in generalizing the results to all stroke patients with aphasia.37 
Although both the derivation cohort and the validation cohort consist of well over a 
hundred participants, sample sizes may be considered rather small for adequate 
modelling.29, 37 This is reflected in the slight imbalance of baseline characteristics between 
both study cohorts. This imbalance may underpin the necessity of larger sample sizes to 
better reflect the population of stroke patients with aphasia.      
A much debated issue is the potential lack of sensitivity of rating scales for analyses of 
spontaneous speech in aphasia.38 In the current study, we dichotomized outcome, further 
reducing sensitivity. It can be argued that the definition of “good outcome” with an ASRS of 
4 or 5 is somewhat optimistic. A score of 4, or sometimes even 5, does not imply full 
recovery. Patients with a score of 4 still experience difficulties with word finding or 
formulating thoughts into language. 
The ScreeLing is currently only available in Dutch, which severely limits the applicability 
of the prediction model. However, translation into other languages should not be very 
complicated as the ScreeLing Phonology subscale contains well-known tasks to measure 
phonological processing, e.g. repetition, discrimination of minimal pairs, and 
phoneme/grapheme conversion.20 
Finally, the RATS-3 database contained several missing values. Of the participants who 
refused evaluation at six months, three had fully recovered, which may have introduced a 
slight bias. Missing values for other variables in the model mostly resulted from 
inconsistencies in reporting the scores. We used generally accepted methods for imputation 
of the data and for most variables few data were missing (<5%).28 For the Barthel Index 10% 
had to be imputed, which is a fairly large proportion. There were no clear reasons for these 
missing values, other than clinicians sometimes just forgot to fill out the score form, which in 
our view justifies imputation.   
 
 
CONCLUSION 
 
The original SPEAK model, renamed SPEAK-12, performs well in predicting language recovery 
after one year in patients with aphasia due to stroke. As calibration was initially 
unsatisfactory, we propose an updated version of SPEAK-12 for the prediction of the 
probability of good language outcome at six months: SPEAK-6. Further external validation of 
SPEAK-12 and SPEAK-6 is recommended. Special attention should be given to timing, as time 
after stroke onset at which predictors and outcome data are collected appears crucial for 
adequate model validation. Our results show that SPEAK-6 may be used in daily practice to 
discriminate between stroke patients with good and patients with poor language recovery at 
six months after stroke. 
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ABSTRACT  
 
Background 
Aphasia due to stroke affects communication and quality of life. Most stroke survivors with 
aphasia receive speech and language therapy. Although an early start of treatment is 
advocated in clinical practice, evidence for “The earlier, the better” in aphasia rehabilitation 
is weak.   
Hence, clinicians are faced with the dilemma when to initiate intensive treatment: as 
early as possible, when most of the spontaneous recovery occurs but when patients are 
often ill, or later, when the patients’ condition is more stabilized. 
 
Methods 
In this literature-based overview, we discuss whether aphasia outcome is affected by timing 
of treatment in relation to stroke onset and whether there is evidence for an optimal 
window of time during which language therapy should be provided. Findings from various 
rehabilitation research fields are discussed and combined to provide principles for future 
research.  
  
 
 
INTRODUCTION 
 
Approximately one-third of stroke patients have aphasia, a deficit potentially affecting all 
language modalities.1 People with aphasia (PWA) generally receive speech and language 
therapy (SLT) to enhance their communication. A recent large survey among stroke 
survivors, their caregivers and health professionals, placed treatment of aphasia as third in 
the top ten priorities in stroke research. This underlines the dramatic consequences of 
aphasia for communication and quality of life.2  
When studying the efficacy of SLT, many factors need to be taken into account, because 
SLT comprises many different therapeutic interventions and strategies, not all of which have 
been thoroughly studied.3 When to start SLT after stroke, i.e. timing of treatment, is an 
important clinical issue.  
In general, the field of stroke rehabilitation tends to promote early initiation of 
treatment.4-9 Well-known, often expert-based statements about rehabilitation advocate 
“The earlier, the better” and “Use it or lose it”. Supposedly, early therapy is more effective 
than treatment initiated at a later stage, because of the interaction between spontaneous 
and learning-dependent neural recovery processes.10, 11 However, there is no conclusive 
evidence supporting these notions.4, 12, 13  
Also for SLT, evidence supporting immediate treatment is weak, since as yet timing of 
treatment has received little attention in aphasia research. The authors of the latest 
Cochrane review are unable to draw any conclusion regarding optimal timing of SLT.1 They 
found a wide variation between stroke onset and initiation of treatment in trials, ranging 
from two days to 22 years, hampering comparison across studies. None of the trials directly 
studied the effect of timing on the efficacy of SLT by comparing early initiated treatment 
with later initiated treatment. In fact, the authors, as well as other experts in the field, call 
upon future researchers to study the effect of timing of aphasia treatment.1, 4, 14  
Hence, clinicians are faced with the dilemma whether they should provide treatment as 
soon as possible after stroke, or initiate therapy later. Some patients are physically weak 
immediately after stroke and the treating physician may consider SLT not feasible or even 
hazardous in this stage. Physicians have to take patient related factors into account, but are 
also faced with changing health care policy and budget cutbacks.  
We conducted a literature search in PubMed and Embase with the search terms: early, 
treatment, aphasia and stroke; and found no trials primarily studying the effect of timing of 
SLT for aphasia due to stroke on treatment efficacy in the acute stage. Hence, we aim to 
explore the evidence for current recommendations in clinical practice by summarizing what 
we do know about aphasia treatment in different stages after stroke and by using recovery 
models derived from neuroimaging studies, animal studies and studies on motor 
rehabilitation.  
 
What exactly do we mean by timing of post-stroke rehabilitation? Definitions of early 
and late stages in the recovery process of language. 
In order to evaluate the influence of timing of SLT on language recovery, agreement is 
required about the terminology used to describe stages of recovery after stroke. There is a 
difference between fields regarding the terms used to define stages in recovery from stroke. 
Clinicians often identify three stages: the acute, sub-acute and chronic stage, a distinction 
that seems to coincide with availability of rehabilitation resources. The acute stage is the 
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phase of hospitalization and the sub-acute phase the period of active rehabilitation after 
discharge from the hospital or acute stroke unit. The chronic stage is the final phase, when 
treatment intensity gradually diminishes and treatment is often focused on compensation, 
rather than restoration of function.4, 12, 15  
Authors reporting randomized controlled trials (RCT) on aphasia treatment use a variety 
of terms referring to different stages after stroke onset. These terms are usually related to 
phases in the rehabilitation process rather than changing neurophysiological processes. In an 
RCT on very early SLT, Laska et al. start therapy within two days after stroke,16, 17 whereas 
Bowen and colleagues define early as the first four months after stroke.14 Godecke et al. 
published on the efficacy of early initiated SLT, defining the very early phase as within two 
weeks after stroke and the early phase as the period from two to six weeks after stroke.18 
Commonly used terms in neuroimaging literature on aphasia recovery are the hyper-
acute, acute, sub-acute and chronic phase.19-25 There is a lack of consensus on the 
differentiation between stages and the duration of each of these phases. Some denominate 
the first hours after stroke as the acute stage, but others claim this phase lasts up to a week. 
The same holds for the outset of the chronic stage, which may be from two months up to 
more than six months after stroke.19, 20, 22, 24, 26, 27  
Despite this large variety and seemingly arbitrariness in using these different terms, 
there is a certain consensus on differentiating at least between an early or acute stage in 
which spontaneous recovery occurs and a late or chronic stage in which spontaneous 
recovery has virtually ceased. Based on the fact that several studies indicate that the first 
three months, and specifically the first six weeks, after stroke are the most dynamic period 
in the recovery process, we suggest using acute stage for the first three months after stroke 
and chronic stage for the period after three months.24, 25, 28-30   
 
What do we know about recovery processes in the language system of PWA? Evidence 
from neuroimaging studies. 
Continuously improving imaging techniques have increased our understanding of the brain, 
its functions and its response to acute focal damage occurring after stroke.24, 31, 32 Results 
from studies using fMRI, CT and PET-scans have shown that distinct stages can be recognized 
in the process of post-stroke language recovery.19-21, 33, 34  
fMRI studies support the existence of at least three phases.20, 21, 26 Immediately after 
stroke, not only functions of brain areas that are involved in the lesion are disrupted. 
Unaffected areas, functionally connected to the lesion, become dysfunctional as well, as a 
consequence of edema or reduced metabolism; a condition called diaschisis.19-21, 26 This may 
result in a general breakdown of the language system, often manifesting as global aphasia.  
In the next phase, diaschisis resolves and unaffected brain regions regain their function. 
In hours to days after stroke, vulnerable tissue of the penumbra (partly) recovers as a result 
of reperfusion.19, 21, 26 In this phase language activation is observed in preserved areas in the 
left hemisphere, but there may also be increased activation in homologue regions in the 
right hemisphere.19, 21, 34, 35 This latter activation might occur as a result of disinhibition of 
the right, non-dominant, hemisphere.35 If persistent, this might be interpreted as a, possibly 
maladaptive, compensation mechanism.26, 36 The size of the lesion likely plays a role in this 
activation shift, simply because in case of a large lesion in the left hemisphere there is not 
much tissue left to form a new language network.26 Until now it is unknown whether 
activation in the right hemisphere enhances or disturbs language processing.21 
 
 
The third phase is characterized by further reorganization of functional networks and 
compensation.26 Activation in this chronic stage is observed in unaffected areas in the left 
hemisphere, perilesional tissue and homologue regions in the right hemisphere. In this final 
phase, activation favorably might shift back to the left hemisphere.20, 21, 37 
Given these different phases, each with specific ongoing recovery processes, it is very 
likely that the efficacy of various therapeutic strategies will interact with these processes, 
and thus with the time elapsed after stroke.  
 
Does timing of SLT in post-stroke aphasia matter in relation to neural reorganization 
and language recovery? Hypotheses derived from observations of recovery processes. 
After a stroke, patients spontaneously learn new behavior as a result of natural adaptation 
to their impairments.38 Consequently, if PWA adapt to language deficits by using alternative 
language production strategies, such as telegraphic speech, remaining neural networks for 
language processing are less intensively triggered, causing ‘learned non-use’. This learned 
non-use may prompt new neural networks, so-called ‘experience-driven plasticity’, that 
function suboptimally compared to the original language network.38-40 To prevent these 
maladaptive processes from occurring, it seems crucial to start early with SLT.  
Generally spoken, SLT can be aimed at restoration of function or at compensation.41 
Restorative treatment focusses on regaining language processing by using the remaining 
linguistic network.40, 42 Compensational treatment is aimed at learning new verbal or 
nonverbal strategies to compensate for language deficits, for instance by integrating 
alternative methods of communication with residual language capacities.43  
It has been suggested that these two approaches should be timed differently after 
stroke, because they compete for available plasticity.23, 44 Code describes language recovery 
processes after stroke in a theoretical framework, taking into account different levels and 
stages of recovery as result of restoration and compensation.23 According to this framework, 
restorative treatment is specifically effective when spontaneous recovery takes place, i.e. 
when the neural network is able to restore. Impairment-based restorative treatment is 
directed at specific linguistic processes such as phonology, semantics or syntax. This 
supposedly triggers the premorbid, yet weakened, language network and prevents the 
formation of new networks at the cost of the original one.45 However, one may question 
whether it will ever be possible to restore such a complex system as the language system 
after stroke and whether the language system will ever function normally again.  
Only after true restoration has stabilized, compensational treatment should be applied, 
triggering plasticity or treatment induced reorganization to further enhance 
communication.23 Yet, this hypothesis was not confirmed by results from an RCT comparing 
six months of restorative cognitive-linguistic treatment to compensatory, communicative 
treatment, started within three weeks of stroke onset.41 The authors found no statistically 
significant difference in the recovery of functional communication between the two 
treatment types.  
Some widely applied principles for effective treatment, such as massed practice, 
behavioral relevance and focusing principles, are derived from ‘Hebbian learning’, based on 
the idea that “Cells that fire together, wire together”.39, 40, 46 Treatment intensity plays an 
important role in these principles. However, in the latest Cochrane review on efficacy of SLT 
in aphasia, the authors conclude that “The potential benefits of intensive SLT over 
conventional SLT were confounded by a significantly higher dropout from intensive SLT”. 
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phase of hospitalization and the sub-acute phase the period of active rehabilitation after 
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from neuroimaging studies. 
Continuously improving imaging techniques have increased our understanding of the brain, 
its functions and its response to acute focal damage occurring after stroke.24, 31, 32 Results 
from studies using fMRI, CT and PET-scans have shown that distinct stages can be recognized 
in the process of post-stroke language recovery.19-21, 33, 34  
fMRI studies support the existence of at least three phases.20, 21, 26 Immediately after 
stroke, not only functions of brain areas that are involved in the lesion are disrupted. 
Unaffected areas, functionally connected to the lesion, become dysfunctional as well, as a 
consequence of edema or reduced metabolism; a condition called diaschisis.19-21, 26 This may 
result in a general breakdown of the language system, often manifesting as global aphasia.  
In the next phase, diaschisis resolves and unaffected brain regions regain their function. 
In hours to days after stroke, vulnerable tissue of the penumbra (partly) recovers as a result 
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It has been suggested that these two approaches should be timed differently after 
stroke, because they compete for available plasticity.23, 44 Code describes language recovery 
processes after stroke in a theoretical framework, taking into account different levels and 
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restorative treatment is specifically effective when spontaneous recovery takes place, i.e. 
when the neural network is able to restore. Impairment-based restorative treatment is 
directed at specific linguistic processes such as phonology, semantics or syntax. This 
supposedly triggers the premorbid, yet weakened, language network and prevents the 
formation of new networks at the cost of the original one.45 However, one may question 
whether it will ever be possible to restore such a complex system as the language system 
after stroke and whether the language system will ever function normally again.  
Only after true restoration has stabilized, compensational treatment should be applied, 
triggering plasticity or treatment induced reorganization to further enhance 
communication.23 Yet, this hypothesis was not confirmed by results from an RCT comparing 
six months of restorative cognitive-linguistic treatment to compensatory, communicative 
treatment, started within three weeks of stroke onset.41 The authors found no statistically 
significant difference in the recovery of functional communication between the two 
treatment types.  
Some widely applied principles for effective treatment, such as massed practice, 
behavioral relevance and focusing principles, are derived from ‘Hebbian learning’, based on 
the idea that “Cells that fire together, wire together”.39, 40, 46 Treatment intensity plays an 
important role in these principles. However, in the latest Cochrane review on efficacy of SLT 
in aphasia, the authors conclude that “The potential benefits of intensive SLT over 
conventional SLT were confounded by a significantly higher dropout from intensive SLT”. 
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This raises questions about the feasibility of intensive SLT, especially shortly after aphasia 
onset.    
Language reorganization may occur in the dominant left hemisphere or in homologous 
regions in the right hemisphere.23, 25, 47, 48 The explanation for this recruitment of the non-
dominant hemisphere has been subject to debate; it occurs either as a result of ‘transcallosal 
disinhibition’, or language processing is incorporated by the right hemisphere, the so-called 
‘laterality-shift’.35 It has been argued that persistence of the spontaneously occurring 
increased activation of the right hemisphere shortly after stroke onset is suboptimal.19, 26, 35, 
36 Hence, the dominant hemisphere should be triggered, either through sensory or motor 
routes or by inhibition of the contralateral hemisphere.35, 37   
Several authors suggest that activating the left hemisphere is especially achieved by 
cognitive-linguistic treatment (CLT). CLT supposedly activates cortical networks involved in 
language processing, such as networks dedicated to phonology, semantics and syntax. 23, 49, 
50 Functional MRI-scans revealed that specific language tasks activate distinct parts and 
networks of the brain.20, 31 One may hypothesize that when metabolic demands increase 
through activation of cortical language areas, adjacent penumbral tissue will benefit, 
especially when circulation is already restored by reperfusion therapy.  
The penumbra in ischemic strokes comprises the region around the core lesion in which 
blood flow is decreased, but can still be revived if blood flow has not decreased more than 
90%, as was shown in animal studies.33 Several techniques have been used to increase blood 
flow to the penumbra to save brain tissue and support recovery in the acute stage of 
ischemic stroke, such as intravenous or intra-arterial thrombolysis or mechanical 
thrombectomy.33 The therapeutic window for reactivating the penumbra is yet unknown and 
it is unclear whether early SLT might save or rather damage penumbral tissue.33  
It seems beneficial to speed up the process of the activation shift back to the left 
hemisphere, since that shift is associated with better language outcome, as was shown in 
language tests and MRI-scans.26, 34, 37 Background of these propositions is that language is 
left lateralized and that language processing is optimal if it is performed by the dominant left 
hemisphere. However, more and more it is recognized that language is a function of a 
complex bilateral network, so this hypothesis might be too simplistic and needs 
modification.35, 51   
 
What do we know about the importance of timing of SLT in post-stroke aphasia? 
Evidence from RCTs on early SLT. 
The efficacy of SLT has been studied extensively in the chronic phase after stroke, 
presumably because recruiting of subjects is easier in this, more stable, phase and ethical 
issues concerning not providing therapy as a control condition are no longer a potentially 
limiting factor.1 Furthermore, spontaneous recovery has ceased, which enables researchers 
to compare treatment effects with a stable control condition.  
A systematic review showed that time since onset did not affect response to treatment in 
subjects with aphasia existing for more than one year.52 In a meta-analysis of 55 studies on 
aphasia treatment, the authors found that the effect of language treatment started in the 
first three months after stroke was larger than when treatment was initiated beyond three 
months.30 However, the methodological quality of included studies was not assessed, many 
of the studies were not controlled or randomized and, more importantly, the meta-analysis 
did not contain any study directly comparing early with later initiated treatment. 
 
 
Nevertheless, some support for the authors’ conclusion comes from an RCT on the efficacy 
of Melodic Intonation Therapy (MIT), showing that MIT initiated before three months post 
onset was more effective than MIT initiated after three months.25 
Recently, several trials have been published on the efficacy of early initiated SLT for 
aphasia due to stroke.14, 16, 17, 53-56 None of these studies directly compared early with later 
initiated SLT. Again terminology is confusing, because the starting point of the treatment 
denominated as ‘early’ in these studies varies from two to thirty days after stroke. We will 
only discuss trials truly starting early after stroke; i.e. within the first week.  
Laska et al. randomized 123 PWA to either 21 days of 45 minutes SLT per weekday, 
initiated within two days after stroke, or no therapy until three weeks after randomization.17 
No significant differences were found between groups on the primary outcome measure 
Amsterdam-Nijmegen Everyday Language Test57 (ANELT) after three weeks (median ANELT 
score in the early group was 1.3 versus 1.2 in the control group; p = 0.37) and after six 
months (median ANELT score in the early group of 1.8 versus 3.0 in the control group; p = 
0.49). This suggests that early therapy has no advantage over therapy started after three 
weeks. Yet, it is unclear whether the intended treatment intensity was reached in all subjects 
and whether this was sufficient to add a therapy effect on top of spontaneous recovery.  
Positive results were found in two pilot RCTs studying the efficacy of very early initiated, 
daily SLT. In the first study, PWA benefitted more from daily therapy started on average 
three days after stroke than from usual care, which was not more than one therapy session 
per week.54 Furthermore, the dropout rate was not higher in the early intensive group. The 
authors conclude that early intensive SLT is both feasible and beneficial early after stroke.   
A second pilot RCT comparing SLT every workday, initiated two days after stroke, with no 
SLT for two weeks, found similar results.56 After two weeks and after six months, the early 
SLT group showed better performance on the Aachen Aphasia Test and fMRI-scans showed 
different activation patterns after two weeks. In the early SLT group, recruitment of the left 
hemisphere, especially the inferior frontal gyrus, was greater than in the no SLT group. The 
authors claim that early SLT triggers early recruitment of language related areas in the left 
hemisphere, resulting in better language performance.  
Although these trials show promising results, due to the paucity of large well-designed 
RCTs it remains impossible to decisively determine whether PWA tolerate intensive SLT 
shortly after stroke and whether it is beneficial to start language therapy very early after 
stroke.1, 17, 54, 56  
 
What do we know about the importance of timing of treatment after stroke? Lessons 
to be learned from studies on motor rehabilitation in animals. 
To obtain clues about the optimal timing of SLT, it may be useful to also consider what is 
known about the effect of timing of therapy in motor recovery. Prior to studying 
rehabilitation techniques in humans, many studies have been performed on mice, rats and 
primates. Timing of treatment has been one of the topics of interest. 
In an overview of studies on forced-use therapy in animals with an induced stroke, the 
authors conclude that early initiated therapy results in increased cortical reorganization and 
improved recovery, and that the effect of therapy attenuates with a longer delay between 
stroke and start of treatment.10 However, they also mention that treatment initiated too 
soon after stroke might be detrimental, probably due to changes in neurotransmitter levels 
that might exacerbate brain injury. For instance, in a study performed in rats with induced 
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50 Functional MRI-scans revealed that specific language tasks activate distinct parts and 
networks of the brain.20, 31 One may hypothesize that when metabolic demands increase 
through activation of cortical language areas, adjacent penumbral tissue will benefit, 
especially when circulation is already restored by reperfusion therapy.  
The penumbra in ischemic strokes comprises the region around the core lesion in which 
blood flow is decreased, but can still be revived if blood flow has not decreased more than 
90%, as was shown in animal studies.33 Several techniques have been used to increase blood 
flow to the penumbra to save brain tissue and support recovery in the acute stage of 
ischemic stroke, such as intravenous or intra-arterial thrombolysis or mechanical 
thrombectomy.33 The therapeutic window for reactivating the penumbra is yet unknown and 
it is unclear whether early SLT might save or rather damage penumbral tissue.33  
It seems beneficial to speed up the process of the activation shift back to the left 
hemisphere, since that shift is associated with better language outcome, as was shown in 
language tests and MRI-scans.26, 34, 37 Background of these propositions is that language is 
left lateralized and that language processing is optimal if it is performed by the dominant left 
hemisphere. However, more and more it is recognized that language is a function of a 
complex bilateral network, so this hypothesis might be too simplistic and needs 
modification.35, 51   
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Evidence from RCTs on early SLT. 
The efficacy of SLT has been studied extensively in the chronic phase after stroke, 
presumably because recruiting of subjects is easier in this, more stable, phase and ethical 
issues concerning not providing therapy as a control condition are no longer a potentially 
limiting factor.1 Furthermore, spontaneous recovery has ceased, which enables researchers 
to compare treatment effects with a stable control condition.  
A systematic review showed that time since onset did not affect response to treatment in 
subjects with aphasia existing for more than one year.52 In a meta-analysis of 55 studies on 
aphasia treatment, the authors found that the effect of language treatment started in the 
first three months after stroke was larger than when treatment was initiated beyond three 
months.30 However, the methodological quality of included studies was not assessed, many 
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of Melodic Intonation Therapy (MIT), showing that MIT initiated before three months post 
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Recently, several trials have been published on the efficacy of early initiated SLT for 
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denominated as ‘early’ in these studies varies from two to thirty days after stroke. We will 
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Amsterdam-Nijmegen Everyday Language Test57 (ANELT) after three weeks (median ANELT 
score in the early group was 1.3 versus 1.2 in the control group; p = 0.37) and after six 
months (median ANELT score in the early group of 1.8 versus 3.0 in the control group; p = 
0.49). This suggests that early therapy has no advantage over therapy started after three 
weeks. Yet, it is unclear whether the intended treatment intensity was reached in all subjects 
and whether this was sufficient to add a therapy effect on top of spontaneous recovery.  
Positive results were found in two pilot RCTs studying the efficacy of very early initiated, 
daily SLT. In the first study, PWA benefitted more from daily therapy started on average 
three days after stroke than from usual care, which was not more than one therapy session 
per week.54 Furthermore, the dropout rate was not higher in the early intensive group. The 
authors conclude that early intensive SLT is both feasible and beneficial early after stroke.   
A second pilot RCT comparing SLT every workday, initiated two days after stroke, with no 
SLT for two weeks, found similar results.56 After two weeks and after six months, the early 
SLT group showed better performance on the Aachen Aphasia Test and fMRI-scans showed 
different activation patterns after two weeks. In the early SLT group, recruitment of the left 
hemisphere, especially the inferior frontal gyrus, was greater than in the no SLT group. The 
authors claim that early SLT triggers early recruitment of language related areas in the left 
hemisphere, resulting in better language performance.  
Although these trials show promising results, due to the paucity of large well-designed 
RCTs it remains impossible to decisively determine whether PWA tolerate intensive SLT 
shortly after stroke and whether it is beneficial to start language therapy very early after 
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What do we know about the importance of timing of treatment after stroke? Lessons 
to be learned from studies on motor rehabilitation in animals. 
To obtain clues about the optimal timing of SLT, it may be useful to also consider what is 
known about the effect of timing of therapy in motor recovery. Prior to studying 
rehabilitation techniques in humans, many studies have been performed on mice, rats and 
primates. Timing of treatment has been one of the topics of interest. 
In an overview of studies on forced-use therapy in animals with an induced stroke, the 
authors conclude that early initiated therapy results in increased cortical reorganization and 
improved recovery, and that the effect of therapy attenuates with a longer delay between 
stroke and start of treatment.10 However, they also mention that treatment initiated too 
soon after stroke might be detrimental, probably due to changes in neurotransmitter levels 
that might exacerbate brain injury. For instance, in a study performed in rats with induced 
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infarcts, lesion size increased due to hyperthermia in the perilesional area after constraint-
induced movement therapy (CIMT; restraining the unaffected limb in order for the affected 
limb to be used), initiated 24 hours after stroke.58 In another study, rats with induced brain 
infarcts were placed either in standard cages with no training, or were provided with early 
training (24 hours post onset) or late training (seven days post onset) in enriched 
environment cages.59 Both groups of rats placed in the enriched environments performed 
significantly better than rats in standard cages, with the late training group performing best 
overall. Infarct sizes were significantly larger in the early group compared to both other 
groups, indicating that starting too early might be harmful.10  
Research on recovery of motor functioning in animal models has shown that after a 
stroke brain regions around the infarct become temporarily hyperexcitable, due to 
neurotrophic changes.10, 24, 32, 37, 44, 60 In most cases, stroke causes a loss of innervation and 
an imbalance of network activation and inhibition, which triggers positive adaptation.32 
Animal studies have shown that levels of genes and proteins involved in neuronal and 
dendritic growth, and synaptogenesis early in life also increase after a stroke.37, 60, 61 This 
offers an ideal condition for neuroplasticity and pleads for an early start of rehabilitation to 
optimally profit from these temporary changes.61  
A limited window of time for optimal rehabilitation is suggested by results from a study 
comparing three starting points of Enriched Rehabilitation (ER) for rats with induced 
ischemia.62 Rats exposed to ER five days after stroke performed best on functional 
outcomes, and rats exposed after 14 days also improved, but less pronounced. The benefit 
of ER diminished in rats that were exposed to ER after 30 days, as they performed equally to 
rats receiving no training.    
As mentioned above, it has been suggested that early treatment should aim at regaining 
normal functioning. An example of training focused on normal functioning is CIMT. Evidence 
for this form of forced-use therapy is equivocal.10, 32, 37, 63 Some authors report that with 
CIMT cortical representations are retained, but others report increased cell-loss due to 
hyperthermia and changed neurotransmitter levels by which the lesion size increases.10, 32, 37, 
60, 61, 63 The authors of a review and meta-analysis conclude that there is no evident benefit 
of CIMT on neurobehavioral measures, and state that they cannot draw any conclusions 
about the optimal time to start CIMT.63  
The effect of task-specific training regimens such as CIMT may be augmented by placing 
animals in an enriched environment, since animals are thereby challenged to engage in 
normal behavior. This supposedly enlarges spontaneous recovery processes, by triggering 
original neural networks.44, 60   
In conclusion, animal studies on motor rehabilitation have provided us with three 
findings: (1) there is a critical window of time in a relatively early stage after stroke in which 
the brain is more sensitive to rehabilitation, (2) starting intensive treatment very early after 
stroke may be detrimental due to extended damage to the penumbra, and (3) a challenging, 
enriched environment augments spontaneous recovery.10 Evidently, results from these 
studies on motor recovery in animals do not necessarily translate to language recovery in 
humans.61, 63  
 
 
 
What do we know about the importance of timing of treatment after stroke? Lessons 
to be learned from studies on motor rehabilitation in humans.  
More than a decade ago the importance of timing of motor rehabilitation was addressed in 
an observational study in stroke patients with matched controls (n = 135).64 Allocation 
depended on an administrative waiting list. Three rehabilitation start intervals were 
compared: early (<20 days after stroke), intermediate (21 to 40 days) and late (41 to 60 
days). An early start was associated with better outcome, but it is unclear whether inclusion 
and attrition bias may have confounded these results.  
In a large prospective observational cohort study (n = 969), the relationship between 
several factors in the rehabilitation process and clinical outcomes was studied.65 A significant 
association was found between an earlier start of rehabilitation and better functional 
outcomes. This association was strongest in severely affected patients. A longer time interval 
between stroke onset and start of rehabilitation was correlated with lower total scores on 
the Functional Independence Measure at discharge and lower functional motor 
independence scores in a subset of participants with moderate and severe strokes (n = 
830).13 These results must be confirmed in an RCT in order to rule out selection bias, control 
for patient differences and to study causality instead of association.  
In a study based on a retrospective chart review (n = 435), significantly better functional 
outcome scores were found in patients who were admitted to rehabilitation within 30 days 
after stroke, than in those starting after 30 days.66 An early start was also associated with 
earlier discharge from the rehabilitation center. The group with deferred rehabilitation 
improved also, but not as much as the early group and it took them longer to recover. 
Findings such as these were summarized in a European evidence-based guidance document 
for stroke rehabilitation, in which the authors conclude that early initiated rehabilitation 
seems beneficial in medically stable patients.4  
However, Teasell et al. have argued that many observational studies perhaps wrongly 
conclude that an early start is causally related to better outcome, as findings might in fact be 
explained by the underlying reason why the rehabilitation process is delayed in some 
patients.12 If a patient is seriously ill after stroke it is logical that rehabilitation is postponed 
until the patient is physically or mentally able to receive treatment. The relationship 
between timing of treatment and treatment efficacy should ideally be studied in well-
constructed RCTs, taking into account general factors concerning the medical status of the 
patients after stroke.  
In an RCT comparing an early start of CIMT (within three to nine months after stroke; n = 
106) with a late start (15 to 21 months after stroke; n = 116), both groups showed significant 
improvement immediately after two weeks of CIMT and after twelve months, but there was 
a statistically significant difference in favor of the group that started CIMT earlier after 
stroke.67 Another RCT (n = 52) comparing high-intensity CIMT to either standard-intensity 
CIMT or standard treatment for two weeks, initiated approximately ten days after stroke, 
showed no benefit of high-intensity CIMT over standard treatment or standard-intensity 
CIMT measured on the Action Research Arm Test (ARAT).68 At the primary endpoint, 90 days 
after stroke, the intensive CIMT group even showed significantly less improvement on the 
ARAT than the control groups. This suggests that very intensive restrictive treatment might 
be detrimental, when initiated too early after stroke. This might be due to disturbed 
homeostatic mechanisms regulating excitability in neural networks, but it is still unclear 
whether this is a valid explanation, since activation is already low around the infarct.37       
Treatment of aphasia: Evidence for early aphasia treatment |  83
4
 
 
infarcts, lesion size increased due to hyperthermia in the perilesional area after constraint-
induced movement therapy (CIMT; restraining the unaffected limb in order for the affected 
limb to be used), initiated 24 hours after stroke.58 In another study, rats with induced brain 
infarcts were placed either in standard cages with no training, or were provided with early 
training (24 hours post onset) or late training (seven days post onset) in enriched 
environment cages.59 Both groups of rats placed in the enriched environments performed 
significantly better than rats in standard cages, with the late training group performing best 
overall. Infarct sizes were significantly larger in the early group compared to both other 
groups, indicating that starting too early might be harmful.10  
Research on recovery of motor functioning in animal models has shown that after a 
stroke brain regions around the infarct become temporarily hyperexcitable, due to 
neurotrophic changes.10, 24, 32, 37, 44, 60 In most cases, stroke causes a loss of innervation and 
an imbalance of network activation and inhibition, which triggers positive adaptation.32 
Animal studies have shown that levels of genes and proteins involved in neuronal and 
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enriched environment augments spontaneous recovery.10 Evidently, results from these 
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What do we know about the importance of timing of treatment after stroke? Lessons 
to be learned from studies on motor rehabilitation in humans.  
More than a decade ago the importance of timing of motor rehabilitation was addressed in 
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and attrition bias may have confounded these results.  
In a large prospective observational cohort study (n = 969), the relationship between 
several factors in the rehabilitation process and clinical outcomes was studied.65 A significant 
association was found between an earlier start of rehabilitation and better functional 
outcomes. This association was strongest in severely affected patients. A longer time interval 
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the Functional Independence Measure at discharge and lower functional motor 
independence scores in a subset of participants with moderate and severe strokes (n = 
830).13 These results must be confirmed in an RCT in order to rule out selection bias, control 
for patient differences and to study causality instead of association.  
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between timing of treatment and treatment efficacy should ideally be studied in well-
constructed RCTs, taking into account general factors concerning the medical status of the 
patients after stroke.  
In an RCT comparing an early start of CIMT (within three to nine months after stroke; n = 
106) with a late start (15 to 21 months after stroke; n = 116), both groups showed significant 
improvement immediately after two weeks of CIMT and after twelve months, but there was 
a statistically significant difference in favor of the group that started CIMT earlier after 
stroke.67 Another RCT (n = 52) comparing high-intensity CIMT to either standard-intensity 
CIMT or standard treatment for two weeks, initiated approximately ten days after stroke, 
showed no benefit of high-intensity CIMT over standard treatment or standard-intensity 
CIMT measured on the Action Research Arm Test (ARAT).68 At the primary endpoint, 90 days 
after stroke, the intensive CIMT group even showed significantly less improvement on the 
ARAT than the control groups. This suggests that very intensive restrictive treatment might 
be detrimental, when initiated too early after stroke. This might be due to disturbed 
homeostatic mechanisms regulating excitability in neural networks, but it is still unclear 
whether this is a valid explanation, since activation is already low around the infarct.37       
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Studying improvement of function is no sinecure, because it is very difficult to rightfully 
distinguish improved function as a result of true recovery, from gains through 
compensation.60, 61 It is important to differentiate between these processes while providing 
treatment and measuring treatment efficacy in RCTs, because supposedly rehabilitation is 
most successful when restoration of function is accomplished.60, 61 
In summary, an early start of motor rehabilitation after stroke seems beneficial for 
functional outcome, but there are also signs indicating that intensive treatment might be 
harmful if initiated too early after stroke.68 It is unclear whether these findings can be 
extrapolated to language rehabilitation, because recovery from aphasia might have a 
different course than motor recovery and other processes might interfere with recovery.69, 70 
We believe that, in contrast to motor functioning, language processing not only addresses an 
intricate network of cortical and subcortical networks, but relies more on cognitive systems 
also. Besides, motor rehabilitation is not only focused on regaining function, but also on 
preventing complications such as contractures, which do not affect language functioning.10, 
71  
 
EXPERT COMMENTARY 
 
The currently available evidence is inconclusive and therefore insufficient to answer the 
question of when to start SLT in aphasia due to stroke. Studies on post-stroke language 
recovery using neuroimaging techniques provide some arguments favoring an early start, 
such as stimulating the penumbra to salvage function, making use of a hyperexcitable brain, 
facilitating an activation shift from right to left and preventing learned non-use. On the other 
hand, studies on motor recovery in animals and humans have suggested that starting too 
early might be detrimental because of damage to the penumbra, metabolic changes or 
overheating, which might increase lesion size.  
Most evidence supporting the importance of an early start comes from the field of motor 
rehabilitation. Cohort studies show a relationship between early initiated interventions and 
better recovery. Yet, without results from RCTs directly comparing early with later 
treatment, the observed association might merely reflect the fact that patients who can 
tolerate treatment early after stroke probably recover better.    
In this stage of the research on the relationship between timing of aphasia treatment and 
its efficacy, we cannot conclude that early initiated treatment is more beneficial for the 
recovery of aphasia than later initiated treatment. However, two smaller RCTs have shown 
that early SLT is tolerated and report better language functioning and recruitment of 
language related brain areas than in the control condition. This urgently calls for further 
research on this topic.   
Considering the important implications for clinical practice, more research is needed to 
clarify the relationship between timing of SLT and response to treatment. In the next 
paragraph, we will provide some minimal requirements for conducting research in the early 
phase after stroke to which researchers should adhere.   
 
FIVE-YEAR VIEW AND PRINCIPLES FOR FUTURE RESEARCH 
 
Currently, we lack solid evidence linking efficacy of SLT to the stage of aphasia recovery. 
Experience has taught us that recruitment for large RCTs with PWA is challenging and time-
 
 
consuming, especially when recruiting early after stroke. Hence, we do not expect evidence 
will accumulate rapidly in the upcoming five years. At the moment, there are some research 
groups dedicated to studying the topic of timing. A search in clinical trial registries revealed 
two ongoing RCTs studying the efficacy of early initiated intensive SLT for the recovery of 
aphasia, so we do expect more insights soon into this component of timing.72, 73   
RCTs are considered as the golden standard for unbiased research. However, the group 
of PWA is very heterogeneous and aphasic characteristics are unstable shortly after stroke, 
observed by rapid changes in behavior and often dramatic improvement in the hours and 
days after stroke. As a result, it is impossible to form adequate subgroups this early on. 
Therefore, in order to allow for stratified analyses, sample sizes ought to be large, a criterion 
that can be met by collaborations, either in multicenter or cross-national trials. Next to 
sample size, sound RCTs should adhere to the CONSORT statement and make use of and 
transparently report accurate methods for selection, randomization, blinding and analyses.74  
The second, and possibly most important principle, is choosing proper interventions. In 
the critical phase after stroke, all experiences and actions trigger plasticity, some of it 
maladaptive.35, 37, 38 It is therefore of the utmost importance and our obligation to 
participants to carefully select aphasia treatment. It still has to be confirmed whether in an 
early stage of treatment restorative SLT is preferred over compensational treatment because 
of the supposed interaction with the recovery of language-specific neural circuits.    
To study an interaction between treatment and recovery, it would be ideal to compare 
an intervention to no intervention, hence to spontaneous recovery. It has often been argued 
that it is very difficult to distinguish improved functioning as a result of true neural recovery 
from improvement due to compensation. Interventions should therefore be very task-
specific and impairment focused, e.g. CLT.60  
It should be noted that a control condition with no specific language treatment does not 
mean that participants do not receive some form of colloquial communication training in 
normal daily life. It is therefore sensible to take into account the social environment of the 
participants. We suggest to monitor language or communication related activities in the 
control group, but also in the intervention group. It might even be possible to study social 
environment as a variable in RCTs, for instance by only placing the intervention group in an 
enriched communication environment.    
If the intervention will be studied over a longer period ethical issues may prevent 
scientists from using a control group without treatment. In these cases, the chosen control 
intervention should contrast the study intervention maximally. A paradigm like this is ideal 
to compare the efficacy of task-specific restorative training to that of compensational 
training early after stroke. For instance, it would be clinically relevant to compare CILT 
training using ‘normal’ grammatical sentences (restoration), with training of agrammatic 
sentences, so-called ellipses (compensation).75 Both training methods may have a direct 
effect on the quality of verbal communication in daily life, but are supposed to be different 
in their effect on neural repair and optimal timing in the rehabilitation course.      
Treatment intensity is also of great importance, because insufficiently intensive 
treatment is ineffective. To reproduce results from animal studies, we must force up 
treatment intensity in studies on SLT. We suggest that participants at the least receive daily 
training. The question remains which stroke patients with aphasia, to which extent, tolerate 
highly intensive training shortly after stroke.  
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CONCLUSION 
 
Although studies on motor recovery in animals and humans more and more show benefits of 
early initiated rehabilitation, it is unclear whether this also holds for SLT for recovery of 
aphasia. A robust foundation for the current strategy in clinical practice to start SLT as early 
as possible still requires methodologically sound research to test hypotheses about the 
relationship between timing of SLT and its efficacy.  
 
Key issues 
 Although it is often advocated that speech and language therapy should start as soon as 
possible after a stroke, evidence supporting this notion is weak.  
 Animal studies have shown that there is a limited critical treatment window during 
which the brain is optimally responsive to rehabilitation training.  
 Cohort studies have shown that there is a relationship between an early start of 
rehabilitation and better recovery, but in absence of evidence from RCTs it is unclear 
whether this relationship might merely reflect that stroke survivors who can tolerate 
early intensive training have a better potential for recovery anyway.  
 Animal and human studies have shown that too early initiated and too intensive motor 
training might be detrimental.    
 More solid evidence is needed to determine the relationship between timing of speech 
and language therapy and its efficacy in patients with aphasia due to stroke.   
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INTRODUCTION  
 
About one fifth to a quarter of all stroke patients suffer from aphasia.1 Aphasia after stroke 
is a major health problem with dramatic consequences for the quality of life of affected 
individuals. Communication is essential in daily life and may influence the outcome of 
rehabilitation, since different forms of therapy are usually instructed verbally.2 Hence, 
speech and language therapy (SLT) is considered very important in the acute phase after 
stroke. 
The effectiveness of SLT has been evaluated in a variety of studies, many of which relied 
on small samples and were of limited methodological quality. Recently, the Cochrane 
Collaboration has published a review of 39 trials on the efficacy of language therapy for 
aphasia after stroke.3 The authors conclude that there is some evidence that SLT is more 
effective than no SLT for recovery of communication after stroke and that efficacy of SLT 
seems to be influenced by intensity of therapy. However, they emphasize that these results 
should be interpreted cautiously, as many studies lack proper methodology and comparison 
across studies is hampered by a large degree of heterogeneity regarding characteristics of 
the study population, applied treatment methods, timing and duration of therapy, and 
outcome assessments. 
There are two main approaches in aphasia treatment: cognitive-linguistic treatment (CLT) 
and communicative or functional therapy.4 CLT focuses on deficits in linguistic components, 
such as semantics (word meaning), phonology (speech sounds) and syntax (sentence level), 
and aims at restoring linguistic processes that are the foundation of language. 
Communicative therapy focuses on compensation by making use of all communicative 
channels; patients learn to utilize preserved verbal as well as nonverbal communicative 
functions. Communicative therapy is provided in a realistic everyday environment and uses 
gestures, communication aids, such as an icon board, role-plays and the Promoting Aphasics’ 
Communicative Effectiveness (PACE) method.5 CLT is mostly applied in early stages after 
stroke and communicative therapy later on. 
Our group previously studied the efficacy of CLT, aimed at semantic and phonological 
processing, in comparison to communicative therapy in the acute stage of aphasia in the 
Rotterdam Aphasia Therapy Study (RATS) – 2.6 A total of 80 aphasic patients were 
randomized to either CLT or communicative therapy for six months, starting within three 
weeks after stroke. We found no significant difference between groups on the primary 
outcome measure, the Amsterdam-Nijmegen Everyday Language Test, A-scale (ANELT-A).7 
However, the majority of the secondary outcome measures on semantics and phonology 
were in favor of CLT. Perhaps the treatment intensity of both interventions, on average 2.1 
hours per week, was insufficient to generate a significant treatment effect on top of 
spontaneous recovery.8-10 
Recovery of communication usually occurs shortly after stroke.11-14 Most likely, 
restoration of the perilesional network in the left hemisphere is the primary mechanism 
underlying this spontaneous recovery.15 Therapeutic strategies to restore cerebral blood 
flow, such as thrombolysis, enhance spontaneous recovery. SLT is aimed at stimulating 
cortical networks involved in language, hence increasing blood flow to these damaged areas. 
CLT especially stimulates the linguistic cortical network through specific exercises for 
linguistic components, such as semantics, phonology and syntax.4 Hence SLT, and in 
particular CLT, is thought to contribute positively to spontaneous recovery of language.14, 15 
 
 
ABSTRACT 
 
Background 
Aphasia is a severely disabling condition occurring in 20 to 25% of stroke patients. Most 
patients with aphasia due to stroke receive speech and language therapy. Methodologically 
sound randomized controlled trials investigating the effect of specific interventions for 
patients with aphasia following stroke are scarce. The currently available evidence suggests 
that intensive speech and language therapy is beneficial for restoration of communication, 
but the optimal timing of treatment is as yet unclear. 
In the Rotterdam Aphasia Therapy Study (RATS) – 3 we aim to test the hypothesis that 
patients with aphasia due to stroke benefit more from early intensive cognitive-linguistic 
treatment than from deferred regular language therapy. 
 
Methods  
In a single blinded, multicenter, randomized controlled trial, 150 patients with first-ever 
aphasia due to stroke will be randomized within two weeks after stroke to either early 
intensive cognitive-linguistic treatment (intervention group) or deferred regular therapy 
(control group). The intervention group will start as soon as possible, at the latest two weeks 
after stroke, with a four week period of one hour a day treatment with cognitive-linguistic 
treatment. In the control group professional speech and language therapy is deferred for 
four weeks. After this period, patients will follow the conventional procedure of speech and 
language therapy. Participants will be tested with an extensive linguistic test battery at four 
weeks, three months and six months after inclusion. Primary outcome measure is the 
difference in score between the two treatment groups on the Amsterdam-Nijmegen 
Everyday Language Test, a measure of everyday verbal communication, four weeks after 
randomization. 
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Some, therefore, claim that the focus of speech and language therapists (SL-therapists) in 
the acute stage of aphasia, when restoration of the linguistic network is still plausible, should 
be on CLT.14, 16 
In this respect, several clinical studies suggest that therapy provided immediately after 
stroke results in more beneficial effects than deferred treatment.11 In a review article that 
was not restricted to randomized trials but also included studies with other designs, the 
authors conclude that SLT in the acute stages of aphasia following stroke is almost twice as 
effective as natural recovery alone.10 This assumes the presence of a ‘critical period’ after 
stroke during which the brain is more susceptible to rehabilitation. Furthermore, it implies 
that SLT should be initiated as soon as possible after stroke. This assumption also suggests 
that if SLT is initiated too late, recovery might be restricted. The length of this supposed 
‘critical period’, however, is unclear and optimal timing of therapy remains uncertain. 
A second mechanism of recovery is neural plasticity.17 Intensive training, for instance, 
massed practice, is thought to trigger remodeling and consolidation of neural networks.15 
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Participants and recruitment 
RATS-3 is coordinated by the Erasmus MC – University Medical Center Rotterdam, and over 
40 hospitals, nursing homes and rehabilitation centers in the Netherlands participate. SL-
therapists in participating centers are trained and supervised by the trial team. 
Hospitalized patients with aphasia due to stroke are screened by the local SL-therapist 
for eligibility with the inclusion and exclusion criteria within two weeks after stroke (Table 1). 
 
Table 1. Eligibility criteria for the Rotterdam Aphasia Therapy Study (RATS) – 3 
Inclusion criteria: 
1. Aphasia after stroke, determined by a neurologist or rehabilitation physician and speech and 
language therapist 
2. Within two weeks after stroke 
3. Testable with ScreeLing20 
4. Aphasia ascertained with shortened Token Test21 and/or a score <5 on Aphasia Severity 
Rating Scale22 
5. Age between 18 and 85 years 
6. Language near native Dutch 
7. Life expectancy of more than six months 
Exclusion criteria: 
1.  Pre-existing aphasia 
2.  Subarachnoid/subdural hemorrhage/hematoma 
3.  Severe threats to success and/or feasibility of language therapy: 
       Severe dysarthria 
       Premorbid dementia 
       Illiteracy 
       Severe developmental dyslexia 
       Severe visual perceptual disorders 
       Recent psychiatric history 
 
Written informed consent is acquired by the local SL-therapist from eligible patients 
and/or their family. Patient information and consent forms are approved by the Medical 
Ethical Committee of the Erasmus MC – University Medical Center Rotterdam. Local SL-
therapists will inform the RATS-3 team of every new participant. 
 
Baseline tests 
All candidates will be tested with the ScreeLing, a screening instrument for aphasia.20 
Aphasia is ascertained with the shortened version of the Token Test21 and a sample of 
spontaneous speech assessed with the Aphasia Severity Rating Scale22. Activities of daily life 
will be reported with the Barthel Index23 and observational data on social and 
(neuro)psychological functioning and wellbeing will be collected with the MAAS (Multi-axial 
Aphasia System24). 
 
 
Randomization 
Each participant is assigned to either the intervention group or the control group by 
restricted randomization via stratification for severity of aphasia and center of inclusion. The 
allocation sequence is computer generated and concealed in consecutively numbered, 
opaque, sealed envelopes. The trial coordinator randomizes participants to treatment 
groups after severity of aphasia is assessed. A score on the Aphasia Severity Rating Scale22 of 
0 to 2 is considered to reflect severe aphasia and a score of 3 to 5 reflects moderate to mild 
aphasia. 
 
Intervention 
As soon as possible after randomization the intervention period of four weeks starts, during 
which the intervention group receives early intensive CLT and the control group receives no 
SLT. 
 
Intervention group (n = 75) 
Participants allocated to the intervention group receive intensive CLT with the treatment 
programs BOX25 and/or FIKS26. The BOX and FIKS programs are commonly used in the 
Netherlands and aim at the improvement of word finding (Table 2). BOX focuses on 
semantics and FIKS on phonology. Both interventions are well outlined, which ensures 
homogeneity of treatment in this group.6 BOX and FIKS consist of several subparts that 
provide a large number of specific exercises, to treat various layers of semantic and 
phonological processing. Exercises can be presented visually and/or orally and require 
receptive and productive skills. Each subpart contains different levels of complexity, which 
makes these programs suitable to all types and severity levels of aphasia. Both programs are 
also available on computer (eBOX and eFIKS) to facilitate homework. 
Therapy will start at the latest two weeks after stroke. However, as soon as participants 
are included and randomized, therapy can be started. 
Recent findings on intensity of treatment suggest that one hour of language therapy per 
day is sufficiently intensive to generate an effect of therapy on top of the effect of 
spontaneous recovery.3, 8 This high intensity is uncommon in the Netherlands. Therefore SL-
therapists will treat participants at least two hours a week, supplemented with homework 
using paper or digital versions of the therapy programs. The SL-therapists register all therapy 
sessions in minutes on special registration forms. These forms will be handed to the patient 
and/or his caretaker also for homework registration. 
The trial coordinator contacts SL-therapists every week to check whether the allocated 
treatment is adequately applied and ask if any problems arise complying with the protocol. 
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Table 2. Illustration of CLT with the semantic therapy program BOX and the phonological program 
FIKS 
Semantic therapy program BOX 
Subject: word meaning 
Objective: consolidate the internal semantic network to improve word finding 
Presentation: oral, visual or by computer (eBOX) 
 
Examples: 
 
Word level Sentence level 
Which word does not match? Is this sentence correct? 
   Ruler    The balloon flies in the air. 
   Musical scale    Correct. 
   Gauge  
   Balance    The candle is burning embittered. 
   Measuring tape    Incorrect. Please correct the sentence. 
Phonological therapy program FIKS 
Subject: processing and production of speech sounds 
Objective: consolidate the internal phonological network and improve production of speech, to 
improve word finding 
Presentation: oral, visual or by computer (eFIKS) 
 
Examples: 
 
Word level  
Which word is printed here? tion trans la = translation 
Read it out loud please. ment ta tes = testament 
Sentence level  
Please finish the sentence with a rhyming word: The enthusiastic amateur cook, 
 read the recipe carefully in his cooking– … 
 
Control group (n = 75) 
Language therapy is deferred in the control group. Regular language therapy will start four 
weeks after randomization. During these four weeks no SLT is allowed. SL-therapists, 
however, will be attentive to participants in the control group. They may inform the patient 
and his caretakers about aphasia and its consequences and provide advice to avoid severe 
communication distress. Additional diagnostic tests and specific observations on 
communicative functioning may be performed to set detailed therapy goals. 
Therapy after four weeks by an SL-therapist will be arranged if the patient is discharged 
home. The trial coordinator will keep in contact with the patient during these four weeks. If 
the patient is released to a rehabilitation center or nursing home, the coordinator will 
contact the SL-therapist after two weeks to evaluate whether the protocol can be followed 
correctly. 
 
 
 
Follow-up measurements 
Verbal communicative abilities of participants will be evaluated four weeks after 
randomization, three months after inclusion and six months after inclusion, using an 
extensive linguistic test battery (Table 3). Tests requiring a verbal response are recorded 
digitally. All SL-therapists receive a manual for the administration of the linguistic tests. 
Results will be scored in a booklet containing all score forms per test moment. The trial team 
will score all tests and report results to the SL-therapists. 
 
Table 3. Linguistic test battery in RATS-3 
General communication tests 
  ANELT-A: communicative functioning in daily life7 
  Semi-standardized interview for spontaneous speech rated with the Aphasia Severity Rating 
Scale22 
  Sabadel: connected speech27 
  ScreeLing: screening of three linguistic components: semantics, phonology and syntax20, 28 
  Token Test, short version: measures severity of aphasia21 
  Boston Naming Test: identifies word finding difficulties29 
Specific semantic tests 
  Semantic Association Test, verbal version (SAT)30 
  Comprehensive Aphasia Test, word comprehension (CAT)31 
  Semantic Word Fluency32 
Specific phonological tests 
  Nonword repetition, PALPA33 
  Auditory Lexical Decision, PALPA33 
  Letter Fluency34 
General 
  Barthel Index: activities of daily life23 
  Multi-axial Aphasia System (MAAS)24 
  Partner ANELT: partner’s perspective on communicative functioning35 
  Self-evaluation of communicative functioning on a 0 to 10 scale 
  EQ-5D-3L : quality of life36 
  Modified Rankin Scale: activities of daily life (mRS)37 
 
Aphasia type will be determined with the Aachen Aphasia Test (AAT)38 between the four 
week and three month test. This period after spontaneous recovery is chosen because we 
assume aphasia type will then be stabilized. 
 
Sequel after the four week test 
Regular language therapy will start in the control group and the intervention group 
continues with regular therapy after the four week test. Regular therapy in the Netherlands 
Treatment of aphasia: Design of RATS-3 |  101
4
 
 
Table 2. Illustration of CLT with the semantic therapy program BOX and the phonological program 
FIKS 
Semantic therapy program BOX 
Subject: word meaning 
Objective: consolidate the internal semantic network to improve word finding 
Presentation: oral, visual or by computer (eBOX) 
 
Examples: 
 
Word level Sentence level 
Which word does not match? Is this sentence correct? 
   Ruler    The balloon flies in the air. 
   Musical scale    Correct. 
   Gauge  
   Balance    The candle is burning embittered. 
   Measuring tape    Incorrect. Please correct the sentence. 
Phonological therapy program FIKS 
Subject: processing and production of speech sounds 
Objective: consolidate the internal phonological network and improve production of speech, to 
improve word finding 
Presentation: oral, visual or by computer (eFIKS) 
 
Examples: 
 
Word level  
Which word is printed here? tion trans la = translation 
Read it out loud please. ment ta tes = testament 
Sentence level  
Please finish the sentence with a rhyming word: The enthusiastic amateur cook, 
 read the recipe carefully in his cooking– … 
 
Control group (n = 75) 
Language therapy is deferred in the control group. Regular language therapy will start four 
weeks after randomization. During these four weeks no SLT is allowed. SL-therapists, 
however, will be attentive to participants in the control group. They may inform the patient 
and his caretakers about aphasia and its consequences and provide advice to avoid severe 
communication distress. Additional diagnostic tests and specific observations on 
communicative functioning may be performed to set detailed therapy goals. 
Therapy after four weeks by an SL-therapist will be arranged if the patient is discharged 
home. The trial coordinator will keep in contact with the patient during these four weeks. If 
the patient is released to a rehabilitation center or nursing home, the coordinator will 
contact the SL-therapist after two weeks to evaluate whether the protocol can be followed 
correctly. 
 
 
 
Follow-up measurements 
Verbal communicative abilities of participants will be evaluated four weeks after 
randomization, three months after inclusion and six months after inclusion, using an 
extensive linguistic test battery (Table 3). Tests requiring a verbal response are recorded 
digitally. All SL-therapists receive a manual for the administration of the linguistic tests. 
Results will be scored in a booklet containing all score forms per test moment. The trial team 
will score all tests and report results to the SL-therapists. 
 
Table 3. Linguistic test battery in RATS-3 
General communication tests 
  ANELT-A: communicative functioning in daily life7 
  Semi-standardized interview for spontaneous speech rated with the Aphasia Severity Rating 
Scale22 
  Sabadel: connected speech27 
  ScreeLing: screening of three linguistic components: semantics, phonology and syntax20, 28 
  Token Test, short version: measures severity of aphasia21 
  Boston Naming Test: identifies word finding difficulties29 
Specific semantic tests 
  Semantic Association Test, verbal version (SAT)30 
  Comprehensive Aphasia Test, word comprehension (CAT)31 
  Semantic Word Fluency32 
Specific phonological tests 
  Nonword repetition, PALPA33 
  Auditory Lexical Decision, PALPA33 
  Letter Fluency34 
General 
  Barthel Index: activities of daily life23 
  Multi-axial Aphasia System (MAAS)24 
  Partner ANELT: partner’s perspective on communicative functioning35 
  Self-evaluation of communicative functioning on a 0 to 10 scale 
  EQ-5D-3L : quality of life36 
  Modified Rankin Scale: activities of daily life (mRS)37 
 
Aphasia type will be determined with the Aachen Aphasia Test (AAT)38 between the four 
week and three month test. This period after spontaneous recovery is chosen because we 
assume aphasia type will then be stabilized. 
 
Sequel after the four week test 
Regular language therapy will start in the control group and the intervention group 
continues with regular therapy after the four week test. Regular therapy in the Netherlands 
102  |  Chapter 4.2
 
 
comprises a combination of CLT and communicative therapy and focuses mainly on therapy 
goals set by the patient. Regular therapy intensity is on average approximately two hours 
per week.39 Registration of therapy sessions and therapy type (either CLT or communicative 
or a combination) will be continued, although not as meticulously as during the four weeks 
of intervention. 
 
Primary outcome 
The primary outcome measure in RATS-3 is the difference in score on the ANELT-A7 at the 
four week test moment (after intervention) between the two groups. CLT aims at improving 
linguistic skills, which theoretically results in better daily communication. The A-scale of the 
valid and reliable ANELT measures verbal communicative ability.40 Participants’ verbal 
responses to ten everyday communicative scenarios are scored on a five-point scale for 
information content. 
 
Secondary outcomes 
The difference in scores between groups at the four week test on the Semantic Association 
Test (SAT), verbal version30; Semantic Word Fluency32, Psycholinguistic Assessment of 
Language Processing in Aphasia (PALPA), Nonword repetition33; PALPA, Auditory Lexical 
Decision33; and Letter Fluency34 will be used as secondary outcome measures. Other 
secondary outcomes are differences in all test scores at three months, and differences in 
scores on the EQ-5D-3L 36 (quality of life) and modified Rankin Scale (functional outcome)37. 
 
Tertiary outcomes 
Scores on the above mentioned tests at six months after inclusion, including ANELT-A, will be 
used as tertiary outcome measures. 
 
Sample size 
A sample of 75 participants in each treatment group, a total of 150 participants, is estimated 
to provide 84% power to detect a statistically significant difference between groups on the 
primary outcome measure at a 5% two-sided significance level. An inclusion period of two 
years is estimated to be required for recruitment. 
 
Blinding 
Due to the intervention type, therapy or no therapy, it is impossible for participants and SL-
therapists to be blinded for intervention. Assessment of the primary outcome, however, will 
be blinded. Two experienced independent observers, who are blinded for treatment 
allocation and test moment, will score the primary outcome measure ANELT-A. The mean 
score of both independent observers will be used in the analyses. Interobserver agreement 
will be assessed by means of a plot of differences between scores versus their mean. The 
mean difference between observers will be calculated with a 95% confidence interval (95% 
CI). 
 
Statistical analyses 
Difference in score on ANELT-A between groups will be compared with analysis of 
covariance (ANCOVA) with a 95% CI, adjusted for baseline severity. Baseline severity is 
 
 
determined according to the Aphasia Severity Rating Scale22 in a sample of spontaneous 
speech. 
This method will also be used for the additional linguistic tests in the secondary and 
tertiary outcome measures. 
 
Ethics 
The RATS-3 study protocol is approved by the independent Medical Ethical Committee of the 
Erasmus MC – University Medical Center Rotterdam (MEC-2005-347), and registered in the 
Dutch Trial Register (NTR3271)41. 
 
Trial status 
The trial started January 2012. We estimate that inclusion will be finished in January 2014. 
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ABSTRACT  
 
Background 
One third of patients with acute stroke have aphasia. The majority receive speech and 
language therapy (SLT). There is evidence for a beneficial effect of SLT on restoring 
communication, but it is unknown whether and how efficacy of SLT is influenced by timing of 
treatment. We studied whether SLT early after stroke by way of intensive cognitive-linguistic 
treatment (CLT) is more effective than no SLT in the Rotterdam Aphasia Therapy Study 
(RATS) – 3, a multicenter randomized single-blind trial.   
 
Methods  
Stroke patients with first-ever aphasia were randomized within two weeks of onset to either 
four weeks of early intensive CLT (one hour/day) or no language treatment. Hereafter, both 
groups received regular SLT. Primary outcome was the score on the Amsterdam-Nijmegen 
Everyday Language Test (ANELT), measuring everyday verbal communication, four weeks 
after randomization. Secondary outcomes were ANELT at three and six months. The study 
was powered to detect a clinically relevant difference of four points on the ANELT. 
 
Results  
Of the 152 included patients, 80 patients were allocated to intervention. Median treatment 
intensity in the intervention group was 24.5 hours. The adjusted difference between groups 
in mean ANELT scores four weeks after randomization was 0.39, 95% CI: -2.70 to 3.47, p = 
0.81. No statistically significant differences were found at three and six months after 
randomization either.  
 
Conclusion  
Four weeks of intensive CLT initiated within two weeks of stroke is not more effective than 
no language treatment for the recovery of aphasia due to stroke. Our results exclude a 
clinically relevant effect of very early CLT on everyday language. 
 
 
 
 
 
INTRODUCTION 
 
Aphasia occurs in about one third of stroke patients and has severe consequences for verbal 
communication and quality of life.1, 2 Several randomized controlled trials (RCT) have 
reported a benefit of speech and language therapy (SLT) over no treatment for patients with 
aphasia due to stroke.3 Hence, most patients receive SLT as part of their rehabilitation 
program.  
The relationship between timing of SLT, i.e. the interval between stroke onset and start 
of treatment, and its efficacy is unclear.4 In a meta-analysis comparing studies with different 
starting points of SLT, the average effect size in studies evaluating treatment initiated in the 
first three months after stroke was larger than that in studies performed in a later stage.5 
However, this analysis was mainly based on uncontrolled and non-randomized studies. The 
efficacy of early initiated SLT has been studied in four trials with contradictory findings; two 
large studies were neutral, but two smaller studies suggested an effect of early treatment.6-9 
The need for more research on the effect of timing of SLT was explicitly accentuated in a 
Cochrane review on efficacy of SLT for aphasia due to stroke.10  
 In the early phase after stroke, impairment-based cognitive-linguistic treatment (CLT) is 
often preferred over other types of SLT, as it targets specific linguistic functions, supposedly 
stimulating functional neural networks.11-13 As most recovery occurs within the first three 
months after stroke,5, 14-16 standard practice early after stroke often comprises CLT.17 When 
linguistic performance reaches a plateau, SLT may be continued with compensatory 
treatment instead of CLT.   
There is some evidence suggesting that high-intensity treatment may be more effective 
than less frequent therapy.3, 18, 19 However, the feasibility of high-intensity treatment is 
questionable, as in several trials compliance with treatment was significantly lower in 
intervention groups with intensive language treatment.3  
Experts in language rehabilitation suggest a best practice regimen of early initiated 
intensive CLT.13, 17 Scientific evidence underpinning this recommendation is frail. The 
objective of the Rotterdam Aphasia Therapy Study (RATS) – 3 was to study whether early 
intensive CLT for four weeks is more effective than no language treatment in the first four to 
six weeks after stroke, and whether this approach generates a long-lasting benefit.  
 
METHODS 
 
Essential elements of the study design are described below. Detailed methods were 
published elsewhere.20 RATS-3 is a prospective multicenter controlled clinical trial with 
randomized treatment allocation, open label treatment and blinded evaluation of the 
primary outcome measure (PROBE design).21 Thus, after randomization both patients and 
therapists were aware of the allocated treatment. Fourteen regional networks for integrated 
stroke care comprising a total of 23 hospitals and 66 rehabilitation facilities across the 
Netherlands participated (Appendix I). Within two weeks of stroke onset, patients were 
randomized to four weeks of either intensive CLT or no language treatment. After the four 
weeks, both groups received regular SLT.  
The study protocol was approved by the Medical Ethical Committee of the Erasmus MC 
(MEC-2005-347) and the study was registered in the Netherlands Trial Register (NTR3271).  
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Participants 
Speech and language therapists (SL-therapists) from participating centers checked eligibility 
criteria (Table 1) and requested informed consent from patients and/or their proxy. 
Information about RATS-3 was provided to patients and their relatives orally and on paper, 
including simplified information leaflets adapted to people with aphasia.  
Patients who were not eligible or who did not consent to participation were not 
registered. 
 
Table 1. Eligibility criteria for RATS-3  
Inclusion criteria: 
1. Aphasia after stroke, diagnosed by a neurologist or rehabilitation physician and SL-therapist 
2. Aphasia ascertained with shortened Token Test (score<29) or Aphasia Severity Rating Scale 
(score<5) 
3. Testable with ScreeLing 
4. Treatment can be started within two weeks after stroke onset 
5. Age 18-85 years 
6. Language near-native Dutch 
7. Life expectancy of more than six months 
Exclusion criteria: 
1.  Pre-existing aphasia 
2.  Subarachnoid/subdural hemorrhage/hematoma 
3.  Language therapy is not feasible because of: 
      Severe dysarthria 
      Premorbid dementia 
      Illiteracy 
      Severe developmental dyslexia 
      Severe visual perceptual disorders 
      Recent psychiatric history 
 
Randomization 
The trial coordinator verified inclusion criteria and, after written informed consent was 
obtained, included and randomized participants within two weeks of stroke onset. 
Independent trial assistants concealed computer-generated allocation sequences in 
consecutively numbered, opaque, sealed envelopes. Randomization was stratified according 
to baseline aphasia severity (Aphasia Severity Rating Scale: ASRS score 0 to 2 = severe; ASRS 
score 3 to 4 = moderate/mild) and including center.  
 
Baseline tests 
At baseline, a short test battery was conducted including the ScreeLing, the 36-item Token 
Test and a semi-standardized interview for eliciting spontaneous speech, which was rated 
with the ASRS.20 An experienced SL-therapist blinded to treatment allocation classified the 
 
 
spontaneous speech samples as fluent or non-fluent. Baseline characteristics and the Barthel 
Index were recorded, as well as treatment with intravenous alteplase, as this is associated 
with rapid recovery from stroke.22  
 
Intervention 
Patients in the intervention group were to receive at least one hour of CLT every day of the 
week for a period of four weeks. The hour of treatment could be delivered in more than one 
session per day, if preferable. We chose an intervention period of four weeks for three 
reasons. First, intervention in the control group had to reflect usual care in the Netherlands, 
where SLT for aphasia starts on average three to six weeks after onset. Second, we 
specifically aimed to study the effect of early initiated treatment. With a maximal inclusion 
period of two weeks and a four-week intervention period this early phase was not exceeded. 
Lastly, we expected that a longer intervention with high intensity would be too burdensome 
for many patients.  
Treatment was directed at semantics using the therapy program BOX23 and/or phonology 
using the therapy program FIKS24, to improve word finding deficits. Participating SL-
therapists had ample experience in using both Dutch therapy programs and carefully 
selected exercises for face-to-face treatment and homework, registered as part of the total 
amount of treatment provided. Treatment could be delivered at the local treatment facility 
or at home, whatever was most convenient for patients. 
The control group received no language treatment during the first four weeks after 
randomization. Minimal counseling was allowed, aimed at preventing communication 
problems and included elaborate information about aphasia and providing communication 
advice. Concise diagnostics for therapy goal setting was allowed also.  
The trial coordinator had at least two-weekly contact with the SL-therapists to ensure no 
treatment was provided in the control group and to monitor compliance in the intervention 
group. After four weeks, further SLT was left to the discretion of the local SL-therapist in 
both groups.  
 
Assessments 
An extensive linguistic test protocol was conducted at three time points; four weeks, three 
months and six months after randomization, with the following tests for language and 
communication: Amsterdam-Nijmegen Everyday Language Test (ANELT) for everyday 
functional verbal communication,25 a semi-standardized interview from the Aachen Aphasia 
Test (AAT) rated with the reliable and valid ordered categorical six-point ASRS; the ScreeLing, 
the Token Test, and the Boston Naming Test. The battery also included tests for semantic 
processing: Semantic Association Test (SAT), verbal version; Comprehensive Aphasia Test 
(CAT), word comprehension; and Category Fluency; and for phonological processing: 
Nonword repetition and Auditory Lexical Decision from the Psycholinguistic Assessment of 
Language Processing in Aphasia (PALPA) and Letter Fluency. In addition, we assessed general 
functional outcome with the EQ-5D-3L for quality of life, and the modified Rankin Scale 
(mRS) and Barthel Index for level of independency. 
 
Outcomes 
Primary outcome was the ANELT-A score ‘understandability’ (score range: 10 to 50, higher 
scores equal better performance), measuring the adequacy of verbal communication, four 
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consecutively numbered, opaque, sealed envelopes. Randomization was stratified according 
to baseline aphasia severity (Aphasia Severity Rating Scale: ASRS score 0 to 2 = severe; ASRS 
score 3 to 4 = moderate/mild) and including center.  
 
Baseline tests 
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spontaneous speech samples as fluent or non-fluent. Baseline characteristics and the Barthel 
Index were recorded, as well as treatment with intravenous alteplase, as this is associated 
with rapid recovery from stroke.22  
 
Intervention 
Patients in the intervention group were to receive at least one hour of CLT every day of the 
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session per day, if preferable. We chose an intervention period of four weeks for three 
reasons. First, intervention in the control group had to reflect usual care in the Netherlands, 
where SLT for aphasia starts on average three to six weeks after onset. Second, we 
specifically aimed to study the effect of early initiated treatment. With a maximal inclusion 
period of two weeks and a four-week intervention period this early phase was not exceeded. 
Lastly, we expected that a longer intervention with high intensity would be too burdensome 
for many patients.  
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or at home, whatever was most convenient for patients. 
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The trial coordinator had at least two-weekly contact with the SL-therapists to ensure no 
treatment was provided in the control group and to monitor compliance in the intervention 
group. After four weeks, further SLT was left to the discretion of the local SL-therapist in 
both groups.  
 
Assessments 
An extensive linguistic test protocol was conducted at three time points; four weeks, three 
months and six months after randomization, with the following tests for language and 
communication: Amsterdam-Nijmegen Everyday Language Test (ANELT) for everyday 
functional verbal communication,25 a semi-standardized interview from the Aachen Aphasia 
Test (AAT) rated with the reliable and valid ordered categorical six-point ASRS; the ScreeLing, 
the Token Test, and the Boston Naming Test. The battery also included tests for semantic 
processing: Semantic Association Test (SAT), verbal version; Comprehensive Aphasia Test 
(CAT), word comprehension; and Category Fluency; and for phonological processing: 
Nonword repetition and Auditory Lexical Decision from the Psycholinguistic Assessment of 
Language Processing in Aphasia (PALPA) and Letter Fluency. In addition, we assessed general 
functional outcome with the EQ-5D-3L for quality of life, and the modified Rankin Scale 
(mRS) and Barthel Index for level of independency. 
 
Outcomes 
Primary outcome was the ANELT-A score ‘understandability’ (score range: 10 to 50, higher 
scores equal better performance), measuring the adequacy of verbal communication, four 
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weeks after randomization. This valid and reliable test was chosen to verify whether the 
impairment-based CLT generalizes to everyday communication.25 All ANELTs were audio-
recorded and rated by five experienced and additionally trained independent assessors, 
blinded to intervention and time point. Each ANELT was scored by two assessors. If scores of 
the two assessors differed more than six points, they were asked to rate the test again 
without providing them details about the direction of the differences. The mean of these 
two scores was used for analyses. In case of persistent differences between assessors, the 
scores were averaged with the score of a third independent assessor, who was unaware of 
other scores. Secondary outcomes were scores on the linguistic tests, EQ-5D-3L and mRS at 
four weeks, and scores on the ANELT-A, the linguistic tests, EQ-5D-3L, and mRS at three and 
six months after randomization.  
 
Sample size 
We considered a four-point difference between both groups on the ANELT-A a clinically 
worthwhile treatment effect. This is 50% of the critical difference for individual 
improvement and half a standard deviation of average ANELT-A scores in previous RATS 
trials.25-27 We estimated that a sample of 150 participants would provide 84% power to find 
a statistically significant treatment effect at a 5% two-sided significance level.  
 
Blinding and data safety 
To ensure data safety and blinding, the primary outcome for each patient was scored by two 
of the five independent assessors, who were blinded to treatment allocation and time point. 
Furthermore, data were collected in four separate anonymized databases, which were 
merged after patient inclusion and data collection were completed. Hence, during data 
collection the trial coordinator could only access individual patient data. Scores on the 
primary outcome measure remained masked for the entire RATS-3 investigator team until 
data collection was completed. 
An independent assessor verified a random sample of 10% of all participants’ files, by 
comparing all data points in the databases with the original source files. Apart from minor 
inaccuracies, no critical errors endangering data quality were found. Yet, all data points were 
checked against source data again by the study coordinator, further minimizing errors.  
 The trial was not overseen by a data monitoring committee, as this concerned a non-
medical intervention study without anticipated adverse events.  
 
Statistical analyses 
Primary analyses were performed on intention-to-treat basis. In addition, on-treatment 
analyses were performed, with on-treatment being defined for the intervention group as 
having accomplished at least the intended intensity of 28 hours in four weeks and for the 
control group as having received no language treatment during four weeks after 
randomization. We used linear regression to analyze the treatment effect as a mean 
difference in ANELT-A scores between the intervention and control group four weeks after 
randomization, adjusted for age (years), sex, education (high or low), baseline aphasia 
severity (ASRS score), type of stroke (ischemic or hemorrhagic), location of stroke (right or 
left hemisphere) and baseline Barthel Index score. Linear regression was also used to analyze 
the effect of treatment on the specific linguistic measures and measures of general 
functional outcome at four weeks, three months and six months after randomization, with 
 
 
the same adjustments as in the primary analysis. For the ordered categorical variable mRS 
we used multivariable ordinal logistic regression.  
 
Handling of missing data  
Standard simple imputation techniques were used to impute missing baseline variables; 
study mean for continuous variables and study mode for binary and categorical data. 
Patients who died during the intervention period were assigned the worst score on all 
outcome measures and this score was carried forward during follow-up. Subjects with 
missing values at a certain time point were excluded from analyses at that time point. 
Statistical analyses were performed using IBM SPSS software version 23.0.  
 
Post-hoc subgroup analyses 
Post-hoc subgroup analyses were conducted with the ANELT-A four weeks after 
randomization per covariate used for baseline adjustment in the regression analyses. We 
also compared treatment effects in patients treated with intravenous alteplase and those 
who were not, and in patients with and without a cardiac source of emboli. 
 
Synthesis of evidence 
In order to put our findings into perspective we have performed a concise meta-analysis of 
the available evidence on the topic of early initiated SLT. In December of 2015, we searched 
PubMed and the Cochrane Library for studies published between 1990 and 2015 with the 
search terms: aphasia, stroke, treatment, therapy, rehabilitation, acute, early and timing. We 
selected randomized controlled trials on early initiated SLT for aphasia due to stroke, i.e. the 
largest part of the treatment was provided within four weeks of stroke onset. Only RCTs 
comparing early treatment to no treatment, or early intensive treatment to no treatment or 
usual care were selected. We have used results from the primary outcomes reported in the 
selected studies and our primary outcome for the meta-analysis by standardizing the mean 
differences between study arms.    
 
RESULTS 
 
From 1 January 2012 until 2 December 2014 we included 153 participants with first-ever 
aphasia due to stroke, of whom 80 were allocated to the intervention group (Figure 1). One 
participant in the control group was excluded after randomization, because more detailed 
assessment revealed that a brain tumor had been misdiagnosed as hemorrhagic infarct. The 
baseline distribution of clinical characteristics was similar for both groups (Table 2).  
In the intervention group, two patients died in the intervention period, and in the control 
group one patient died in the intervention period and one just afterwards, before testing 
could be performed (Figure 1). During follow-up, in each group two patients died. Five 
participants from the intervention group did not receive the allocated treatment; one was 
very ill and four refused intensive treatment. In the control group, ten participants refused 
deferred treatment and received regular SLT. The trial coordinator did not interfere with 
treatment, and details on the content of SLT provided to these patients were not recorded.  
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Figure 1. Flow-chart Rotterdam Aphasia Therapy Study – 3 
 
 
Table 2. Baseline characteristics of participants in RATS-3 
 Intervention group  
(n = 80) 
Control group  
(n = 72) 
Age in years, mean (SD)  66 (12) 66 (12) 
Male sex, n (%) 48 (60%) 37 (51%) 
Handedness, n (%)   
 Right  63 (79%) 61 (85%) 
Left  6 (8%) 7 (10%) 
Ambidextrous  5 (6%) 1 (1%) 
Unknown 6 (8%) 3 (4%) 
Level of education, n (%)   
 No/unfinished elementary school  3(4%) 0 
Elementary school 13 (16%) 11 (15%) 
Unfinished junior secondary vocational education 4 (5%) 8 (11%) 
Junior secondary vocational education 27 (34%) 13 (18%) 
         Total low education  47 (59%) 32 (44%) 
Senior vocational education 17 (21%) 16 (22%) 
Higher education 13 (16%) 18 (25%) 
University 2 (3%) 3 (4%) 
         Total high education 32 (40%) 37 (51%) 
Unknown 1 (1%) 3 (4%) 
Type of stroke, n (%)   
 Ischemic 60 (75%) 61 (85%) 
Hemorrhagic 20 (25%) 11 (15%) 
Location of lesion, n (%)   
 Left hemisphere 77 (96%) 69 (96%) 
Right hemisphere 3 (4%) 3 (4%) 
Treatment with intravenous alteplase, n (%)   
 Yes 28 (35%) 16 (22%) 
No 50 (63%) 55 (76%) 
Unknown 2 (3%) 1 (1%) 
Time between stroke and randomization  
in days, mean (range) 
8 (1-18) 8 (2-15) 
Time between stroke and start treatment  
in days, mean (range)  
12 (5-22) n.a. 
Barthel Index score, median (IQR) 15 (6-20) 17 (7.5-20) 
Aphasia severity, n (%)   
 Severe (ASRS score = 0 to 2) 44 (55%) 30 (42%) 
Mild-moderate (ASRS score = 3 to 4) 36 (45%) 42 (58%) 
Fluency, n (%)   
 Fluent aphasia 26 (33%) 30 (42%) 
 Non-fluent aphasia 52 (65%) 42 (58%) 
 Missing 2 (3%) 0 
Abbreviations: n = number; SD = standard deviation; IQR = Interquartile Range; ASRS = Aphasia Severity Rating 
Scale; n.a. = not applicable.  
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Compliance 
A treatment intensity of 28 hours in four weeks in the intervention group was achieved by 23 
of 80 patients (29%). The median treatment intensity was 24.5 hours in four weeks (IQR: 19 
to 29) (Figure 2). 
 
Figure 2. Distribution of treatment intensity in the intervention group  
Reasons for not achieving the intended intensity:  
 Fatigue: n = 5 
 Concomitant illness: n = 8  
 Inability to practice independently: n = 7  
 Lack of motivation: n = 11  
 Organizational issues: n = 2  
 Combination of factors above: n = 15  
 Died during intervention period: n = 2 
 Unknown: n = 7 
 
 
Intention-to-treat analysis 
The mean score on the primary outcome, the ANELT-A at four weeks, was 33.2 in the 
intervention group and 36.2 in the control group, with a difference of -3.01; 95% CI: -7.15 to 
1.14. Baseline aphasia severity and baseline Barthel Index were strong prognostic factors in 
the regression model (Table 3). The adjusted mean difference in scores on the ANELT-A was 
0.39; 95% CI: -2.70 to 3.47, p = 0.81 (Figure 3). There were also no statistically significant 
differences on the ANELT-A between groups at three months (adjusted difference = 0.54, 
95% CI: -3.04 to 4.12, p = 0.77) and six months after randomization (adjusted difference = -
0.41, 95% CI: -3.70 to 2.89, p = 0.81) (Figure 3).  
 
Table 3. Prognostic factors in the linear regression model with ANELT-A at four weeks as outcome 
 β 95% CI p-value 
Sex (female or male) -2.08 [-5.17 – 1.02]   0.19 
Age  0.02 [-0.10 – 0.15]   0.74 
Type of stroke (hemorrhagic or ischemic)   1.46 [-2.39 – 5.31]   0.45 
Location stroke (right or left hemisphere)  0.35 [-7.16 – 7.85]   0.93 
Education (high or low)  2.64 [-0.47 – 5.75]   0.10 
Barthel Index score (0-20)  0.37 [0.11 – 0.62]   0.01* 
Aphasia Severity Rating Scale score (0-5)  5.90 [4.58 – 7.23] <0.01* 
Abbreviations: β = unstandardized difference; 95% CI = 95% confidence interval.  
* Statistically significant at a 95% confidence level.  
 
No statistically significant treatment effects were observed on the linguistic tests and on 
the measures for general functional outcome, at any time point (Table 4).  
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Figure 3. Differences in outcome and treatment effect between intervention and control on the 
ANELT-A  
Abbreviations: 95% CI = 95% Confidence Interval; ANELT = Amsterdam-Nijmegen Everyday Language Test; 
unadj. diff = unadjusted differences.  
* Statistically significant at a 95% confidence level.  
◊ Primary outcome. 
 
 
 
 
Table 4. Differences in outcome and treatment effect between intervention and control on 
secondary outcomes: intention-to-treat analyses 
 Intervention 
mean (SD) 
Control 
mean (SD) 
Unadjusted 
difference                   
[95% CI] 
Adjusted 
difference             
[95% CI] 
p-value 
SAT verbal 
(0-30) 
4 weeks 21.2 (7.9) 22.1 (7.8) -0.86  [-3.50 – 1.78] 
1.09  
[-1.27 – 3.45] 0.36 
3 months 22.7 (7.6) 24.1 (6.2) -1.41 [-3.81 – 0.99] 
-0.34  
[-2.58 – 1.91] 0.77 
6 months 23.0 (7.3) 24.2 (6.6) -1.25  [-3.70 – 1.20] 
-0.12  
[-2.41 – 2.18] 0.92 
Category 
Fluency   
(no. words/ 
minute) 
4 weeks 12.6 (11.0) 15.9 (11.9) -3.32  [-7.13 – 0.50] 
-0.06  
[-3.09 – 2.96] 0.97 
3 months 16.2 (11.0) 20.3 (12.8) -4.13  [-8.26 – 0.00] 
-1.50  
[-4.86 – 1.86] 0.38 
6 months 16.5 (11.7) 21.1 (13.3) -4.56  [-8.98 – -0.13] 
-1.77  
[-5.47 – 1.93] 0.35 
CAT            
(0-30) 
4 weeks 25.0 (6.9) 24.9 (7.4) 0.12  [-2.26 – 2.50] 
1.40  
[-0.93 – 3.72] 0.24 
3 months 25.5 (6.6) 26.4 (6.0) -0.96  [-3.11 – 1.20] 
-0.10  
[-2.20 – 2.01] 0.93 
6 months 25.8 (7.0) 27.0 (5.4) -1.18  [-3.40 – 1.05] 
-0.45  
[-2.66 – 1.76] 0.69 
PALPA 
Nonword 
repetition 
(0-24) 
4 weeks 16.6 (7.6) 18.3 (6.3) -1.76  [-4.10 – 0.58] 
-0.39  
[-2.46 – 1.67] 0.71 
3 months 16.9 (7.6) 19.1 (6.0) -2.15  [-4.52 – 0.22] 
-1.02  
[-3.04 – 0.99] 0.32 
6 months 16.7 (7.5) 18.6 (5.7) -1.90  [-4.26 – 0.46] 
-0.79  
[-2.91 – 1.34] 0.47 
Letter 
Fluency   
(no. words / 
minute) 
4 weeks 11.4 (9.6) 14.0 (10.9) -2.62  [-6.04 – 0.80] 
-0.29  
[-3.25 – 2.67] 0.85 
3 months 12.8 (9.7) 17.1 (12.6) -4.33  [-8.19 – -0.47] 
-2.19  
[-5.65 – 1.28] 0.21 
6 months 15.0 (10.4) 17.3 (12.5) -2.35  [-6.39 – 1.69] 
0.04  
[-3.56 – 3.64] 0.98 
PALPA 
Auditory 
Lexical 
Decision   
(0-80) 
4 weeks 67.2 (18.4) 70.8 (14.6) -3.61  [-9.18 – 1.97] 
-1.46  
[-6.91 – 3.99] 0.60 
3 months 68.1 (17.6) 72.3 (14.2) -4.23  [-9.78 – 1.32] 
-2.18  
[-7.57 – 3.22] 0.43 
6 months 68.7 (18.4) 72.3 (14.3) -3.64  [-9.50 – 2.22] 
-1.79  
[-7.63 – 4.05] 0.55 
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difference             
[95% CI] 
p-value 
SAT verbal 
(0-30) 
4 weeks 21.2 (7.9) 22.1 (7.8) -0.86  [-3.50 – 1.78] 
1.09  
[-1.27 – 3.45] 0.36 
3 months 22.7 (7.6) 24.1 (6.2) -1.41 [-3.81 – 0.99] 
-0.34  
[-2.58 – 1.91] 0.77 
6 months 23.0 (7.3) 24.2 (6.6) -1.25  [-3.70 – 1.20] 
-0.12  
[-2.41 – 2.18] 0.92 
Category 
Fluency   
(no. words/ 
minute) 
4 weeks 12.6 (11.0) 15.9 (11.9) -3.32  [-7.13 – 0.50] 
-0.06  
[-3.09 – 2.96] 0.97 
3 months 16.2 (11.0) 20.3 (12.8) -4.13  [-8.26 – 0.00] 
-1.50  
[-4.86 – 1.86] 0.38 
6 months 16.5 (11.7) 21.1 (13.3) -4.56  [-8.98 – -0.13] 
-1.77  
[-5.47 – 1.93] 0.35 
CAT            
(0-30) 
4 weeks 25.0 (6.9) 24.9 (7.4) 0.12  [-2.26 – 2.50] 
1.40  
[-0.93 – 3.72] 0.24 
3 months 25.5 (6.6) 26.4 (6.0) -0.96  [-3.11 – 1.20] 
-0.10  
[-2.20 – 2.01] 0.93 
6 months 25.8 (7.0) 27.0 (5.4) -1.18  [-3.40 – 1.05] 
-0.45  
[-2.66 – 1.76] 0.69 
PALPA 
Nonword 
repetition 
(0-24) 
4 weeks 16.6 (7.6) 18.3 (6.3) -1.76  [-4.10 – 0.58] 
-0.39  
[-2.46 – 1.67] 0.71 
3 months 16.9 (7.6) 19.1 (6.0) -2.15  [-4.52 – 0.22] 
-1.02  
[-3.04 – 0.99] 0.32 
6 months 16.7 (7.5) 18.6 (5.7) -1.90  [-4.26 – 0.46] 
-0.79  
[-2.91 – 1.34] 0.47 
Letter 
Fluency   
(no. words / 
minute) 
4 weeks 11.4 (9.6) 14.0 (10.9) -2.62  [-6.04 – 0.80] 
-0.29  
[-3.25 – 2.67] 0.85 
3 months 12.8 (9.7) 17.1 (12.6) -4.33  [-8.19 – -0.47] 
-2.19  
[-5.65 – 1.28] 0.21 
6 months 15.0 (10.4) 17.3 (12.5) -2.35  [-6.39 – 1.69] 
0.04  
[-3.56 – 3.64] 0.98 
PALPA 
Auditory 
Lexical 
Decision   
(0-80) 
4 weeks 67.2 (18.4) 70.8 (14.6) -3.61  [-9.18 – 1.97] 
-1.46  
[-6.91 – 3.99] 0.60 
3 months 68.1 (17.6) 72.3 (14.2) -4.23  [-9.78 – 1.32] 
-2.18  
[-7.57 – 3.22] 0.43 
6 months 68.7 (18.4) 72.3 (14.3) -3.64  [-9.50 – 2.22] 
-1.79  
[-7.63 – 4.05] 0.55 
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BNT           
(0-60) 
4 weeks 28.6 (17.9) 31.4 (20.4) -3.08 [-9.44 – 3.29] 
1.40  
[-3.99 – 6.78] 0.23 
3 months 33.0 (17.7) 37.5 (18.3) -4.42  [-10.61 – 1.76] 
-1.46  
[-6.85 – 3.94] 0.59 
6 months 34.9 (18.0) 39.5 (17.9) -4.56  [-10.86 – 1.74] 
-1.29  
[-6.85 – 4.28] 0.65 
Token Test 
(0-36) 
4 weeks 20.9 (10.4) 23.7 (10.3) -2.84  [-6.30 – 0.62] 
-0.10  
[-2.98 – 2.78] 0.94 
3 months 23.3 (10.6) 26.0 (9.3) -2.75  [-6.17 – 0.67] 
-0.86  
[-3.68 – 1.95] 0.55 
6 months 23.7 (10.9) 26.7 (9.1) -3.00  [-6.57 – 0.57] 
-0.83  
[-3.92 – 2.25] 0.59 
EQ-5D-3L  
(0-1) 
4 weeks 0.79 (0.11) 0.81 (0.11) -0.02  [-0.06 – 0.02] 
-0.01  
[-0.05 – 0.02] 0.48 
3 months 0.82 (0.12) 0.81 (0.13) 0.01  [-0.03 – 0.05] 
0.02  
[-0.02 – 0.06] 0.32 
6 months 0.82 (0.13) 0.82 (0.13) -0.01  [-0.05 – 0.04] 
-0.01  
[-0.05 – 0.04] 0.78 
mRS         
(5-0) 
4 weeks 3 3 -0.22  [-0.80 – 0.36] 
-0.01  
[-0.62 – 0.62] 0.99 
3 months 2 2 -0.23  [-0.82 – 0.36] 
0.06  
[-0.57 – 0.70] 0.85 
6 months 2 2 -0.23  [-0.83 – 0.38] 
-0.07 
[-0.70 – 0.57] 0.84 
 
Abbreviations: SD = standard deviation; 95% CI = 95% confidence interval; SAT = Semantic Association Test; CAT 
= Comprehensive Aphasia Test; PALPA = Psycholinguistic Assessment of Language Processing in Aphasia; BNT = 
Boston Naming Test; mRS = modified Rankin Scale. 
 Mode is reported for this categorical variable. 
 
On-treatment analysis 
In the on-treatment analysis we included all patients of the intervention group who received 
at least the prespecified intensity of 28 hours in four weeks (n = 23, 29%) and all subjects in 
the control group who did not receive any treatment (n = 62, 86%). Baseline characteristics 
of the intervention and control group included in the on-treatment analyses were similar 
(Table 5).  
When on-treatment criteria were applied, the intervention group reached significantly 
higher scores than the control group after four weeks on the primary outcome ANELT-A 
(adjusted difference = 5.41, 95% CI: 1.52 to 9.31, p = 0.01); SAT verbal (adjusted difference = 
3.57, 95% CI: 0.36 to 6.78, p = 0.03) and CAT word comprehension (adjusted difference = 
3.64, 95% CI: 0.58 to 6.69, p = 0.02) (Figure 3, Table 6). On all other outcome measures and 
time points results did not differ from those of the intention-to-treat analyses.  
 
 
 
Table 5. Baseline characteristics of participants in the on-treatment analyses 
 Intervention  
(n = 23) 
Control  
(n = 62) 
Age in years, mean (SD)  64 (11) 66 (12) 
Male sex, n (%) 17 (74%) 31 (50%) 
Handedness, n (%)   
 Right  20 (87%) 53 (86%) 
Left  2 (9%) 7 (11%) 
Ambidextrous  1 (4%) 1 (2%) 
Unknown 0 1 (2%) 
Level of education, n (%)   
 No/unfinished elementary school  1 (4%) 0 
Elementary school 3 (13%) 9 (15%) 
Unfinished junior secondary vocational 
education 
1 (4%) 7 (11%) 
Junior secondary vocational education 7 (30%) 10 (16%) 
         Total low education  12 (52%) 28 (45%) 
Senior vocational education 4 (17%) 15 (24%) 
Higher education 6 (26%) 16 (26%) 
University 1 (4%) 3 (5%) 
         Total high education 11 (48%) 34 (55%) 
Unknown 0 2 (3%) 
Type of stroke, n (%)   
 Ischemic 18 (78%) 53 (86%) 
Hemorrhagic 5 (22%) 9 (15%) 
Location of lesion, n (%)   
 Left hemisphere 22 (96%) 59 (95%) 
Right hemisphere 1 (4%) 3 (5%) 
Treatment with intravenous alteplase, n (%)   
 Yes 9 (39%) 16 (26%) 
No 14 (61%) 45 (73%) 
Unknown 0 1 (2%) 
Time between stroke and randomization  
in days, mean (range)  
7 (2-14) 8 (2-15) 
Time between stroke and start treatment  
in days, mean (range)  
11 (6-19) n.a. 
Barthel Index Score, median (IQR) 20 (7.5-20) 17 (6-20) 
Aphasia severity, n (%)   
 Severe (ASRS score = 0 to 2) 12 (52%) 25 (40%) 
Mild-moderate (ASRS score = 3 to 4) 11 (48%) 37 (60%) 
Abbreviations: n = number; SD = standard deviation; IQR = Interquartile Range; ASRS = Aphasia Severity Rating 
Scale; n.a. = not applicable.  
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BNT           
(0-60) 
4 weeks 28.6 (17.9) 31.4 (20.4) -3.08 [-9.44 – 3.29] 
1.40  
[-3.99 – 6.78] 0.23 
3 months 33.0 (17.7) 37.5 (18.3) -4.42  [-10.61 – 1.76] 
-1.46  
[-6.85 – 3.94] 0.59 
6 months 34.9 (18.0) 39.5 (17.9) -4.56  [-10.86 – 1.74] 
-1.29  
[-6.85 – 4.28] 0.65 
Token Test 
(0-36) 
4 weeks 20.9 (10.4) 23.7 (10.3) -2.84  [-6.30 – 0.62] 
-0.10  
[-2.98 – 2.78] 0.94 
3 months 23.3 (10.6) 26.0 (9.3) -2.75  [-6.17 – 0.67] 
-0.86  
[-3.68 – 1.95] 0.55 
6 months 23.7 (10.9) 26.7 (9.1) -3.00  [-6.57 – 0.57] 
-0.83  
[-3.92 – 2.25] 0.59 
EQ-5D-3L  
(0-1) 
4 weeks 0.79 (0.11) 0.81 (0.11) -0.02  [-0.06 – 0.02] 
-0.01  
[-0.05 – 0.02] 0.48 
3 months 0.82 (0.12) 0.81 (0.13) 0.01  [-0.03 – 0.05] 
0.02  
[-0.02 – 0.06] 0.32 
6 months 0.82 (0.13) 0.82 (0.13) -0.01  [-0.05 – 0.04] 
-0.01  
[-0.05 – 0.04] 0.78 
mRS         
(5-0) 
4 weeks 3 3 -0.22  [-0.80 – 0.36] 
-0.01  
[-0.62 – 0.62] 0.99 
3 months 2 2 -0.23  [-0.82 – 0.36] 
0.06  
[-0.57 – 0.70] 0.85 
6 months 2 2 -0.23  [-0.83 – 0.38] 
-0.07 
[-0.70 – 0.57] 0.84 
 
Abbreviations: SD = standard deviation; 95% CI = 95% confidence interval; SAT = Semantic Association Test; CAT 
= Comprehensive Aphasia Test; PALPA = Psycholinguistic Assessment of Language Processing in Aphasia; BNT = 
Boston Naming Test; mRS = modified Rankin Scale. 
 Mode is reported for this categorical variable. 
 
On-treatment analysis 
In the on-treatment analysis we included all patients of the intervention group who received 
at least the prespecified intensity of 28 hours in four weeks (n = 23, 29%) and all subjects in 
the control group who did not receive any treatment (n = 62, 86%). Baseline characteristics 
of the intervention and control group included in the on-treatment analyses were similar 
(Table 5).  
When on-treatment criteria were applied, the intervention group reached significantly 
higher scores than the control group after four weeks on the primary outcome ANELT-A 
(adjusted difference = 5.41, 95% CI: 1.52 to 9.31, p = 0.01); SAT verbal (adjusted difference = 
3.57, 95% CI: 0.36 to 6.78, p = 0.03) and CAT word comprehension (adjusted difference = 
3.64, 95% CI: 0.58 to 6.69, p = 0.02) (Figure 3, Table 6). On all other outcome measures and 
time points results did not differ from those of the intention-to-treat analyses.  
 
 
 
Table 5. Baseline characteristics of participants in the on-treatment analyses 
 Intervention  
(n = 23) 
Control  
(n = 62) 
Age in years, mean (SD)  64 (11) 66 (12) 
Male sex, n (%) 17 (74%) 31 (50%) 
Handedness, n (%)   
 Right  20 (87%) 53 (86%) 
Left  2 (9%) 7 (11%) 
Ambidextrous  1 (4%) 1 (2%) 
Unknown 0 1 (2%) 
Level of education, n (%)   
 No/unfinished elementary school  1 (4%) 0 
Elementary school 3 (13%) 9 (15%) 
Unfinished junior secondary vocational 
education 
1 (4%) 7 (11%) 
Junior secondary vocational education 7 (30%) 10 (16%) 
         Total low education  12 (52%) 28 (45%) 
Senior vocational education 4 (17%) 15 (24%) 
Higher education 6 (26%) 16 (26%) 
University 1 (4%) 3 (5%) 
         Total high education 11 (48%) 34 (55%) 
Unknown 0 2 (3%) 
Type of stroke, n (%)   
 Ischemic 18 (78%) 53 (86%) 
Hemorrhagic 5 (22%) 9 (15%) 
Location of lesion, n (%)   
 Left hemisphere 22 (96%) 59 (95%) 
Right hemisphere 1 (4%) 3 (5%) 
Treatment with intravenous alteplase, n (%)   
 Yes 9 (39%) 16 (26%) 
No 14 (61%) 45 (73%) 
Unknown 0 1 (2%) 
Time between stroke and randomization  
in days, mean (range)  
7 (2-14) 8 (2-15) 
Time between stroke and start treatment  
in days, mean (range)  
11 (6-19) n.a. 
Barthel Index Score, median (IQR) 20 (7.5-20) 17 (6-20) 
Aphasia severity, n (%)   
 Severe (ASRS score = 0 to 2) 12 (52%) 25 (40%) 
Mild-moderate (ASRS score = 3 to 4) 11 (48%) 37 (60%) 
Abbreviations: n = number; SD = standard deviation; IQR = Interquartile Range; ASRS = Aphasia Severity Rating 
Scale; n.a. = not applicable.  
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Table 6. Differences in outcome and treatment effect between intervention and control on 
secondary outcomes: on-treatment analyses 
 Intervention 
mean (SD) 
Control 
mean (SD) 
Unadjusted 
difference                   
[95% CI] 
Adjusted 
difference             
[95% CI] 
p-value 
SAT verbal 
(0-30) 
4 weeks 24.8 (4.1) 22.1 (8.0) 2.67  [-0.81 – 6.14] 
3.57  
[0.36 – 6.78] 0.03* 
3 months 26.1 (2.5) 24.1 (6.3) 1.93  [-0.92 – 4.77] 
1.92  
[-0.88 – 4.73] 0.18 
6 months 26.3 (2.5) 24.2 (6.8) 2.04  [-1.23 – 5.30] 
2.17  
[-0.99 – 5.33] 0.18 
Category 
Fluency   
(no. words/ 
minute) 
4 weeks 17.6 (11.4) 16.4 (12.0) 1.25  [-4.48 – 6.99] 
1.61  
[-3.12 – 6.33] 0.50 
3 months 22.5 (10.0) 21.1 (13.0) 1.41  [-4.85 – 7.66] 
1.03  
[-4.49 – 6.55] 0.37 
6 months 24.1 (12.4) 21.6 (13.6) 2.46  [-4.72 – 9.63] 
1.74  
[-4.77 – 8.26] 0.60 
CAT            
(0-30) 
4 weeks 28.0 (2.5) 25.0 (7.3) 3.01  [-0.08 – 6.10] 
3.64  
[0.58 – 6.69] 0.02* 
3 months 28.1 (1.8) 26.3 (6.1) 1.80  [-0.92 – 4.52] 
1.99  
[-0.72 – 4.70] 0.15 
6 months 28.4 (1.9) 27.0 (5.6) 1.44  [-1.26 – 4.14] 
1.50  
[-1.27 – 4.27] 0.28 
PALPA 
Nonword 
repetition 
(0-24) 
4 weeks 20.0 (3.3) 18.3 (6.5) 1.73  [-1.11 – 4.56] 
1.79  
[-0.86 – 4.43] 0.18 
3 months 20.6 (2.6) 19.4 (5.9) 1.27  [-1.37 – 3.91] 
0.85  
[-1.52 – 3.21] 0.48 
6 months 20.6 (2.4) 18.6 (5.8) 2.05  [-0.76 – 4.86] 
1.35  
[-1.34 – 4.04] 0.32 
Letter 
Fluency   
(no. words / 
minute) 
4 weeks 15.0 (10.7) 14.3 (11.2) 0.67  [-4.70 – 6.03] 
0.93  
[-3.85 – 5.72] 0.70 
3 months 17.0 (10.4) 17.4 (13.0) -0.49  [-6.77 – 5.80] 
-1.12  
[-6.99 – 4.75] 0.71 
6 months 21.0 (11.1) 17.5 (12.8) 3.51  [-3.19 – 10.21] 
2.70  
[-3.46 – 8.87] 0.39 
PALPA 
Auditory 
Lexical 
Decision   
(0-80) 
4 weeks 73.7 (5.9) 70.6 (15.2) 3.07  [-3.43 – 9.56] 
3.31  
[-3.24 – 9.86] 0.32 
3 months 75.3 (3.9) 71.9 (14.9) 3.46  [-3.12 – 10.04] 
3.39  
[-3.31 – 10.09]  0.32 
6 months 75.5 (3.6) 72.0 (14.9) 3.48  [-3.62 – 10.58] 
3.06  
[-4.21 – 10.34] 0.40 
 
 
BNT           
(0-60) 
4 weeks 37.3 (14.6) 31.7 (20.0) 5.52  [-3.57 – 14.61] 
6.27  
[-1.38 – 13.93] 0.11 
3 months 41.9 (13.7) 38.0 (17.9) 3.82  [-4.74 – 12.38] 
4.65  
[-3.39 – 12.69] 0.25 
6 months 42.7 (14.7) 40.0 (17.5) 2.69  [-6.39 – 11.76] 
3.19  
[-4.96 – 11.34] 0.44 
Token Test 
(0-36) 
4 weeks 24.4 (8.0) 24.1 (10.2) 0.35  [-4.35 – 5.04] 
1.12  
[-2.83 – 5.08] 0.57 
3 months 27.8 (7.4) 26.5 (9.2)  1.30  [-3.14 – 5.75] 
1.33  
[-2.57 – 5.24] 0.50 
6 months 29.4 (6.7) 26.9 (9.1) 2.59  [-2.06 – 7.25] 
2.29  
[-1.79 – 6.36] 0.27 
EQ-5D-3L  
(0-1) 
4 weeks 0.83 (0.12) 0.81 (0.11) 0.02  [-0.04 – 0.08] 
0.01  
[-0.04 – 0.06] 0.72 
3 months 0.86 (0.11) 0.81 (0.12) 0.05  [-0.02 – 0.11] 
0.03  
[-0.03 – 0.09] 0.29 
6 months 0.87 (0.11) 0.83 (0.13) 0.04  [-0.03 – 0.11] 
0.02  
[-0.05 – 0.09] 0.53 
mRS       
(5-0) 
4 weeks 3 2 0.45  [-0.43 – 1.33]  
0.64  
[-0.31 – 1.59] 0.19 
3 months 2 2 0.35  [-0.55 – 1.24] 
0.41  
[-0.54 – 1.37] 0.39 
6 months 2 2 0.50  [-0.39 – 1.39] 
0.62  
[-0.32 – 1.57] 0.20 
 
Abbreviations: SD = standard deviation; 95% CI = 95% confidence interval; SAT = Semantic Association Test; CAT 
= Comprehensive Aphasia Test; PALPA = Psycholinguistic Assessment of Language Processing in Aphasia; BNT = 
Boston Naming Test; mRS = modified Rankin Scale. 
* Statistically significant at a 95% confidence level.  
 Mode is reported for this categorical variable. 
 
Post-hoc subgroup analyses 
We also compared treatment effects per covariate used for baseline adjustment and we 
compared patients treated with intravenous alteplase and those who were not, and patients 
with and without a cardiac source of emboli. There was a statistically significant interaction 
between sex and intervention (adjusted β = -5.94; 95% CI: -10.20 to -1.68, p = 0.01), but not 
for other subgroups (Figure 4).  
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Table 6. Differences in outcome and treatment effect between intervention and control on 
secondary outcomes: on-treatment analyses 
 Intervention 
mean (SD) 
Control 
mean (SD) 
Unadjusted 
difference                   
[95% CI] 
Adjusted 
difference             
[95% CI] 
p-value 
SAT verbal 
(0-30) 
4 weeks 24.8 (4.1) 22.1 (8.0) 2.67  [-0.81 – 6.14] 
3.57  
[0.36 – 6.78] 0.03* 
3 months 26.1 (2.5) 24.1 (6.3) 1.93  [-0.92 – 4.77] 
1.92  
[-0.88 – 4.73] 0.18 
6 months 26.3 (2.5) 24.2 (6.8) 2.04  [-1.23 – 5.30] 
2.17  
[-0.99 – 5.33] 0.18 
Category 
Fluency   
(no. words/ 
minute) 
4 weeks 17.6 (11.4) 16.4 (12.0) 1.25  [-4.48 – 6.99] 
1.61  
[-3.12 – 6.33] 0.50 
3 months 22.5 (10.0) 21.1 (13.0) 1.41  [-4.85 – 7.66] 
1.03  
[-4.49 – 6.55] 0.37 
6 months 24.1 (12.4) 21.6 (13.6) 2.46  [-4.72 – 9.63] 
1.74  
[-4.77 – 8.26] 0.60 
CAT            
(0-30) 
4 weeks 28.0 (2.5) 25.0 (7.3) 3.01  [-0.08 – 6.10] 
3.64  
[0.58 – 6.69] 0.02* 
3 months 28.1 (1.8) 26.3 (6.1) 1.80  [-0.92 – 4.52] 
1.99  
[-0.72 – 4.70] 0.15 
6 months 28.4 (1.9) 27.0 (5.6) 1.44  [-1.26 – 4.14] 
1.50  
[-1.27 – 4.27] 0.28 
PALPA 
Nonword 
repetition 
(0-24) 
4 weeks 20.0 (3.3) 18.3 (6.5) 1.73  [-1.11 – 4.56] 
1.79  
[-0.86 – 4.43] 0.18 
3 months 20.6 (2.6) 19.4 (5.9) 1.27  [-1.37 – 3.91] 
0.85  
[-1.52 – 3.21] 0.48 
6 months 20.6 (2.4) 18.6 (5.8) 2.05  [-0.76 – 4.86] 
1.35  
[-1.34 – 4.04] 0.32 
Letter 
Fluency   
(no. words / 
minute) 
4 weeks 15.0 (10.7) 14.3 (11.2) 0.67  [-4.70 – 6.03] 
0.93  
[-3.85 – 5.72] 0.70 
3 months 17.0 (10.4) 17.4 (13.0) -0.49  [-6.77 – 5.80] 
-1.12  
[-6.99 – 4.75] 0.71 
6 months 21.0 (11.1) 17.5 (12.8) 3.51  [-3.19 – 10.21] 
2.70  
[-3.46 – 8.87] 0.39 
PALPA 
Auditory 
Lexical 
Decision   
(0-80) 
4 weeks 73.7 (5.9) 70.6 (15.2) 3.07  [-3.43 – 9.56] 
3.31  
[-3.24 – 9.86] 0.32 
3 months 75.3 (3.9) 71.9 (14.9) 3.46  [-3.12 – 10.04] 
3.39  
[-3.31 – 10.09]  0.32 
6 months 75.5 (3.6) 72.0 (14.9) 3.48  [-3.62 – 10.58] 
3.06  
[-4.21 – 10.34] 0.40 
 
 
BNT           
(0-60) 
4 weeks 37.3 (14.6) 31.7 (20.0) 5.52  [-3.57 – 14.61] 
6.27  
[-1.38 – 13.93] 0.11 
3 months 41.9 (13.7) 38.0 (17.9) 3.82  [-4.74 – 12.38] 
4.65  
[-3.39 – 12.69] 0.25 
6 months 42.7 (14.7) 40.0 (17.5) 2.69  [-6.39 – 11.76] 
3.19  
[-4.96 – 11.34] 0.44 
Token Test 
(0-36) 
4 weeks 24.4 (8.0) 24.1 (10.2) 0.35  [-4.35 – 5.04] 
1.12  
[-2.83 – 5.08] 0.57 
3 months 27.8 (7.4) 26.5 (9.2)  1.30  [-3.14 – 5.75] 
1.33  
[-2.57 – 5.24] 0.50 
6 months 29.4 (6.7) 26.9 (9.1) 2.59  [-2.06 – 7.25] 
2.29  
[-1.79 – 6.36] 0.27 
EQ-5D-3L  
(0-1) 
4 weeks 0.83 (0.12) 0.81 (0.11) 0.02  [-0.04 – 0.08] 
0.01  
[-0.04 – 0.06] 0.72 
3 months 0.86 (0.11) 0.81 (0.12) 0.05  [-0.02 – 0.11] 
0.03  
[-0.03 – 0.09] 0.29 
6 months 0.87 (0.11) 0.83 (0.13) 0.04  [-0.03 – 0.11] 
0.02  
[-0.05 – 0.09] 0.53 
mRS       
(5-0) 
4 weeks 3 2 0.45  [-0.43 – 1.33]  
0.64  
[-0.31 – 1.59] 0.19 
3 months 2 2 0.35  [-0.55 – 1.24] 
0.41  
[-0.54 – 1.37] 0.39 
6 months 2 2 0.50  [-0.39 – 1.39] 
0.62  
[-0.32 – 1.57] 0.20 
 
Abbreviations: SD = standard deviation; 95% CI = 95% confidence interval; SAT = Semantic Association Test; CAT 
= Comprehensive Aphasia Test; PALPA = Psycholinguistic Assessment of Language Processing in Aphasia; BNT = 
Boston Naming Test; mRS = modified Rankin Scale. 
* Statistically significant at a 95% confidence level.  
 Mode is reported for this categorical variable. 
 
Post-hoc subgroup analyses 
We also compared treatment effects per covariate used for baseline adjustment and we 
compared patients treated with intravenous alteplase and those who were not, and patients 
with and without a cardiac source of emboli. There was a statistically significant interaction 
between sex and intervention (adjusted β = -5.94; 95% CI: -10.20 to -1.68, p = 0.01), but not 
for other subgroups (Figure 4).  
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Figure 4. Subgroup comparisons for the ANELT-A at four weeks after randomization 
 
 
* Statistically significant interaction. 
 
 
 
Synthesis of evidence 
We found two RCTs comparing early intensive SLT to no treatment, one comparing early SLT 
to no SLT, and one comparing early intensive SLT to usual care.6-9 We conducted a meta-
analysis with the primary outcomes reported in these trials and our findings (Figure 5). The 
effect of early initiated SLT over deferred regular SLT or no treatment was small and not 
statistically significant (standardized mean difference = 0.21, 95% CI: -0.13 to 0.56).  
 
Figure 5. Forest plot comparing standardized mean differences between early initiated intensive SLT 
and no treatment or usual care 
 
Abbreviations: ANELT = Amsterdam-Nijmegen Everyday Language Test; AQ = Aphasia Quotient; WAB = Western 
Aphasia Battery; TOM = Therapy Outcome Measure, functional communicative ability; AAT = Aachen Aphasia 
Test. 
Data derived from the Cochrane Systematic Review10 and original manuscripts. 
The figure was made using Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, 
The Cochrane Collaboration, 2014. 
 
DISCUSSION 
 
Principal findings  
In this multicenter RCT in 152 patients with aphasia due to stroke, we found that four weeks 
of early intensive CLT did not result in better everyday verbal communication than no early 
language treatment. The 95% CIs for the adjusted differences between groups did not 
include the prespecified clinically relevant difference of four points on the ANELT-A, which 
allows us to conclude that early intensive CLT is not effective.    
This contradicts the findings from two smaller RCTs in which a benefit of early intensive 
treatment was reported. In 59 patients, 30 to 80 minutes of impairment-based SLT per 
workday for four weeks initiated three days after stroke, improved communication more 
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than usual care (<80 minutes per week).7 Although nearly 20% of patients in the intervention 
group did not achieve the minimum treatment intensity of 150 minutes per week, the 
authors conclude that daily treatment is feasible early after stroke and, if tolerated, is 
effective for recovery of aphasia. In another study, 12 patients were randomly allocated to 
two weeks of either one-hour sessions of impairment-based SLT on workdays starting on 
average 2.2 days after stroke or no SLT.8 In addition to statistically significant better scores in 
the early treatment group on the AAT subparts Naming and Written language processing, 
the authors report significant differences between groups in post treatment recruitment of 
brain areas on functional MRI-scans. However, this is a very small trial with only six 
participants per treatment arm.  
Our findings are in line with those from two larger RCTs on early initiated SLT. In a trial 
among 123 patients, Laska et al. found no effect of three weeks of early intensive 
impairment-based SLT on ANELT-A scores three weeks and six months after stroke onset.6 
Bowen et al. randomly allocated 170 stroke patients with communication deficits to either 
agreed best practice SLT or social support provided by trained volunteers for 16 weeks 
starting on average two weeks after stroke onset.9 They found no differences regarding 
functional communication at follow-up and conclude that SLT is not more effective than 
social support. This trial differs from ours, as stroke patients with either aphasia, dysarthria 
or both were included, which makes the results difficult to interpret. Furthermore, 
treatment intensity was tailored to the individuals’ needs and possibilities. Consequently, 
treatment intensity was on average only 1.5 hours per week, which may not have been 
sufficient to reach a sizeable treatment effect.3, 18, 19 
While the concept of early language rehabilitation after stroke is attractive, the summary 
of evidence in our meta-analysis shows that SLT, whether or not intensive, when started 
within four weeks after stroke onset, is not more effective in improving verbal 
communication or language functioning, than regular, less intensive or deferred treatment. 
 
Strengths and weaknesses 
Strengths of RATS-3 are its large size, multicenter design, a clearly defined clinically relevant 
intervention contrast, and representative cohort of patients with aphasia due to stroke. The 
treatment programs used in the intervention group are frequently applied in daily practice in 
the Netherlands and have good potential to generate an effect on language recovery, as 
exercises are directed at facilitating word finding, an essential problem in aphasia. 
Consequently, results of our trial are highly generalizable to daily practice. We could have 
opted for a more distinct intervention contrast by actively limiting all language related 
activities in the control group e.g. reading, writing and computer use, but that would not 
reflect daily reality. In fact, our aim was to study whether intensive CLT, added to language 
related activities people with aphasia engage in naturally, is effective for the recovery of 
aphasia.  
Many efficacy studies on impairment-based treatment have used impairment-based 
language tests as outcome measures, e.g. naming or word comprehension, as these are 
closely related to the intervention being studied.28 However, scores on linguistic tests are 
rather artificial and do not necessarily reflect adequate functional communication in daily 
life, which should be the ultimate goal of aphasia treatment.3 Therefore, a relevant and 
reliable measure of communication, most closely reflecting the patients’ sense of recovery 
and return to normal functioning, is preferable.10 Hence, in line with our previous trials, both 
 
 
in which we found that improvement on the ANELT-A was correlated with improvement at 
the impairment level, we used the ANELT-A as primary outcome measure.16, 26, 27  
Our study has limitations. Although we accomplished a high median treatment intensity 
of 24.5 hours in four weeks, achieving the intended intensity of 28 hours appeared a major 
challenge. Even with a strictly protocolled treatment regimen and highly motivated SL-
therapists who were frequently contacted by the trial coordinator, less than 30% of the 
intervention group achieved the requested intensity. Patients were often too tired or ill to 
practice one hour per day, even if treatment was spread over the day. Although poor 
adherence to the protocol was mainly caused by patient related issues, organizational 
problems such as limited availability of therapists, or priority given to motor rehabilitation 
also played a role, albeit minor. While this trial was no feasibility study, the results 
demonstrate that even if intensive treatment had been found more effective for selected 
patients, feasibility is improbable for all stroke patients with aphasia early after onset. This is 
in line with findings from the most recent Cochrane review.3  
Patient selection seems essential to generate a potential beneficial effect of early 
intensive CLT on recovery of aphasia, as the on-treatment analyses did show a limited effect. 
However, this finding should be interpreted with great caution, as on-treatment analyses 
could only be performed in patients in the intervention group who could tolerate intensive 
treatment, whereas the control group comprised both patients who may and may not 
tolerate this intensive regimen.  
Completeness of follow-up for the primary outcome was 93%, which is in line with other 
studies in this field.3 At six months after stroke 19% of participants had refused follow-up 
testing. This may have reduced the validity of our findings, but the measurements at three 
and six month follow-up are secondary outcomes and are in line with the primary outcome. 
 
Implications  
Despite the lack of unequivocal proof for a beneficial effect of early SLT, deferring treatment 
in aphasia due to stroke has long been considered unethical.29 However, early after stroke, 
patients may suffer from concomitant illness or fatigue and may not tolerate intensive 
impairment-based treatment. Our findings demonstrate that it is not detrimental to delay 
CLT in the first weeks after stroke onset in these vulnerable patients, which also occasionally 
happens unintentionally due to waiting lists or lengthy diagnostic pathways.   
However, our findings do not justify the conclusion that the work of SL-therapists is 
redundant in the first weeks after stroke, as patients with aphasia and their proxies 
definitely need guidance and help in coping with their deficits early after stroke. In times of 
radical changes in health care policy and budget cutbacks, SL-therapists are urged to utilize 
their limited resources effectively for patients with acute stroke. Instead of focusing on 
impairment-based treatment, they might better put more emphasis on counseling and 
providing communication support, which are essential for coping with communication 
problems and prevention of social isolation. CLT may be more effective later in the course of 
this disabling condition.  
 
Future research 
Future studies should aim to find the optimal timing of commonly used treatment types, 
either impairment-based or functional approaches. New studies may be focused on patient 
selection also, as results from our on-treatment analyses indicate that some patients might 
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benefit from early intensive treatment. International cooperation is one way to conduct 
large aphasia trials that allow for more reliable prespecified subgroup analyses, which is of 
great importance to identify factors contributing to treatment success and may enable 
individualization of SLT.  
 
CONCLUSION 
 
Our study shows that four weeks of intensive CLT aimed at semantic and phonological 
processing started within two weeks after stroke onset does not improve the recovery of 
aphasia, either in the short or long-term. 
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ABSTRACT 
 
Background  
Aphasia due to stroke is often very severe immediately after onset. However, knowledge 
about the impact of severity on therapeutic potential in the first months is scarce. The 
optimal therapeutic approach for patients with severe aphasia is still subject to debate.  
 
Objective 
To explore the recovery pattern of verbal communication in stroke patients with aphasia of 
varying degrees of severity receiving language therapy during the first six months post 
stroke. 
 
Methods  
We used data from our previous trial in which 80 patients with aphasia due to stroke were 
randomized within the first three weeks post onset for either cognitive-linguistic treatment 
or communicative therapy. All patients were tested at baseline and three and six months 
after aphasia onset. We formed three severity groups, based on baseline Amsterdam-
Nijmegen Everyday Language Test scores. We used repeated measures ANOVA to compare 
test scores at baseline, three and six months post stroke onset for each of the three severity 
groups, stratified for the two treatments.  
 
Results  
Patients with severe or very severe aphasia improved substantially during follow-up; 
especially during the first three months post stroke. Improvement was less pronounced in 
the moderate to mild group. Although improvement did not differ significantly between the 
two treatment arms of the trial during the first six months post stroke, the very severe group 
seemed to benefit particularly from cognitive-linguistic treatment (mean difference between 
treatments was 4.1 points; 95% CI: -4.0 to 12.2). 
 
Conclusion  
Even in very severely aphasic patients, considerable improvement of functional 
communication is possible. These patients might benefit more from early initiated cognitive-
linguistic treatment than generally assumed. Hence, speech and language therapists should 
not refrain from applying cognitive-linguistic treatment in the acute phase of rehabilitation 
of severe aphasia.  
 
 
INTRODUCTION 
 
Aphasia caused by stroke is often severe; between 26% and 61% of these patients have 
global aphasia at onset.1, 2 Severity of aphasia is known to be an important prognostic factor 
for the recovery of stroke.3-7 Few recovery studies concerning aphasia have provided specific 
data on severely affected patients in the acute stage and severely aphasic patients were 
excluded from several randomized controlled trials (RCT) investigating the effect of linguistic 
treatment in the acute stage.7-9 The majority of the studies in severely aphasic people are 
conducted in the chronic stage. One reason for excluding patients with severe aphasia from 
acute therapy studies is obviously the challenge to obtain informed consent in patients with 
severe comprehension deficits.7 Nevertheless, the lack of research data possibly also reflects 
some clinicians’ pessimistic view on treatment induced language recovery from severe 
aphasia, despite some reports of patients regaining language function beyond expectation.5-
8, 10-12 
The influence of treatment on language processing of people with severe aphasia in the 
acute stage is as yet unclear. Roughly, there are two main approaches to aphasia treatment; 
cognitive-linguistic treatment (CLT) and communicative treatment.13 The first is directed at 
restoration of the affected linguistic function and the latter at compensation strategies.  
In the first weeks after stroke, speech and language therapist (SL-therapists) often focus 
their treatment on functional communication in patients with severe aphasia. Treatment in 
this vulnerable stage is usually aimed at enhancing communicative abilities using verbal and 
nonverbal channels. 
CLT may be applied in later stages, although it has been suggested that recovery is 
hampered by the extensive neural damage in these severely affected patients.6, 11 
Furthermore, because of the widespread damage to the language system in severe aphasia, 
it may be difficult to determine which linguistic deficit(s) should be treated with CLT.14 
Studies on the efficacy of CLT in patients with severe aphasia are scarce, whereas 
communicative therapy for severe aphasia has been evaluated in quite a number of 
studies.15-21 However, this paucity of reports on the efficacy of treatment in patients with 
severe aphasia may be the result of bias in research studies and does not necessarily reflect 
true clinical practice. Some case studies and studies in small samples do suggest that a 
cognitive-linguistic approach might be beneficial for severely affected people.22-26   
Given the high incidence of severe aphasia in acute stroke, the impact of this disorder, 
the burden on healthcare, and the association between aphasia and the success of 
rehabilitation,27, 28 more knowledge about recovery and the potential effect of treatment in 
severely aphasic patients is needed. 
We therefore explored the recovery pattern of verbal communication in stroke patients 
with aphasia of varying degrees of severity who received either CLT or communicative 
therapy during the first six months post stroke. 
 
METHODS 
 
All patients included in the present study participated in the Rotterdam Aphasia Therapy 
Study (RATS) – 2, a multicenter, single blinded RCT on the efficacy of CLT among 80 patients 
with aphasia due to stroke.13 RATS-2 was approved by the Medical Ethical Committee of the 
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Erasmus MC – University Medical Center Rotterdam, the Netherlands. Written informed 
consent was obtained from all patients and/or their proxy before inclusion. 
The design and main results have been described elsewhere.13 In brief, stroke patients 
aged between 18 and 85 years with impaired verbal communication and an overt semantic 
and/or phonological disorder were randomized within three weeks after stroke to six 
months of either CLT or communicative therapy. Mean treatment intensity was 2.1 hours 
per week. 
CLT was directed at two basic language components, lexical semantics using BOX29, 30 and 
phonology using FIKS30, 31. BOX and FIKS are well described verbal treatment programs 
targeting lexical semantic and phonological processing on word, sentence and text level. 
Strengthening the semantic relations between words is the focus of the BOX therapy. Within 
each task the patient is required to deny or confirm the semantic relationship between 
written and/or auditory presented content words, either presented separately or within the 
context of a sentence or text. FIKS is directed to the phonological in- and output routes with 
word discrimination tasks indicating phonemic (dis)similarities (auditory presentation) and 
word production tasks (repetition, reading aloud and producing phonemic similar words). To 
enhance the generalization effect, both programs offer a great variety of tasks. Moreover, a 
considerable number of items on different levels of difficulty is included to ensure that the 
SL-therapist is able to spend enough time on tasks that correspond to the patients’ needs. 
Consequently, these treatment methods are appropriate for all aphasia types and severity 
degrees. For each patient, based on the test results, the participating SL-therapists 
determined which parts of BOX and/or FIKS were suitable to meet the individual needs.  
Communicative therapy was directed at functional communicative behavior using all 
verbal and nonverbal strategies available to the subject. Treatment was tailored to the 
requirements in daily life, for instance to enhance the ability to bring the message across 
using the Promoting Aphasics’ Communicative Effectiveness.32 In deliberation with the 
patient and their proxies, treatment was focused on actions relevant in everyday life via 
role-playing and conversational coaching (if necessary together with the partner), guided 
discussions about actual topics and written diaries. The SL-therapist used the test results to 
determine the level of treatment in terms of the nature of the support during the activities. 
No impairment-based linguistic treatment, such as semantic or phonological treatment was 
allowed.  
Meetings were organized regularly for SL-therapists to discuss the progress of the trial 
and the content of treatment and to establish compliance to treatment. At any time during 
the study, the trial team could be consulted for advice.   
At baseline, as well as three and six months post aphasia onset, patients were tested 
with the Amsterdam-Nijmegen Everyday Language Test (ANELT), a test for everyday verbal 
communication with scores ranging from 10 to 50.33, 34 Subjects are presented with ten 
everyday situations, for instance “You have a doctor’s appointment, but for some reason you 
cannot make it. So you call the doctor and what do you say?”. Two practice items are used 
to familiarize participants with the task and to instruct them to respond verbally, using direct 
speech. Verbal responses are audio recorded and rated for informational content on 
“Understandability” (ANELT-A scale), a five-point scale, by two independent experts, blinded 
to test moment and treatment allocation. A score of 1 is given when a response is not 
understandable at all, a score of 3 reflects a partial message and a score of 5 reflects a fully 
understandable and adequate response. For instance a response like “I have an 
 
 
appointment, but I cannot make it. Can I make another appointment?” to the scenario 
presented above, is rewarded a score of 5, but “I need an appointment” gets a score of 3 
and “Yesterday today going away yes no you know” gets a score of 1.   
The average scores of both independent experts were used for the analysis if they did 
not deviate more than seven points. If the difference between scores of the two judges 
exceeded seven points, both experts were requested to score the test a second time. If the 
difference between experts was again larger than seven points, a third expert scored the 
test. The average score of the three judges was used for the analysis.  
For the present study, we used the baseline ANELT scores to form three severity groups; 
very severe aphasia (ANELT-A score 10 to 15), severe aphasia (ANELT-A score 16 to 30) and 
moderate to mild aphasia (ANELT-A score 31 to 50). Our severity groups are based on 
adjusted severity levels from the test manual.35 According to the manual very severe aphasia 
is defined as ANELT scores between 10 and 19, severe as 20 to 29, moderate as 30 to 39 and 
mild as 40 to 48. Because these criteria resulted in skewed data and a gap between the 
lowest score of 10 and higher scores, we adjusted severity group cut-off values. The adjusted 
categorization results in a more evenly distributed number of subjects per severity group 
and matches daily practice in a better way.  
Baseline characteristics such as handedness assessed by means of the Edinburgh 
Handedness Inventory,36 educational level (low = junior vocational education or lower), 
stroke type (ischemic or hemorrhagic) and location of the lesion were collected. In addition, 
the Token Test, a general measure for severity of aphasia was administered at baseline.37 
Correlation between baseline Token Test scores and baseline ANELT scores was calculated to 
confirm the ANELT as a valid measure for severity of aphasia in our patient group.   
Scores at baseline, three and six months post stroke onset were compared between 
severity groups, stratified for the two treatment types, using repeated measures ANOVA 
with 95% confidence intervals (95% CI).  
 
RESULTS 
 
Table 1 shows the baseline characteristics of the study population for each severity group. 
Baseline tests were administered on average 19 days post stroke onset. Pearson’s 
correlation between the two blinded raters of ANELT-A scores at baseline was r = 0.975, p 
<0.05, at the three month test r = 0.978, p <0.05 and r = 0.971, p <0.05 for the six month 
test. The ANELT scores at baseline were strongly correlated with the Token Test scores (rs = 
0.589, p <0.01).  
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Table 1. Baseline characteristics of the study population, by severity of aphasia 
 Very severe  
(n = 35) 
Severe  
(n = 26)  
Moderate to mild  
(n = 19) 
ANELT score, range 10-15 16-30 31-50 
ANELT score, mean (SD) 11.0 (1.4) 23.2 (4.6) 37.3 (3.5) 
Therapy group:       
    CLT, n (%) 16 (46%) 13 (50%) 9 (47%) 
    Communicative therapy, n (%) 19 (54%) 13 (50%) 10 (53%) 
Age in years, mean (SD) 68 (11) 65 (18) 70 (13) 
Male sex, n (%) 19 (54%) 10 (38%) 9 (47%) 
Right-handedness, n (%)  28 (80%) 20 (77%) 18 (95%) 
Low educational level, n (%) 23 (66%) 20 (77%) 12 (63%) 
Stroke type:    
    Ischemic stroke, n (%) 29 (83%) 22 (85%) 16 (84%) 
    Hemorrhagic stroke, n (%) 5 (14%) 2 (8%) 2 (11%) 
    Missing, n (%) 1 (3%) 2 (8%) 1 (5%) 
Abbreviations: ANELT = Amsterdam-Nijmegen Everyday Language Test scale A (understandability); SD = 
standard deviation; CLT = cognitive-linguistic treatment. 
 
Figure 1 displays mean ANELT scores of the three severity groups at baseline, three 
months and six months post aphasia onset. In patients with very severe aphasia the mean 
improvement on ANELT was 12 points from baseline to three months and 2 points from 
three to six months, regardless of therapy type (Table 2). This improvement was statistically 
significant from baseline to three months and from three months to six months. For the 
severe group the mean improvement from baseline to three months was 14 points and from 
three to six months 1 point. The mean improvement in the moderate to mild group from 
baseline to three months was 6 points and from three to six months 2 points. The severe and 
moderate to mild group significantly improved during the first three months, but not 
between three and six months post onset.  
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Table 2. Improvement on ANELT during the first six months post stroke, by severity of aphasia 
 Mean improvement 
[95% CI] 
F (df) p-value 
Baseline to three months post stroke    
    Very severe aphasia 12.2 [7.4 – 17.1] F (1,33) = 40.93   0.00 
    Severe aphasia 14.1 [10.2 – 18.1] F (1,24) = 84.97   0.00 
    Moderate to mild aphasia 5.5   [2.6 – 8.5] F (1,17) = 25.44   0.00 
Three to six months post stroke    
    Very severe aphasia 2.2 [ 0.2 – 4.3] F (1,33) = 7.64   0.01 
    Severe aphasia 1.3 [-1.2 – 3.7] F (1,24) = 1.75 >0.05 
    Moderate to mild aphasia 1.5 [-1.0 – 4.0] F (1,17) = 2.63 >0.05 
Abbreviations: ANELT = Amsterdam-Nijmegen Everyday Language Test scale A (understandability); 95% CI = 
95% confidence interval; F = test of within subjects contrasts; df = degrees of freedom. 
 
The mean difference in ANELT scores at six months post aphasia onset between CLT and 
communicative therapy in the very severe group was 4.1 points (95% CI: -4.0 to 12.2), in the 
severe group -0.2 points (95% CI: -5.7 to 5.3) and in the moderate to mild group -0.8 points 
(95% CI: -5.4 to 3.8). The differences between ANELT scores in both types of treatment were 
not statistically significant in all severity groups. Yet, the difference in ANELT scores between 
CLT and communicative therapy at six months post stroke in the very severe group suggests 
a trend favoring CLT for the rehabilitation of very severe aphasia in the acute stage.    
 
DISCUSSION 
 
Our study shows that in the first three months after stroke verbal communication improved 
significantly in patients of all severity groups who received therapy. Most progress was 
observed in the patients with a severe and in patients with a very severe aphasia. The latter 
group made a statistically significant progress also in the second period of follow-up. Overall, 
there was no difference in the benefit from CLT or communicative therapy. Only the very 
severely aphasic patients showed a trend to benefit more from CLT than from 
communicative therapy. 
Strength of our study is that it was conducted within the setting of a randomized 
controlled clinical trial with standardized assessments by well-trained experts. Furthermore, 
patients were included from over twenty institutions in the Netherlands, which increases 
generalizability. All experts were trained and closely monitored by the trial team to assure 
protocol compliance. The use of the standard treatment programs BOX and FIKS and the 
regular discussions about the communicative treatment approach during the meetings with 
the participating SL-therapists further diminishes inter-site and inter-therapist variability. 
Drawbacks of the present study are that it concerns post-hoc analyses in relatively small 
groups. Moreover, the number of subjects per group in this study was not equal; fewer 
patients were categorized in the severe and moderate to mild groups than in the very severe 
group. The finding that the improvement between three and six months post stroke was not 
significant in the severe and moderate to mild group may have been due to insufficient 
statistical power.   
 
 
We chose to adjust the severity levels of the ANELT manual to have a better distribution 
of subjects per severity group. Applying the severity levels from the manual in the current 
study, with a larger cohort containing all severity levels, resulted in a vast gap between a 
large number of subjects scoring lowest on ANELT (a score of 10) and a more even 
distribution of subjects in the higher range of scores. Adjusting the severity levels resulted in 
a better distribution of subjects over the groups, although the number of subjects per group 
was still uneven.   
It is increasingly recognized that treatment intensity may be related to outcome.38 The 
relatively low treatment intensity of on average 2.1 hours per week in our study may thus 
have influenced our findings. However, our results are clinically relevant, because the 
treatment intensity of our study reflects general daily practice in the Netherlands. A higher 
intensity is often not feasible in rehabilitation settings.    
The significant correlation in our data between ANELT and Token Test at baseline is of 
particular interest. All patients scoring low on the ANELT are diagnosed with severe aphasia 
by means of the Token Test as well, showing that this high occurrence of low scores cannot 
be attributed to a prominent disorder in speech production.   
Several researchers have indicated that substantial improvement may be expected in 
patients with severe aphasia, because low baseline scores provide more room for 
improvement.8, 12, 39 On the other hand, previous findings suggest that greater initial severity 
is associated with poorer outcomes.6 Both notions are confirmed in our study. The results 
show that the moderate to mild group scored highest on the ANELT and reached on average 
a good level of functional communication. Both severe groups did not reach such a high level 
of functional communication, but did show the largest improvement. We cannot rule out the 
possibility that the relatively small increase in the moderate to mild group is caused by a 
ceiling effect. However, the moderate to mild group reached an average ANELT-A score of 
44. None of the participants in the moderate to mild group reached a normal score of 49 to 
50, which leaves some room for improvement, although not as large as in both severe 
groups.     
Our results challenge the assumption that people with severe aphasia are unlikely to 
benefit from restorative CLT and that functional communicative therapy is preferable for this 
aphasic subgroup.11, 14 Patients with very severe aphasia appeared to particularly benefit 
from CLT as compared with communicative therapy, whereas in the other two groups this 
difference between therapy types was absent. This finding is in contrast with the assumption 
that extensive neural damage is a contra-indication for the application of restorative 
impairment-based therapy. In patients with severe aphasia, CLT might trigger specific 
linguistic neural networks in order to restore linguistic functions, more than is generally 
assumed.11 Some basic linguistic content is required to compensate for the reduced 
language behavior in severe aphasia. This can be regained through CLT, as was also observed 
in a recent study in which naming therapy seemed to be more effective than gesture 
learning.40  
The debate on aphasia treatment does not only concern therapy type, but also the 
optimal duration of treatment. All groups showed improvement up until six months after 
stroke onset. Interestingly, the positive slope of the line of the very severe group in Figure 1 
suggests a possibility of ongoing recovery beyond six months after stroke. This finding is 
valuable in the light of changing stroke care policies that seem to continuously limit 
resources to treat stroke patients. Rehabilitation facilities beyond six months post stroke are 
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Table 2. Improvement on ANELT during the first six months post stroke, by severity of aphasia 
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[95% CI] 
F (df) p-value 
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    Moderate to mild aphasia 1.5 [-1.0 – 4.0] F (1,17) = 2.63 >0.05 
Abbreviations: ANELT = Amsterdam-Nijmegen Everyday Language Test scale A (understandability); 95% CI = 
95% confidence interval; F = test of within subjects contrasts; df = degrees of freedom. 
 
The mean difference in ANELT scores at six months post aphasia onset between CLT and 
communicative therapy in the very severe group was 4.1 points (95% CI: -4.0 to 12.2), in the 
severe group -0.2 points (95% CI: -5.7 to 5.3) and in the moderate to mild group -0.8 points 
(95% CI: -5.4 to 3.8). The differences between ANELT scores in both types of treatment were 
not statistically significant in all severity groups. Yet, the difference in ANELT scores between 
CLT and communicative therapy at six months post stroke in the very severe group suggests 
a trend favoring CLT for the rehabilitation of very severe aphasia in the acute stage.    
 
DISCUSSION 
 
Our study shows that in the first three months after stroke verbal communication improved 
significantly in patients of all severity groups who received therapy. Most progress was 
observed in the patients with a severe and in patients with a very severe aphasia. The latter 
group made a statistically significant progress also in the second period of follow-up. Overall, 
there was no difference in the benefit from CLT or communicative therapy. Only the very 
severely aphasic patients showed a trend to benefit more from CLT than from 
communicative therapy. 
Strength of our study is that it was conducted within the setting of a randomized 
controlled clinical trial with standardized assessments by well-trained experts. Furthermore, 
patients were included from over twenty institutions in the Netherlands, which increases 
generalizability. All experts were trained and closely monitored by the trial team to assure 
protocol compliance. The use of the standard treatment programs BOX and FIKS and the 
regular discussions about the communicative treatment approach during the meetings with 
the participating SL-therapists further diminishes inter-site and inter-therapist variability. 
Drawbacks of the present study are that it concerns post-hoc analyses in relatively small 
groups. Moreover, the number of subjects per group in this study was not equal; fewer 
patients were categorized in the severe and moderate to mild groups than in the very severe 
group. The finding that the improvement between three and six months post stroke was not 
significant in the severe and moderate to mild group may have been due to insufficient 
statistical power.   
 
 
We chose to adjust the severity levels of the ANELT manual to have a better distribution 
of subjects per severity group. Applying the severity levels from the manual in the current 
study, with a larger cohort containing all severity levels, resulted in a vast gap between a 
large number of subjects scoring lowest on ANELT (a score of 10) and a more even 
distribution of subjects in the higher range of scores. Adjusting the severity levels resulted in 
a better distribution of subjects over the groups, although the number of subjects per group 
was still uneven.   
It is increasingly recognized that treatment intensity may be related to outcome.38 The 
relatively low treatment intensity of on average 2.1 hours per week in our study may thus 
have influenced our findings. However, our results are clinically relevant, because the 
treatment intensity of our study reflects general daily practice in the Netherlands. A higher 
intensity is often not feasible in rehabilitation settings.    
The significant correlation in our data between ANELT and Token Test at baseline is of 
particular interest. All patients scoring low on the ANELT are diagnosed with severe aphasia 
by means of the Token Test as well, showing that this high occurrence of low scores cannot 
be attributed to a prominent disorder in speech production.   
Several researchers have indicated that substantial improvement may be expected in 
patients with severe aphasia, because low baseline scores provide more room for 
improvement.8, 12, 39 On the other hand, previous findings suggest that greater initial severity 
is associated with poorer outcomes.6 Both notions are confirmed in our study. The results 
show that the moderate to mild group scored highest on the ANELT and reached on average 
a good level of functional communication. Both severe groups did not reach such a high level 
of functional communication, but did show the largest improvement. We cannot rule out the 
possibility that the relatively small increase in the moderate to mild group is caused by a 
ceiling effect. However, the moderate to mild group reached an average ANELT-A score of 
44. None of the participants in the moderate to mild group reached a normal score of 49 to 
50, which leaves some room for improvement, although not as large as in both severe 
groups.     
Our results challenge the assumption that people with severe aphasia are unlikely to 
benefit from restorative CLT and that functional communicative therapy is preferable for this 
aphasic subgroup.11, 14 Patients with very severe aphasia appeared to particularly benefit 
from CLT as compared with communicative therapy, whereas in the other two groups this 
difference between therapy types was absent. This finding is in contrast with the assumption 
that extensive neural damage is a contra-indication for the application of restorative 
impairment-based therapy. In patients with severe aphasia, CLT might trigger specific 
linguistic neural networks in order to restore linguistic functions, more than is generally 
assumed.11 Some basic linguistic content is required to compensate for the reduced 
language behavior in severe aphasia. This can be regained through CLT, as was also observed 
in a recent study in which naming therapy seemed to be more effective than gesture 
learning.40  
The debate on aphasia treatment does not only concern therapy type, but also the 
optimal duration of treatment. All groups showed improvement up until six months after 
stroke onset. Interestingly, the positive slope of the line of the very severe group in Figure 1 
suggests a possibility of ongoing recovery beyond six months after stroke. This finding is 
valuable in the light of changing stroke care policies that seem to continuously limit 
resources to treat stroke patients. Rehabilitation facilities beyond six months post stroke are 
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usually restricted or even unavailable for aphasic patients. Our results suggest that the 
rehabilitation period perchance might be prolonged beyond the usual six months to realize 
optimal recovery.    
The claim that CLT could be effective in an early stage of severe aphasia needs to be 
confirmed in future studies, preferably in a randomized controlled trial controlling for 
severity.  
 
CONCLUSION 
 
We conclude that very severely aphasic patients, although they achieve a lower outcome 
level than milder cases, do have the capacity to significantly regain communicative abilities 
during the first six months after stroke. There is a trend for very severely aphasic patients to 
benefit more from CLT than from communicative treatment. This suggests that aphasia 
therapy, especially restorative treatment, should not be postponed or withheld in this group 
of patients. We also plead for the inclusion of very severe and severe patients in future trials.  
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The aim of this thesis was to study language rehabilitation of stroke patients with aphasia, 
with a main focus on timing of speech and language therapy (SLT). In this concluding chapter 
I will recapitulate and discuss the main findings of this thesis. Methodological limitations and 
implications for clinical practice will be discussed also, as well as directions for future 
research.  
 
MAIN FINDINGS  
 
The following three questions were addressed in this thesis: 
 
 How accurately can we diagnose the presence of aphasia in the early stage after stroke?  
 Which factors are of importance for an accurate prediction of aphasia outcome in 
stroke?  
 Is there a relationship between the timing of aphasia treatment and its efficacy? 
 
I will start with discussing findings from the cornerstone of this thesis: the Rotterdam 
Aphasia Therapy Study (RATS) – 3, a randomized controlled trial (RCT) on the efficacy of 
early initiated intensive cognitive-linguistic treatment (CLT) in aphasia due to stroke. After 
that, I will discuss the two other questions. 
 
Efficacy of early intensive CLT 
In RATS-3, we set out to answer the important clinical question of whether intensive SLT is 
effective early after stroke onset. We first wrote a literature-based narrative overview on 
what is known about the relationship between timing and efficacy of aphasia treatment, by 
exploring evidence from language rehabilitation, but also from motor rehabilitation and 
animal studies. Directly after stroke onset, increased neuroplasticity in the brain may help 
the brain to optimally benefit from SLT. Correlations between an early start of treatment and 
good recovery of motor function have been reported. Although these findings suggest that 
early treatment may be effective, most findings were not supported by RCTs. Thus, this may 
merely reflect that patients who can tolerate early treatment have greater potential for 
recovery.1-13 There are also arguments against an early start of intensive rehabilitation. In 
animals with induced stroke, it was found that intensive training early after stroke onset 
increased the lesion size, and human stroke patients who started early after stroke with 
intensive constraint-induced movement treatment showed less improvement of motor 
function than those receiving early usual treatment or less intensive restrictive treatment. 
This infers that, when started early after stroke onset, intensive motor treatment is not only 
ineffective, but might even be detrimental.14, 15   
We concluded from this literature-based review that there is still insufficient evidence to 
favor an early start of SLT for aphasia after stroke. Hence, we conducted a large multicenter 
RCT: RATS-3. In this RCT we included patients with first-ever aphasia within two weeks after 
stroke, and randomly allocated them to four weeks of either intensive CLT or no language 
treatment. The intention-to-treat analyses showed neither statistically significant, nor 
clinically relevant differences between groups on the primary outcome: the score on the 
ANELT after four weeks; adjusted difference = 0.39, 95% confidence interval (95% CI): -2.70 
to 3.47. No effect of early treatment on everyday communication was found three months 
(adjusted difference = 0.54, 95% CI: -3.04 to 4.12) and six months (adjusted difference = -
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0.41, 95% CI: -3.70 to 2.89) after randomization either. The 95% CIs did not include the 
predefined clinically relevant difference between groups of four points on the ANELT. In 
addition, no statistically significant differences between groups were found for the 
secondary outcomes, i.e. impairment-based linguistic tests and measures for general 
functional outcome, at all time points. Potential clinically relevant differences between 
groups on the secondary outcome measures were also ruled out by the corresponding 95% 
CIs.  
These findings consistently exclude an effect of a boost of CLT initiated in the first two 
weeks after stroke onset on the recovery of aphasia due to stroke. A meta-analysis 
combining our primary outcome results with those of the only four published RCTs on early 
intensive treatment versus no SLT or usual care, convincingly showed no benefit of early 
intensive treatment. Hence, in general it is not necessary to start CLT as soon as possible 
after stroke onset and a waiting list or longer diagnostic phase are not detrimental.  
 
Factors associated with efficacy of treatment 
We additionally conducted on-treatment analyses including only the patients who actually 
adhered to the RATS-3 protocol, i.e. patients in the intervention group who received 28 
hours of treatment or more (n = 23) and patients in the control group who received no 
treatment at all (n = 62). Results from these analyses suggest an effect of early intensive CLT, 
but this effect was restricted to only three linguistic tests, including the ANELT, only after the 
four week intervention period. No effects were observed on other tests and other time 
points. This might imply that the selected group of patients who tolerated early intensive 
CLT may benefit from this approach.  
Although this finding seems promising, the effect was only short-term and had 
disappeared at three months after stroke, and we must be careful interpreting results of this 
subgroup analysis, as I will discuss later. Furthermore, characteristics of the patients 
included in the on-treatment intervention group must be identified first and subsequently a 
new trial may be designed specifically to confirm this potential effect.    
Findings from these on-treatment analyses suggest that it is important to carefully select 
patients who might benefit from early SLT. Important factors for such a selection process are 
as yet unclear. Findings from the intention-to-treat regression analysis showed that everyday 
verbal language performance at four weeks after randomization was predominantly related 
to aphasia severity and stroke severity at baseline, suggesting that these two factors may 
affect early outcome more than SLT and may be relevant factors for patient selection.    
To study the relationship between recovery of aphasia in patients receiving SLT and 
baseline aphasia severity, we plotted recovery profiles of three groups with different aphasia 
severity levels according to baseline ANELT scores in a post-hoc study using the data from 
RATS-2. The groups with severe and very severe aphasia showed comparable recovery 
profiles, with a steep increase from baseline to three months and further, yet less steep 
improvement from three to six months. Patients in the moderate to mild group showed a 
rather flat improvement curve during the entire six month follow-up period.  
We also studied whether the severity groups would respond differently to type of 
treatment, permitted by the random allocation to either CLT or communicative treatment in 
RATS-2. Exclusively in the group with very severe aphasia we observed a trend of a greater 
effect of CLT than of communicative treatment on ANELT scores at follow-up. This 
 
 
contradicts the general notion of severely aphasic patients not benefitting from CLT, and 
that they ought to be treated with compensatory communicative treatment.6, 16   
 
Early diagnosis of aphasia 
Available aphasia screening tests were evaluated in a systematic review to explore whether 
they are reliable and valid for detecting aphasia early after stroke. A systematic search was 
conducted to identify screening tests that were evaluated in validation studies. We found 
eight screening tests that fitted the prespecified criteria. Four tests had good sensitivity and 
specificity properties, but only three validation studies on two tests, i.e. the Language 
Screening Test (LAST)17 and ScreeLing18, had an intermediate or low risk of bias. Therefore, 
we concluded that the LAST and ScreeLing can be reliably used in clinical practice for 
diagnosing the presence of aphasia early after stroke. The ScreeLing was also used in RATS-3 
for inclusion purposes.   
 
Predicting aphasia outcome after stroke 
We used data from RATS-3 to externally validate a previously published prognostic model, 
derived from the observational prospective study SPEAK (Sequential Prognostic Evaluation of 
Aphasia after StroKE).19 In this model a limited number of baseline variables is used to 
predict long-term outcome of aphasia due to stroke and internal validation was good. The 
external validation process showed that the SPEAK model had good discriminative 
properties, but calibration was insufficient. This may have been caused by differences 
between the SPEAK and RATS-3 cohorts regarding timing of the collection of outcome 
variables. The SPEAK model predicts good outcome one year after stroke, but we collected 
outcome data in RATS-3 at six months after stroke. Although in SPEAK there was no 
statistically significant improvement in ASRS scores between six months and one year after 
stroke, there was some improvement. This apparent small improvement may have caused 
the insufficient calibration. We therefore suggest an update of the model to predict good 
aphasia outcome at six months after stroke.   
 
Language recovery after intra-arterial treatment for ischemic stroke 
Rapid changes in language functioning early after stroke were also demonstrated in the 
post-hoc analysis of patients with aphasia in the MR CLEAN trial. We found that intra-arterial 
treatment (IAT) added to usual care was more effective than usual care alone for the 
recovery of aphasia.20 We also found that, in line with observations in the clinic, motor 
function recovers significantly faster than language function in the early stage after stroke. 
At 24 hours after IAT, motor function had recovered beyond that of language function, but 
this difference almost disappeared after a week.  
 
METHODOLOGICAL LIMITATIONS 
 
I will discuss the most important limitations of the research presented in this thesis, focusing 
on the most comprehensive study, RATS-3.  
 
Ethical considerations 
In RATS-1 and RATS-2 we did not include a control group without treatment, because we 
considered withholding treatment for more than six months to be unethical. In RATS-3 we 
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did introduce a control group that received no SLT for six weeks at maximum after stroke 
onset. This raised considerable stir in the Netherlands and abroad. Many clinicians asked 
whether depriving patients with aphasia of language treatment was ethically justifiable, as in 
clinical practice they often observe improvement during therapy and thus consider early 
treatment effective. However, at the time we initiated our trial solid evidence showing that 
starting treatment as soon as possible is more effective than initiating treatment in a later 
stage was lacking. Thus, there was clinical equipoise regarding the potential effect of early 
initiated SLT, and there were no ethical arguments against this trial design. Consequently, 
medical ethical approval was acquired.  
We have carefully chosen for a duration of four weeks for the intervention phase. Our 
hypothesis was derived from the theory that especially CLT positively interacts with 
spontaneous neural recovery and therefore should be provided in the early phase after 
stroke, as in this phase most spontaneous recovery occurs.6 However, there is no consensus 
in the literature on the duration of the spontaneous recovery phase, like there is no 
consensus on the definition of ‘early phase’ either. Therefore, we coincided with current 
clinical practice in the Netherlands, also for feasibility purposes. SL-therapists strive to start 
treatment as soon as possible after stroke, as this is recommended in the Dutch evidence-
based clinical guideline on care for stroke patients.21 In daily practice, patients generally start 
with impairment-based treatment after three to six weeks, due to transfer time from 
hospital to rehabilitation center, time needed for diagnostics and limited resources. We also 
presumed that a long intervention period with intensive treatment would not be feasible, as 
it is known that stroke patients are generally unable to tolerate intensive treatment early 
after stroke onset.22    
Still, it would have been interesting to defer treatment for a longer period, as the 
contrast between both treatment groups would have been larger. Ideally, for a maximum 
contrast, deferred treatment in the control group should be started as soon as spontaneous 
neural recovery has ceased. The steep recovery curves in the first three months after stroke 
in the aphasia severity groups presented in Chapter 4.4 and other studies indicate that three 
months may be an interesting deferral period.23-25 Hereby, we may better disentangle 
spontaneous recovery and treatment induced recovery. Yet, I expect that recruiting 
sufficient SL-therapists and patients who would want to participate in such a trial would be 
very difficult, as the notion that starting treatment as soon as possible is beneficial is deeply 
embedded in rehabilitation medicine and public opinion.  
 
Feasibility of intensive treatment  
A major finding of RATS-3 is the limited feasibility of high-intensity treatment initiated early 
after stroke. Several studies suggest that more intensive treatment is more effective, but a 
threshold in hours of treatment per week between effective and ineffective treatment 
intensity is as yet unidentified.26, 27 Some studies have suggested that treatment is effective 
if it is provided for nearly nine hours per week, but others showed a benefit of five hours 
weekly, whereas low-intensity treatment, i.e. two hours a week, was not effective.26, 28, 29 
There are also studies indicating that treatment distributed over a longer period (six hours 
per week for eight weeks or ten sessions in five weeks) is better for retaining newly learned 
skills than a short intensive treatment program (16 hours per week for three weeks or ten 
sessions in two weeks),30, 31 while in other studies treatment intensity did not have an impact 
on the efficacy of treatment.32, 33  
 
 
In line with available evidence we chose a fairly high target treatment intensity of 28 
hours in four weeks, to at least provide sufficient therapy in the intervention group. Based 
on Godecke et al.’s pilot RCT we expected that one hour of treatment a day would be 
feasible.34 However, mostly due to fatigue, comorbidities or illness, this turned out not to be 
viable in the majority of patients and despite all our efforts, only 29% of the intervention 
group reached the target intensity. This demonstrates that, although high-intensity 
treatment is often advocated by researchers and clinicians, patients are unable to or do not 
always want to adhere to such a protocol. This result is not surprising though, since in other 
trials higher dropout rates, either from intervention or follow-up, were reported for high-
intensity treatment protocols than for regular SLT.22 When treatment intensity was not 
prescribed in a study-protocol, but instead patients and therapists decided on intensity 
themselves, it was found that 1.5 hours of treatment per week was the preferred and 
tolerated intensity in the first four months after stroke.35    
The fact that only a minority of patients in the intervention group received the intended 
treatment intensity may be considered a limitation of our trial. On the other hand, the 28 
hours in four weeks were more or less arbitrary, and several studies have shown a benefit of 
less than six hours of treatment per week.28, 34, 36 Moreover, in the few published evidence-
based or best practice guidelines on SLT for aphasia the minimally recommended treatment 
intensity is two hours of treatment per week.21, 37-39 When I look at the median treatment 
intensity in RATS-3 of 24.5 hours in four weeks, i.e. more than six hours per week, I am still 
convinced we provided sufficient therapy in order to demonstrate a treatment effect, if 
there would be one.  
In general, a failure to demonstrate superiority of an intervention is not surprising if 
there is no strong contrast between the intervention and control.40 The fact that we 
provided a median treatment intensity of six hours of impairment-based CLT per week to the 
intervention group and no SLT, but only minimal counseling to the control group created a 
large contrast between treatment groups in RATS-3, justifying our conclusion that intensive 
CLT is not superior to no SLT early after stroke onset.  
 
Intervention 
In research, the studied intervention must be standardized in order to adequately evaluate 
and interpret its efficacy.41 Factors such as type of treatment, intensity of treatment, 
individual or group treatment, location where the treatment is provided and who is 
providing treatment have to be reported. Consequently, clinicians know which factors have 
been proven effective in trials and need to be included in their treatment regimen.42 
Downside of this strict demarcating of interventions is that we may end up with lab-
conditions, not reflecting clinical practice, in which many factors and treatment types are 
combined in one therapy session.  
In RATS-3 we have chosen a rather pragmatic approach by using two language treatment 
programs that were already frequently used in daily practice in the Netherlands and that 
were used in the two prior RATS trials. We may debate whether this type of treatment is 
most appropriate early after stroke. CLT presumes some form of meta-linguistic 
consciousness, as it is based on linguistic processing models and exercises target detailed 
semantic, phonological and syntactic operations.43 While communicating, we normally do 
not intentionally process these actions separately. As many stroke patients are faced with 
cognitive impairments,44 this type of treatment may be focused too much on details and too 
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intensity is two hours of treatment per week.21, 37-39 When I look at the median treatment 
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intervention group and no SLT, but only minimal counseling to the control group created a 
large contrast between treatment groups in RATS-3, justifying our conclusion that intensive 
CLT is not superior to no SLT early after stroke onset.  
 
Intervention 
In research, the studied intervention must be standardized in order to adequately evaluate 
and interpret its efficacy.41 Factors such as type of treatment, intensity of treatment, 
individual or group treatment, location where the treatment is provided and who is 
providing treatment have to be reported. Consequently, clinicians know which factors have 
been proven effective in trials and need to be included in their treatment regimen.42 
Downside of this strict demarcating of interventions is that we may end up with lab-
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combined in one therapy session.  
In RATS-3 we have chosen a rather pragmatic approach by using two language treatment 
programs that were already frequently used in daily practice in the Netherlands and that 
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most appropriate early after stroke. CLT presumes some form of meta-linguistic 
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complex, possibly explaining the lack of treatment effect in RATS-3.44-47 However, in the 
post-hoc analysis of the RATS-2 cohort, we found that especially severely impaired patients 
seemed to benefit from CLT, refuting the notion that CLT would be too complicated to 
administer in the acute phase.  
 
Outcome measures 
The baseline test battery in RATS-3 was limited to the 36-item Token Test, ScreeLing and a 
recording of spontaneous speech and did not include the ANELT, our primary outcome 
measure. Consequently, we were unable to compare improvement in ANELT scores between 
groups from baseline to follow-up, i.e. improvement due to an early boost of CLT 
(intervention group) or due to spontaneous recovery (control group). Instead, we compared 
ANELT scores at follow-up with adjustment for baseline aphasia severity. Although 
evaluating improvement in ANELT scores would have been interesting, it has been shown 
that methods comparing change or delta scores introduce more variation in analyses than 
analyses of covariance with a correction for baseline severity.48 We favor the more 
conservative method, and thus chose for the latter option. 
Moreover, RATS-3 was set out to be a pragmatic trial and choices for baseline testing 
were made based on feasibility considerations. Conducting an ANELT very early after stroke 
is not standard practice, as most patients are faced with severe language deficits early after 
stroke. The design of the ANELT requires role-playing in routine situations, which is a difficult 
task for stroke patients in the acute stage.    
The ANELT is designed to assess everyday verbal communication, which is clinically 
relevant as opposed to other rather artificial tests measuring detailed linguistic processing. 
We chose the ANELT as the primary outcome in all RATS trials based on the assumption that 
adequate impairment-based treatment should generalize to everyday communication.49, 50 
The lack of differences in ANELT scores between the intervention and the control group in 
RATS-3 could mean that there is no effect of early CLT, or it may imply that CLT does not 
directly generalize to everyday communication and that this process takes a while. Yet, this 
last explanation seems unlikely as we did not find an effect of early CLT on the ANELT six 
months after the start of treatment either. 
The lack of differences between groups may also be attributed to the scoring of the 
ANELT-A scale. To get the maximum score of five points per item it is not necessary to 
produce semantically, phonologically and syntactically correct utterances. In line with 
normal everyday communication, ellipses or telegram speech are awarded with five points, 
as long as the assessor understands what the patient is expressing. The ANELT may therefore 
be insensitive to pick up improvement or differences in linguistic functioning, which is 
explicitly trained with CLT.51 Yet, the other linguistic tests used in RATS-3 detected no 
differences between groups either, further supporting our conclusion that in fact there is no 
effect of early CLT on recovery of language function in aphasia due to stroke.  
It is however possible to observe early changes in language recovery after stroke. To 
measure the effect of IAT added to usual care on language recovery we used the fairly 
coarse NIHSS Language scale. A detailed analysis of changes in language function would have 
enabled us to better understand language recovery in this very early phase after stroke. The 
ScreeLing would have been a suitable instrument for this, which was pointed out in our 
systematic review on screenings tests for aphasia.   
 
 
 
Randomized controlled trials in aphasia research 
SL-therapists should apply evidence-based practice and implement the highest levels of 
evidence in clinical practice, providing their patients with the best treatment possible. RCTs 
are considered the gold standard in efficacy research and are highly valued by policy 
makers.52 There are two types of RCTs: explanatory trials and pragmatic trials. The first type 
studies whether an intervention is effective under strictly protocoled conditions, i.e. lab-
conditions, and the latter studies whether an intervention is effective when it is applied in 
the real world.53 Pragmatic trials are suitable for interventions that have been proven 
effective in explanatory trials. RATS-3 was a pragmatic trial, set out to study the 
effectiveness of early intensive CLT under clinical practice circumstances. Intensive 
treatment regimens and CLT-approaches have been found more effective than no SLT or 
other treatment approaches in several studies.22, 54 However, when we applied this 
treatment regimen very early after stroke onset in RATS-3, we found that intensive CLT is not 
more effective than no SLT for recovery of aphasia and more importantly that intensive 
treatment is poorly feasible in the average patient with aphasia. 
An ongoing debate in aphasia research is whether RCTs are the optimal study design for 
this group of patients and remarks such as: “Single case design is more appropriate than 
randomized controlled trials for studying treatment effects”55 (p. 401) or “Particular problems 
have arisen when randomized control trials are used to examine therapy provision for a 
client group”56 (p.285) are frequently heard in discussions on this topic.55-57 People who oppose 
using RCTs in aphasia research claim that the group of people with aphasia and the 
treatment provided to them are too heterogeneous to be studied with this study design. 
They are of the opinion that each patient should receive personalized treatment, tailored to 
individual deficits and needs. In their view, this individual approach cannot be tested in an 
RCT, as results on an individual level are disregarded in RCTs. Alternatives for RCTs in aphasia 
research are single-case studies or non-randomized group studies.55, 58 However, showing a 
benefit of an intervention in a small number of patients, does not reliably demonstrate that 
the treatment is effective, as those results in a selective group cannot be generalized to the 
population of people with aphasia and a selection bias is likely at play. Moreover, the only 
way to effectively rule out the effect of spontaneous recovery is by a controlled, preferably 
randomized design. 
The power of an RCT lies in the fact that researchers are able to study the efficacy and 
effectiveness of the operational mechanism(s) underlying the intervention, by investigating a 
group of patients with a similar deficit. This common deficit in patients with aphasia is the 
underlying language disorder and the operational mechanism of SLT may be timing, 
treatment intensity or treatment type. Thus, RCTs are suitable for aphasia research, 
provided that they are properly executed.  
To accurately execute an RCT, sufficient participants have to be recruited, as the 
precision of RCT designs relies heavily on the number of participants. Performing a power 
calculation is therefore an essential part of the methodology.59 According to our calculations 
75 participants in each experimental arm would provide 84% power to detect a clinically 
relevant treatment effect, defined as a four-point difference between groups on the ANELT 
four weeks after randomization. The inclusion rate in RATS-3 was lower than expected. On 
average, in the Netherlands a hospital admits approximately 300 stroke patients per year. 
Approximately a third of these patients has aphasia shortly after stroke, but less than half of 
them remain aphasic for a longer period of time.60, 61 This comes down to around 45 patients 
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as long as the assessor understands what the patient is expressing. The ANELT may therefore 
be insensitive to pick up improvement or differences in linguistic functioning, which is 
explicitly trained with CLT.51 Yet, the other linguistic tests used in RATS-3 detected no 
differences between groups either, further supporting our conclusion that in fact there is no 
effect of early CLT on recovery of language function in aphasia due to stroke.  
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group of patients with a similar deficit. This common deficit in patients with aphasia is the 
underlying language disorder and the operational mechanism of SLT may be timing, 
treatment intensity or treatment type. Thus, RCTs are suitable for aphasia research, 
provided that they are properly executed.  
To accurately execute an RCT, sufficient participants have to be recruited, as the 
precision of RCT designs relies heavily on the number of participants. Performing a power 
calculation is therefore an essential part of the methodology.59 According to our calculations 
75 participants in each experimental arm would provide 84% power to detect a clinically 
relevant treatment effect, defined as a four-point difference between groups on the ANELT 
four weeks after randomization. The inclusion rate in RATS-3 was lower than expected. On 
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Approximately a third of these patients has aphasia shortly after stroke, but less than half of 
them remain aphasic for a longer period of time.60, 61 This comes down to around 45 patients 
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per including hospital that might fit the inclusion criteria. Yet, these patients had to be able 
to tolerate intensive treatment and had to provide informed consent, and that appeared 
more difficult than we anticipated. A considerable proportion of eligible stroke patients or 
their representatives refused participation, either because they wanted to start treatment as 
soon as possible, or because they expected the early intervention to be too burdensome. 
This has been reported previously and may be inevitable in RCTs early after stroke.35 Still, by 
extending the inclusion period, we succeeded in recruiting more than 150 subjects for RATS-
3. Nevertheless, this contrasts heavily with the estimated number of 3600 patients each year 
with stroke and lasting aphasia in the Netherlands.62  
Frequently, post-hoc subgroup analyses are performed with data collected in RCTs. 
However, post-hoc analyses should be used for hypothesis generation only, especially those 
from RCTs with a neutral outcome, such as RATS-3. By selecting patients for subgroups, one 
disregards the essential element of RCTs; a reliable comparison of groups that were similar 
at baseline, as a result of the random allocation of intervention. In our on-treatment analysis 
we selected only those patients from the intervention group that apparently were able to 
tolerate high-intensity treatment, but in the control group such a selection was not made. 
Thus, the control group included patients that might and patients that might not tolerate 
early intensive treatment. In this way we compared groups that are actually no longer 
comparable. It might very well be that the results of the on-treatment analyses merely show 
that patients, who are able to start with intensive treatment early after stroke onset, may 
anyhow have more potential to improve, regardless of whether treatment is provided. 
Perhaps being able to tolerate intensive treatment is a predictor for recovery.  
 
CLINICAL IMPLICATIONS  
 
Early after stroke, patients, their family members or medical staff may be fiercely focused on 
impairment-based treatment, assuming that language deficits improve more rapidly when 
treatment is initiated as soon as possible. These notions are endorsed by literature, such as 
the Cochrane review, in which the authors conclude that SLT is more effective than no 
treatment, despite several restrictions.22 Consequently stroke patients, who are often ill and 
exhausted shortly after stroke, are pushed to practice intensively.  
With RATS-3 we have now shown that the urgency to initiate CLT quickly after stroke is 
unfunded. Hence, there is no need to stimulate all patients to start with CLT as soon as 
possible. Perhaps, in this phase it is better to focus on motor rehabilitation to prevent 
maladaptive processes from occurring, and to focus on counseling and guidance. It may also 
be good to take plenty of rest in order not to overload the brain and to let spontaneous 
recovery processes do their work first, as some animal studies have suggested.3, 15, 63 Yet, our 
results also imply that early intensive treatment may not be detrimental in patients who are 
able to tolerate and are motivated for intensive CLT.     
These findings are important in the light of changes in health care policy and budget 
restrictions. In those patients who seem unable to tolerate intensive treatment, SL-
therapists may better focus on enhancing communication in order to prevent isolation, 
instead of training linguistic functioning. In a later phase in the stroke recovery process, this 
may be more effective.   
The post-hoc analysis of RATS-2 on the impact of baseline aphasia severity on recovery of 
language function showed that in all severity groups most improvement occurred in the first 
 
 
three months. Combining these results with other studies presenting similar findings,4, 23-25 it 
appears that the window of opportunity during which most recovery is expected lasts until 
three months after stroke.  
The longest period of improvement was found in the very severely impaired group. The 
recovery profiles in this group showed a positive slope until six months, implying that 
improvement might still be ongoing beyond six months after stroke. This suggests that very 
severely aphasic patients may have a more extended recovery period, and treatment 
resources should be available for a longer period to these patients than the commonly 
prescribed six months. In this group we also observed an unexpected benefit of CLT over 
that of communicative treatment. SLT for very severely affected patients is generally aimed 
at compensation, but our findings suggest that impairment-based CLT may also be a good 
treatment approach.  
Results presented in Chapter 3.2, Chapter 4.1 and 4.4 suggest that spontaneous language 
recovery is most pronounced in the first weeks after stroke, leading to an instable language 
function in this early phase. This implies that taking more time for detailed diagnosis of the 
language deficits before starting targeted treatment is not detrimental, and it may be even 
sensible to wait with detailed diagnostics until aphasia has more or less stabilized.  
From the SPEAK model and its validation we know that baseline variables measured 
during the first week after stroke may provide a grounded prediction of aphasia outcome 
one year after stroke. We must keep in mind that when these baseline variables are 
collected in a later stage after stroke onset, the prognosis derived from the SPEAK model 
may be less accurate. Therefore a good cooperation between the SL-therapist and the 
neurologist is necessary, so that the neurologist is timely provided with essential information 
to provide the patient with an adequate personal prognosis. When the updated model is 
further externally validated, it may be used to predict good outcome six months after stroke.   
Three of the studies I have presented showed a relationship between aphasia severity 
shortly after stroke onset and long-term outcome and recovery: severity of aphasia shortly 
after stroke was a predictor of outcome in the SPEAK model; in RATS-3, baseline aphasia 
severity was significantly associated with ANELT scores at follow-up; and in the post-hoc 
analysis of RATS-2 we found that very severely impaired patients improved for the longest 
period after stroke and seemed to benefit more from CLT than less severely impaired 
patients. These accumulated findings show that adequate estimation of aphasia severity 
shortly after onset is important for reliable prognostication and providing adequate 
individual treatment. The ScreeLing proved to be a valid and reliable instrument, very well 
suitable for this purpose.  
 
FUTURE RESEARCH 
 
With RATS-3 we have consistently demonstrated that starting intensive CLT within two 
weeks of stroke onset is not more effective than starting treatment later after stroke for the 
recovery of aphasia. It is important not to interpret this finding as SLT being of no use in the 
acute and post-acute phase of aphasia due to stroke. SLT comprises much more than CLT 
alone and there is still much more that has to be studied in order to identify which factors 
are of importance for effective rehabilitation of aphasia.  
In our trial we compared the optimal treatment regimen as suggested by the available 
evidence (early intensive CLT), to usual care (later initiated, less intensive treatment). Using 
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be good to take plenty of rest in order not to overload the brain and to let spontaneous 
recovery processes do their work first, as some animal studies have suggested.3, 15, 63 Yet, our 
results also imply that early intensive treatment may not be detrimental in patients who are 
able to tolerate and are motivated for intensive CLT.     
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restrictions. In those patients who seem unable to tolerate intensive treatment, SL-
therapists may better focus on enhancing communication in order to prevent isolation, 
instead of training linguistic functioning. In a later phase in the stroke recovery process, this 
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this design, we did not merely study the effect of timing of therapy, as this would require a 
direct comparison between early initiated intensive treatment and later initiated intensive 
treatment. Neither did we distinctively study the impact of treatment intensity early after 
stroke, as this would imply comparing high-intensity to low-intensity treatment in the early 
stage after stroke.  
Whenever the effect of both timing and intensity was to be studied in one single RCT, 
multiple treatment arms or a more complex method of analysis would be necessary. 
Consequently, large numbers of participants would have to be recruited in order to warrant 
sufficient statistical power. Recruiting sufficient participants for RATS-3 turned out to be 
rather difficult, and I therefore recommend international cooperation to increase feasibility 
of large RCTs. This is one of the reasons the Collaboration of Aphasia Trialists (CATs) was 
founded with funding from the European Cooperation in Science and Technology (COST).64 
The main aim of this collaboration is to improve international cooperation, resulting in joint 
goal setting for future large international multicenter trials, and to further improve quality of 
research on aphasia.  
One project of the CATs is RELEASE (REhabilitation and recovery of peopLE with Aphasia 
after StrokE), aimed at accumulating data from various trials performed in stroke patients 
with aphasia.64 Pooling of data will enable us to more reliably conduct subgroup analyses. 
These retrospective studies are apt for identification of gaps in aphasia research, to identify 
relevant subgroups and to generate hypotheses for future trials. 
We could start by exploring the RATS-3 cohort to identify which factors are associated 
with rapid spontaneous recovery and factors associated with good response to early 
intensive treatment, as during data collection in RATS-3 I have noticed that participants 
could roughly be classified into four groups. I observed individuals in the intervention group 
that seemed to improve rapidly, but also patients from this group showing barely any clinical 
progress. In the control group I also observed patients recovering quickly and patients hardly 
showing any improvement. It would be clinically relevant to identify factors that predict 
which patients may benefit from early treatment and which patients will improve well 
spontaneously. Hereby SLT resources may be better directed to those patients who are 
expected to benefit from language treatment. In this way we can also identify which patients 
will likely not benefit from CLT, and thus may need a different type of intervention to 
improve communication ability, such as communicative treatment.  
One of the factors that we did not take into account in RATS-3 is cognitive functioning 
before and after stroke. It would be meaningful to study whether cognitive functioning after 
stroke is associated with being ready for receiving language treatment, because an 
association between cognitive impairment and rehabilitation success has been reported 
previously.44, 46, 65, 66 Clinical observations in the RATS-3 cohort suggested that patients who 
were less likely to cope with and respond to treatment also had cognitive impairments. 
However, adequate estimation of cognitive functioning will probably be challenging in 
patients with aphasia, as cognition and language are highly intertwined.44, 67 
It is also unknown which types of treatment are effective for which patients. We have 
chosen to study CLT, based on the assumptions that recovery is optimal if the premorbid 
language system is restored and that linguistic functioning can be restored with CLT.6 
However, there are also researchers advocating to implement communicative treatment in 
the early phase after stroke to initiate effective communication as soon as possible.68 
Hereby, maladaptive processes are thought to be prevented and social interaction is 
 
 
enhanced, keeping patients from feeling isolated. It would be interesting to test the 
effectiveness of one-to-one communicative treatment combined with structured education 
of the patients’ social environment, creating a ‘language enriched environment’, in a well-
designed RCT with for instance classical impairment-based SLT as control condition.  
Most findings in this thesis show that the language system is extremely capricious in the 
first days to weeks after stroke. It would be meaningful to include neuroimaging measures in 
future trial designs, and it is important to continue improving neuroimaging techniques and 
our interpretation of the results in order to better understand post-stroke language recovery 
and its response to treatment. Questions such as ‘Is the activity-shift to the right hemisphere 
maladaptive or supportive for language recovery?’ or ‘Can early language treatment salvage 
penumbral tissue?’ remain unanswered still. In particular, we must further explore the effect 
of therapy principles e.g. massed practice, focusing principles, constraint-induced principles 
and enriched environments that allegedly are crucial for effective treatment.69  
To study the effect of intensive CLT on the neural network dedicated to language in acute 
and chronic aphasia, our group conducted a second trial parallel to RATS-3; Functional 
Imaging in Aphasia Treatment (FIAT).70 Patients were randomly allocated to either four 
weeks of intensive CLT or no language treatment at all, comparable to the RATS-3 treatment 
protocol. In addition to the linguistic test data collected in RATS-3, in FIAT functional MRI-
data on language performance were collected. All patients eligible for RATS-3 without 
contra-indications for MRI were asked to participate in FIAT as well. Unfortunately, because 
of the additional MRI-scanning the few eligible candidates were very reluctant to consent 
and we did not succeed in recruiting sufficient participants with acute aphasia, i.e. within 
two weeks after stroke onset. We also aimed at including 40 patients with chronic aphasia, 
defined as aphasia due to stroke existing for at least one year, and eventually succeeded in 
including a number of 38 patients for this group. Results from FIAT in the chronic phase are 
analyzed, but are not yet published. 
Furthermore, in order to better time language treatment, we need to verify the existence 
of a critical window of opportunity during which the brain is hyperexcitable and language 
treatment supposedly positively interacts with neural recovery.2, 3, 71 Findings from RATS-3 
justify longer periods without treatment early after stroke for future studies. However, 
‘doing nothing’ will probably be highly unattractive to most patients, as the majority of 
patients is motivated for rehabilitation. One way to solve this problem is to introduce a 
control condition with other activities instead of SLT. One could think of an attention control 
group, with nonverbal exercises aimed at improving cognitive functioning, such as attention 
and memory.    
Techniques for non-invasive brain stimulation, e.g. transcranial magnetic stimulation or 
transcranial direct current stimulation might also be explored in future studies, as they have 
shown promising results in restoring language function, though working mechanisms are as 
yet unclear.72 In studies like these, a sham control condition is often used, which is a good 
alternative for ‘doing nothing’.     
 
CONCLUSION 
 
In this thesis I showed that early screening for aphasia after stroke is feasible and can be 
done accurately, and I demonstrated that combining clinical information collected early after 
stroke onset improves prognostication in aphasia, while our large multicenter trial did not 
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this design, we did not merely study the effect of timing of therapy, as this would require a 
direct comparison between early initiated intensive treatment and later initiated intensive 
treatment. Neither did we distinctively study the impact of treatment intensity early after 
stroke, as this would imply comparing high-intensity to low-intensity treatment in the early 
stage after stroke.  
Whenever the effect of both timing and intensity was to be studied in one single RCT, 
multiple treatment arms or a more complex method of analysis would be necessary. 
Consequently, large numbers of participants would have to be recruited in order to warrant 
sufficient statistical power. Recruiting sufficient participants for RATS-3 turned out to be 
rather difficult, and I therefore recommend international cooperation to increase feasibility 
of large RCTs. This is one of the reasons the Collaboration of Aphasia Trialists (CATs) was 
founded with funding from the European Cooperation in Science and Technology (COST).64 
The main aim of this collaboration is to improve international cooperation, resulting in joint 
goal setting for future large international multicenter trials, and to further improve quality of 
research on aphasia.  
One project of the CATs is RELEASE (REhabilitation and recovery of peopLE with Aphasia 
after StrokE), aimed at accumulating data from various trials performed in stroke patients 
with aphasia.64 Pooling of data will enable us to more reliably conduct subgroup analyses. 
These retrospective studies are apt for identification of gaps in aphasia research, to identify 
relevant subgroups and to generate hypotheses for future trials. 
We could start by exploring the RATS-3 cohort to identify which factors are associated 
with rapid spontaneous recovery and factors associated with good response to early 
intensive treatment, as during data collection in RATS-3 I have noticed that participants 
could roughly be classified into four groups. I observed individuals in the intervention group 
that seemed to improve rapidly, but also patients from this group showing barely any clinical 
progress. In the control group I also observed patients recovering quickly and patients hardly 
showing any improvement. It would be clinically relevant to identify factors that predict 
which patients may benefit from early treatment and which patients will improve well 
spontaneously. Hereby SLT resources may be better directed to those patients who are 
expected to benefit from language treatment. In this way we can also identify which patients 
will likely not benefit from CLT, and thus may need a different type of intervention to 
improve communication ability, such as communicative treatment.  
One of the factors that we did not take into account in RATS-3 is cognitive functioning 
before and after stroke. It would be meaningful to study whether cognitive functioning after 
stroke is associated with being ready for receiving language treatment, because an 
association between cognitive impairment and rehabilitation success has been reported 
previously.44, 46, 65, 66 Clinical observations in the RATS-3 cohort suggested that patients who 
were less likely to cope with and respond to treatment also had cognitive impairments. 
However, adequate estimation of cognitive functioning will probably be challenging in 
patients with aphasia, as cognition and language are highly intertwined.44, 67 
It is also unknown which types of treatment are effective for which patients. We have 
chosen to study CLT, based on the assumptions that recovery is optimal if the premorbid 
language system is restored and that linguistic functioning can be restored with CLT.6 
However, there are also researchers advocating to implement communicative treatment in 
the early phase after stroke to initiate effective communication as soon as possible.68 
Hereby, maladaptive processes are thought to be prevented and social interaction is 
 
 
enhanced, keeping patients from feeling isolated. It would be interesting to test the 
effectiveness of one-to-one communicative treatment combined with structured education 
of the patients’ social environment, creating a ‘language enriched environment’, in a well-
designed RCT with for instance classical impairment-based SLT as control condition.  
Most findings in this thesis show that the language system is extremely capricious in the 
first days to weeks after stroke. It would be meaningful to include neuroimaging measures in 
future trial designs, and it is important to continue improving neuroimaging techniques and 
our interpretation of the results in order to better understand post-stroke language recovery 
and its response to treatment. Questions such as ‘Is the activity-shift to the right hemisphere 
maladaptive or supportive for language recovery?’ or ‘Can early language treatment salvage 
penumbral tissue?’ remain unanswered still. In particular, we must further explore the effect 
of therapy principles e.g. massed practice, focusing principles, constraint-induced principles 
and enriched environments that allegedly are crucial for effective treatment.69  
To study the effect of intensive CLT on the neural network dedicated to language in acute 
and chronic aphasia, our group conducted a second trial parallel to RATS-3; Functional 
Imaging in Aphasia Treatment (FIAT).70 Patients were randomly allocated to either four 
weeks of intensive CLT or no language treatment at all, comparable to the RATS-3 treatment 
protocol. In addition to the linguistic test data collected in RATS-3, in FIAT functional MRI-
data on language performance were collected. All patients eligible for RATS-3 without 
contra-indications for MRI were asked to participate in FIAT as well. Unfortunately, because 
of the additional MRI-scanning the few eligible candidates were very reluctant to consent 
and we did not succeed in recruiting sufficient participants with acute aphasia, i.e. within 
two weeks after stroke onset. We also aimed at including 40 patients with chronic aphasia, 
defined as aphasia due to stroke existing for at least one year, and eventually succeeded in 
including a number of 38 patients for this group. Results from FIAT in the chronic phase are 
analyzed, but are not yet published. 
Furthermore, in order to better time language treatment, we need to verify the existence 
of a critical window of opportunity during which the brain is hyperexcitable and language 
treatment supposedly positively interacts with neural recovery.2, 3, 71 Findings from RATS-3 
justify longer periods without treatment early after stroke for future studies. However, 
‘doing nothing’ will probably be highly unattractive to most patients, as the majority of 
patients is motivated for rehabilitation. One way to solve this problem is to introduce a 
control condition with other activities instead of SLT. One could think of an attention control 
group, with nonverbal exercises aimed at improving cognitive functioning, such as attention 
and memory.    
Techniques for non-invasive brain stimulation, e.g. transcranial magnetic stimulation or 
transcranial direct current stimulation might also be explored in future studies, as they have 
shown promising results in restoring language function, though working mechanisms are as 
yet unclear.72 In studies like these, a sham control condition is often used, which is a good 
alternative for ‘doing nothing’.     
 
CONCLUSION 
 
In this thesis I showed that early screening for aphasia after stroke is feasible and can be 
done accurately, and I demonstrated that combining clinical information collected early after 
stroke onset improves prognostication in aphasia, while our large multicenter trial did not 
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show a beneficial effect of early initiated CLT. Taking the limitations into consideration, I can 
confidently conclude that we are able to adequately diagnose aphasia in the early phase 
after stroke and predict aphasia outcome. Furthermore, I provided solid evidence rejecting 
the hypothesis that intensive CLT is the optimal treatment approach early after stroke onset.   
Considering that aphasia is a heterogeneous condition, it is unlikely that one therapeutic 
approach suits all patients. Hence, we still need well-designed large multicenter RCTs with 
multiple arms and stratification for at least stroke severity and aphasia severity, but also for 
instance for type of aphasia, and taking into account comorbidities. These future RCTs 
should aim to identify treatment parameters and patient related factors that can predict 
individual response to treatment. Ideally, this would result in a model that provides the 
parameters for an optimal individual treatment regimen, based on individuals’ 
characteristics shortly after stroke onset.  
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after stroke and predict aphasia outcome. Furthermore, I provided solid evidence rejecting 
the hypothesis that intensive CLT is the optimal treatment approach early after stroke onset.   
Considering that aphasia is a heterogeneous condition, it is unlikely that one therapeutic 
approach suits all patients. Hence, we still need well-designed large multicenter RCTs with 
multiple arms and stratification for at least stroke severity and aphasia severity, but also for 
instance for type of aphasia, and taking into account comorbidities. These future RCTs 
should aim to identify treatment parameters and patient related factors that can predict 
individual response to treatment. Ideally, this would result in a model that provides the 
parameters for an optimal individual treatment regimen, based on individuals’ 
characteristics shortly after stroke onset.  
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SUMMARY 
 
In this thesis I discuss various aspects of the diagnosis and treatment of aphasia due to 
stroke. I address questions on adequate recognition and prognostication of aphasia, and I 
study the effect of medical and linguistic interventions on the recovery of language after 
stroke. I am using data from the Rotterdam Aphasia Therapy Study (RATS) – 3 which I 
coordinated and three other studies. The most important findings are summarized in this 
closing chapter.    
 
In Chapter 1 I describe the general background of aphasia due to stroke and its 
consequences. I also address the importance of adequate and timely diagnosis, prediction of 
aphasia recovery and treatment for patients with aphasia.   
I present a systematic review on screening tests for aphasia in Chapter 2. The systematic 
literature search yielded a total of 1021 abstracts. After careful selection, we identified 10 
validation studies and one review paper that fitted our selection criteria, evaluating eight 
screening tests in total. We found that reporting was poor in the majority of studies; only 
three studies had an intermediate or low risk of bias. Two tests were found with the highest 
level of accuracy: the Language Screening Test (LAST) and the ScreeLing.  
In Chapter 3 I analyze aspects regarding the prognosis of aphasia recovery. I evaluate the 
effect of intra-arterial treatment (IAT) on the recovery of language function in ischemic 
stroke in Chapter 3.1. Patients with aphasia were selected from the MR CLEAN trial, a phase 
III randomized controlled trial on the effectiveness of IAT with retrievable stents compared 
to that of usual care. Language function was better in patients treated with IAT than in 
patients who received usual care, showing that this intervention improves the prognosis of 
aphasia recovery. A comparison of language function and motor arm function 24 hours and 
one week after intervention confirmed the thus far unverified clinical impression that motor 
function recovers more quickly than language function.  
In Chapter 3.2 I describe the external validation of a prognostic model for the prediction 
of good aphasia outcome one year after stroke, derived from the observational SPEAK study. 
Using data from RATS-3 we determined the sensitivity and specificity of this model. The 
model proved to be reliable in discriminating patients with good outcome from those with 
poor outcome. Calibration of the model was insufficient, meaning that the proportion of the 
observed outcomes was not similar to the predicted outcomes. This was most likely due to 
differences in timing of the collection of outcome variables between the derivation and 
validation cohort. Hence, we proposed an updated model.      
In Chapter 4, I discuss aspects of aphasia treatment. I review several sources of evidence 
in search of a relationship between timing of language treatment and its efficacy for 
rehabilitation of aphasia in Chapter 4.1. I summarize results from research on aphasia 
rehabilitation, but also on animal studies and motor rehabilitation. There were arguments in 
favor of an early start of treatment, but also signals that early intensive treatment may be 
detrimental. Lack of randomized controlled trials and inconsistent results across all fields of 
research hampered drawing a conclusion on the effect of timing on efficacy of treatment.  
In Chapter 4.2 I describe the rationale and design of RATS-3. In this randomized 
controlled trial we compare the effect of intensive cognitive-linguistic treatment (CLT) 
primarily to that of no treatment in the acute phase after stroke, and secondarily to that of 
deferred regular treatment. A total of 152 stroke patients with aphasia were randomly 
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allocated to four weeks of either daily CLT or no language treatment within the first four to 
six weeks after stroke.  
I present the findings from this trial in Chapter 4.3. With RATS-3 we showed that in 
general there is no effect of four weeks of intensive CLT when initiated within two weeks of 
stroke onset over spontaneous recovery. In the long-term, the early boost of CLT was not 
effective either. Hence, we conclude that there is no need to start impairment-based CLT as 
soon as possible after stroke. Our compliance results even showed that it may not be 
feasible to start this early with intensive CLT in the majority of stroke patients with aphasia.  
When we restricted the analyses to the participants that had adhered to our protocol, we 
found a limited effect of early CLT on three tests measured four weeks after randomization. 
This implies that some patients may benefit from early intensive treatment and possibly that 
patient selection is important to determine who should start therapy early after stroke. 
However, we must be careful interpreting results from these post-hoc analyses.  
Aphasia severity at onset may be one factor of importance for patient selection, and I 
explore this in Chapter 4.4. We compared three recovery profiles of different degrees of 
aphasia severity during the first six months after stroke. We observed statistically significant 
improvement during the first three months after stroke in all groups, but only in the very 
severe group we also found significant improvement in the period from three to six months 
after stroke. Interestingly, the very severe group seemed to benefit more from CLT than 
from communicative treatment. 
In Chapter 5 I discuss the major findings reported in this thesis. Methodological 
limitations are discussed and aims for future research are provided. I also describe the 
following implications of the findings for clinical practice:  
 The ScreeLing is an adequate diagnostic tool for early screening of language function 
and to estimate initial aphasia severity shortly after stroke. 
 Initial aphasia severity is an important factor for predicting the prognosis and recovery 
of language function. 
 Variables collected in the first week after stroke can be used to estimate the expected 
outcome of aphasia one year after stroke. 
 Language function is very capricious in the first weeks after stroke; hence it may be 
better to postpone detailed language diagnosis until language function has stabilized. 
 Early after stroke it may be better to emphasize on restoring communicative abilities 
instead of starting with CLT, especially in those patients who are unable to tolerate 
intensive language treatment. 
 Most language recovery is observed in the first three months after stroke, thus 
providing language treatment in this phase may be important to maximize recovery. 
 In patients with very severe aphasia significant recovery is observed up to six months 
after stroke and maybe even longer, which justifies continuing treatment for six months 
or longer after stroke. 
 Patients with very severe aphasia appeared to benefit more from CLT than patients with 
milder aphasia, hence this type of treatment may also be provided to patients with very 
severe aphasia, which is as yet uncommon.       
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SAMENVATTING 
 
In dit proefschrift behandel ik verschillende aspecten van de diagnostiek en behandeling van 
afasie ten gevolge van een beroerte. Ik bespreek het belang van het adequaat vaststellen 
van afasie en het geven van een gefundeerde prognose ten aanzien van het te verwachten 
herstel, evenals het effect van medische en logopedische interventies op het herstel van de 
taalfunctie na een beroerte. Hiervoor gebruik ik data uit de door mij gecoördineerde 
Rotterdamse Afasie Therapie Studie (RATS) – 3 en drie andere studies. De belangrijkste 
bevindingen vat ik in dit laatste hoofdstuk samen.  
 
Een algemeen kader over afasie ten gevolge van een beroerte en de gevolgen ervan schets ik 
in Hoofdstuk 1. Ik benadruk het belang van een adequate en tijdige diagnostiek van afasie en 
het geven van een gefundeerde persoonlijke prognose ten aanzien van het herstel van de 
afasie. Ook bespreek ik de dagelijkse praktijk van de behandeling van afasiepatiënten.  
Ik beschrijf een systematische review over screeningstesten voor afasie in Hoofdstuk 2. 
De systematische literatuurstudie resulteerde in 1021 abstracts. Na zorgvuldig selecteren, 
bleken tien studies en één review waarin acht screeningstesten besproken worden te 
voldoen aan de gestelde criteria. De meerderheid van de studies was slecht gerapporteerd; 
slechts drie studies hadden een gemiddeld of laag risico op bias. Uiteindelijk bleken de 
Language Screening Test (LAST) en de ScreeLing de enige twee testen te zijn met het hoogste 
niveau van nauwkeurigheid.  
In Hoofdstuk 3 analyseer ik aspecten met betrekking tot de prognose van het herstel van 
afasie. Ik evalueer het effect van intra-arteriële therapie (IAT) op het herstel van de 
taalfunctie bij afasie als gevolg van een herseninfarct in Hoofdstuk 3.1. Patiënten met afasie 
werden geselecteerd uit de MR CLEAN studie, een fase III gerandomiseerd gecontroleerd 
onderzoek naar de effectiviteit van IAT met verwijderbare stents in vergelijking met die van 
de standaard behandeling. De taalfunctie van patiënten die behandeld waren met IAT bleek 
beter te zijn dan die van patiënten die de standaard behandeling hadden gekregen. Dit toont 
aan dat IAT het herstel van afasie bevordert en de prognose verbetert. Een vergelijking 
tussen de taalfunctie en de armmotoriek 24 uur en één week na de interventie bevestigde 
de tot dusver niet systematisch onderzochte klinische indruk dat motoriek sneller herstelt 
dan taal.  
In Hoofdstuk 3.2 beschrijf ik de externe validatie van een prognostisch model dat een 
goede uitkomst van afasie een jaar na de beroerte voorspelt. Het prognostisch model was 
afgeleid van data verzameld uit de observationele SPEAK studie. Met data verzameld uit 
RATS-3 werden de sensitiviteit en specificiteit van het model bepaald. Het SPEAK model 
bleek betrouwbaar in het onderscheiden van patiënten met een goede uitkomst van 
diegenen met een slechte uitkomst. Kalibratie van het model was matig, wat inhoudt dat 
een deel van de geobserveerde uitkomsten niet overeenkwam met de voorspelde 
uitkomsten. Dit is hoogstwaarschijnlijk het gevolg van een verschil in timing tussen de twee 
cohorten ten aanzien van het verzamelen van de uitkomst data. We stelden daarom een 
aanpassing van het model voor. 
In Hoofdstuk 4 bediscussieer ik diverse aspecten van de behandeling van afasie. 
Verschillende soorten wetenschappelijk bewijs betreffende de relatie tussen de timing van 
taaltherapie en de effectiviteit ervan bespreek ik in Hoofdstuk 4.1. Ik vat resultaten samen 
van onderzoek naar de revalidatie van afasie, maar ook van dierstudies en studies naar 
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motorische revalidatie. Er blijken meerdere argumenten voor een vroege start van de 
behandeling, maar er zijn ook signalen dat vroege therapie juist schadelijk zou kunnen zijn. 
Een gebrek aan gerandomiseerde gecontroleerde onderzoeken en inconsistente resultaten 
op alle gebieden van vroege revalidatie na een beroerte bemoeilijken het formuleren van 
een conclusie ten aanzien van het effect van timing op de effectiviteit van een behandeling. 
In Hoofdstuk 4.2 beschrijf ik de rationale en het design van RATS-3. In dit 
gerandomiseerde gecontroleerde onderzoek vergeleken we vroege intensieve cognitief-
linguïstische therapie (CLT) primair met geen taaltherapie in de eerste weken na een 
beroerte, en secundair met uitgestelde reguliere taaltherapie. In totaal werden 152 
patiënten met afasie door een beroerte willekeurig verdeeld over twee behandelgroepen. 
De ene groep kreeg gedurende vier weken dagelijks behandeling met CLT en de andere 
groep kreeg geen taaltherapie gedurende de eerste vier tot zes weken na de beroerte.  
De resultaten van deze trial presenteer ik in Hoofdstuk 4.3. Met RATS-3 hebben we 
aangetoond dat er over het algemeen geen toegevoegd effect is van vier weken intensieve 
CLT bovenop dat van spontaan herstel, wanneer de therapie binnen twee weken na de 
beroerte gestart wordt. Op de lange termijn bleek een vroege boost van CLT ook niet 
effectiever dan later gestarte reguliere therapie. Daarom concluderen we dat er geen 
urgentie is om zo snel mogelijk na de beroerte te starten met stoornisgerichte CLT. De 
resultaten over de therapietrouw in de interventiegroep toonden zelfs aan het in de 
meerderheid van de patiënten met afasie door een beroerte niet haalbaar is om vroeg te 
starten met CLT.  
Wanneer we alleen de patiënten analyseerden die het onderzoeksprotocol trouw 
gevolgd hadden, vonden we een beperkt effect van vroege CLT op drie testen die vier weken 
na de randomisatie afgenomen waren. Dit impliceert dat sommige patiënten wel baat 
zouden kunnen hebben bij vroege intensieve therapie en dat patiëntselectie mogelijk 
belangrijk is bij het bepalen wie er wel en niet in aanmerking komt voor vroege taaltherapie. 
De resultaten van deze post-hoc analyse moeten echter met grote voorzichtigheid worden 
geïnterpreteerd.  
Een factor die van belang zou kunnen zijn bij patiëntselectie is de ernst van de afasie kort 
na de beroerte en dit wordt in Hoofdstuk 4.4 onderzocht. We vergeleken de herstelcurves 
gedurende de eerste zes maanden na de beroerte van drie patiëntgroepen met een 
verschillende ernstgraad van afasie. Statistisch significant herstel werd in alle groepen 
gevonden in de eerste drie maanden na de beroerte, maar uitsluitend de groep met zeer 
ernstige afasie herstelde nog aanzienlijk tussen drie en zes maanden na de beroerte. Tegen 
onze verwachting in, bleek de groep met zeer ernstige afasie, in tegenstelling tot de groepen 
met mildere afasie, meer te profiteren van CLT dan van behandeling gericht op functionele 
communicatie. 
In Hoofdstuk 5 bediscussieer ik de belangrijkste bevindingen van dit proefschrift. 
Methodologische tekortkomingen, evenals aanwijzingen voor toekomstig onderzoek worden 
besproken. In dit hoofdstuk beschrijf ik de volgende implicaties van de bevindingen voor de 
klinische praktijk:  
 de ScreeLing is een geschikt diagnostisch instrument om de taalfunctie kort na de 
beroerte te screenen en een inschatting te maken van de initiële ernst van de afasie. 
 De initiële ernst van de afasie is een belangrijke factor bij het voorspellen van de 
prognose en het herstelverloop van de taalfunctie. 
 
 
 Variabelen die in de eerste week na de beroerte geregistreerd worden, kunnen gebruikt 
worden om een adequate inschatting te maken van de te verwachten ernst van de 
afasie na een jaar. 
 In de eerste weken na de beroerte is de taalfunctie zeer instabiel, waardoor het 
mogelijk beter is om te wachten met gedetailleerde diagnostiek tot de taalfunctie 
gestabiliseerd is. 
 In de vroege fase na een beroerte is het mogelijk beter om de nadruk te leggen op het 
herstellen van communicatiemogelijkheden dan te starten met CLT, met name bij die 
patiënten die intensieve taaltherapie (nog) niet aan kunnen. 
 Het meeste herstel van taalfunctie treedt op in de eerste drie maanden na de beroerte, 
waardoor het geven van taaltherapie in deze fase belangrijk lijkt om herstel te 
maximaliseren.  
 Bij patiënten met een zeer ernstige afasie is nog tot zes maanden, maar mogelijk langer 
significant herstel zichtbaar, wat ervoor pleit om deze patiënten langer dan zes 
maanden na de beroerte te behandelen.  
 Patiënten met zeer ernstige afasie lijken meer baat te hebben bij CLT dan patiënten met 
een mildere afasie, dus deze vorm van therapie kan ook aan patiënten met zeer ernstige 
afasie aangeboden worden, wat tot dusver niet gebruikelijk is.  
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Appendix I. Participating centers with principal local investigators 
 
Hospitals 
Haven Ziekenhuis, Rotterdam 
Sint Franciscus Gasthuis, Rotterdam 
Ikazia Ziekenhuis, Rotterdam 
Maasstad Ziekenhuis, Rotterdam 
Vlietland Ziekenhuis, Schiedam 
IJsselland Ziekenhuis, Capelle aan de IJssel 
Reinier de Graaf Gasthuis, Delft 
MCH Westeinde, Den Haag 
MCH Antoniushove, Leidschendam 
Haga Ziekenhuis, Den Haag 
VUMC, Amsterdam 
Diaconessenhuis, Meppel 
Beatrix Ziekenhuis, Gorinchem 
Amphia Ziekenhuis, Breda 
Onze Lieve Vrouwe Gasthuis, Amsterdam 
Sint Lucas Andreas Ziekenhuis, Amsterdam 
Catharina Ziekenhuis, Eindhoven 
Franciscus Ziekenhuis, Roosendaal 
Isala Klinieken, Zwolle 
Kennemer Gasthuis, Haarlem 
Tergooi Ziekenhuizen, Blaricum 
Jeroen Bosch Ziekenhuis, Den Bosch 
Erasmus MC, Rotterdam 
 
Principal Local Investigator 
Ida Boas 
Joyce van Dalen 
Mathanja Sibon 
Fabiënne Stok 
Obbe de Roos 
Ingrid Arp 
Jolanda van Veldhuizen 
Marike Kamphuis  
Christa Kerkhof 
Nienke Splinter 
Antoinette Keulen 
Cock Meijs 
Tonny Methorst 
Sylvia Goosen 
Fleur Sickinghe 
Sofie van Wessel 
Danielle Boer 
Nicole Dekkers 
Leonore Meilof 
Astrid Vriend 
Marieke van Beek 
Linda Paulus 
Femke Nouwens 
Rehabilitation centers 
Laurens Antonius Binnenweg, Rotterdam 
Laurens Antonius IJsselmonde, Rotterdam 
Rijndam Central clinic, Rotterdam 
Rijndam Central outpatient center, Rotterdam 
Rijndam SFG, Rotterdam 
Rijndam Vlietland, Schiedam 
Rijndam De Waarden, Gorinchem 
Vlietland Ziekenhuis outpatient center, Schiedam 
Centrum voor Reuma en Revalidatie, Rotterdam 
Maasstad Ziekenhuis outpatient center, Rotterdam  
Zonnehuis, Vlaardingen 
Sophia Revalidatie, Delft 
Stichting Pieter van Foreest, Delft 
Sophia Revalidatie, Den Haag 
Florence, Gulden Huis, Den Haag 
Florence, Huize Westhoff, Rijswijk 
Florence, Mariahoeve, Den Haag 
Zonnehuis, Amstelveen 
Reade Revalidatie, Amsterdam 
De Volckaert-SBO, Oosterhout 
Stichting Elisabeth, Breda 
Thebe Aeneas, Breda 
Principal Local Investigator 
Janneke van Hemert 
Ankerien Gerretse 
Mieke van de Sandt 
Miranda de Waard 
Merle Paterson 
Merle Paterson 
Tonny Methorst 
Obbe de Roos 
Anke de Meij 
Fabiënne Stok 
Suzanne van Almenkerk 
Marjolein Zomerdijk 
Margot van Vorstenbosch 
Elske van Egmond 
Charlotte Schmitz 
Charlotte Schmitz 
Charlotte Schmitz 
Jan van Olsthoorn 
Laurien Sietsma 
Marianne Slabbekoorn 
Judith van Bree 
Cirsten Boon 
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De Riethorst-Stromenland, Geertruidenberg 
Stichting de Bilthuysen, Bilthoven 
Zorgcombinatie Noorderboog Reggersoord, Meppel 
Stichting Groenhuysen, Roosendaal 
Avoord Zorg en Wonen, Etten-Leur 
Stichting SHDH Janskliniek, Haarlem 
Stichting Afasietherapie, Amsterdam  
Rivas Waerthove, Sliedrecht 
Rivas Lingesteijn, Leerdam 
Rivas Het Gasthuis, Gorinchem 
Aafje Zorghotel SFG, Rotterdam 
Aafje Zorghotel Maasstad, Rotterdam 
Aafje Schiehoven-Wilgenplan, Rotterdam 
Aafje De Twee Bruggen, Rotterdam 
Aafje De Vijf Havens, Rotterdam 
Aafje ’t Lichtpunt, Rotterdam 
Aafje Afasietrainingscentrum, Rotterdam 
De Zellingen Rijckehove, Rotterdam 
Saffier de Residentie Mechropa, Den Haag 
Respect Zorggroep Scheveningen, Den Haag  
Revant Revalidatie, Breda 
Surplus Zorg, Zevenbergen 
De Trappenberg, Huizen 
Careyn De Plantage, Brielle 
Careyn Mariaoord, Vinkeveen 
Careyn De Vier Ambachten, Spijkenisse 
De Vogellanden, Zwolle 
De Hoogstraat, Utrecht 
Woonzorgconcern IJsselheem, Zwolle 
Osira Leo Polak, Amsterdam 
Osira Sint Jacob, Amsterdam 
Stichting Sint Jacob, Jacobkliniek, Haarlem 
Viattence De Wendhorst, Heerde 
Zonnehuisgroep IJssel-Vecht, Zwolle 
Zorgbalans, Driehuis 
Novicare, Best 
Libra Zorggroep Blixembosch, Eindhoven 
Logopedie Zandvoort, Zandvoort 
Logopediepraktijk M.P. de Boer, Haarlem 
Brabantzorg, Ammerzoden 
Zorggroep Elde, Boxtel 
Van Neynselgroep, Den Bosch 
Tolbrug Revalidatie, Den Bosch 
Vivent, Rosmalen 
Cirsten Boon 
Melanie Swens 
Nelleke Loseman 
Saskia Aarts 
Nancy Schuurman 
Annet Voogd 
Marieta Gerarts  
Tonny Methorst 
Tonny Methorst 
Tonny Methorst 
Deanne de Brabander 
Deanne de Brabander 
Deanne de Brabander 
Deanne de Brabander 
Deanne de Brabander 
Deanne de Brabander 
Deanne de Brabander 
Janine van der Plas 
Natasha Dinwiddy 
Janneke van Zandbergen 
Dineke Blom 
Annelies van Diepen 
Anne Punt 
Lianne Hartog 
Klaske van Sluis  
Ingrid Muller 
Elsbeth Boxum 
Hannelore van de Velden 
Marleen van der Ploeg 
Tenise van de Ven 
Tenise van de Ven 
Marlies van Nouhuys 
Agnes Kleine 
Marjan Jager 
Natascha Darlang 
Renske Groenen 
Marloes Geraeds 
Ineke Schavemaker 
Claudia Philippo 
Marieke de Bruijn 
Mariëlle van Boxtel 
Jannet Coppoolse 
Nicole Verwegen 
Sandra Jansen 
 
 
 
Appendix II. List of abbreviations 
 
AAT    Aachen Aphasia Test 
acOR    adjusted common Odds Ratio  
AIS    Acute Ischemic Stroke  
ANOVA   Analysis of Variance 
ANCOVA   Analysis of Covariance 
ANELT   Amsterdam-Nijmegen Everyday Language Test 
ANELT-A Amsterdam-Nijmegen Everyday Language Test, A-scale for ‘understandability’ 
ARAT    Action Research Arm Test 
ASRS    Aphasia Severity Rating Scale 
AUC    Area Under the ROC Curve 
BDAE    Boston Diagnostic Aphasia Examination 
CAT    Comprehensive Aphasia Test 
CI    Confidence Interval  
CIMT   Constraint-Induced Movement Therapy 
CLT    Cognitive-Linguistic Treatment  
CT    Computer Tomography 
df    degrees of freedom 
DOR    Diagnostic Odds Ratio 
ER    Enriched Rehabilitation 
exp.    expert assessment 
F    Test of within subjects contrasts 
FAST    Frenchay Aphasia Screening Test 
FCP    Functional Communication Profile 
fMRI    functional Magnetic Resonance Imaging 
IAT    Intra-arterial Treatment  
IQR    Inter Quartile Range, presented as the range from 25th to 75th percentile  
IV  Intravenous  
LAST    Language Screening Test 
LR+    Likelihood Ratio of a Positive Test  
LR-    Likelihood Ratio of a Negative Test 
MAAS    Multi-axial Aphasia System  
MAST    Mississippi Aphasia Screening Test 
MAST*  Mobile Aphasia Screening Test 
MCA    Middle Cerebral Artery  
MIT    Melodic Intonation Therapy 
MR CLEAN  Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute  
Ischemic Stroke in the Netherlands 
mRS    modified Rankin Scale  
n  number 
n.a.    not applicable  
n.f.s.   not further specified 
NGA    Norsk Grunntest for Afasi 
NIHSS   National Institutes of Health Stroke Scale  
n.r.    not reported  
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zogenaamd “geconceived”, waardoor ik met een pasklaar studiedesign aan de slag kon. Ik 
weet niet hoeveel vertraging ik opgelopen zou hebben, als jij niet al die voorbereidingen had 
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bent doctor in organiseren en plannen en hebt me vooral gewaarschuwd voor de valkuilen 
die iedere PhD-student tegenkomt. Zo adviseerde je me om voor het submitten van een 
manuscript minimaal een dagdeel te rekenen. Toch denk ik dat vaak nog even te kunnen 
doen en zit dan tot middernacht achter mijn computer. Hester, ster in methodologie en 
statistiek. Hoe simpel jij het analyseren van data kunt doen lijken, is fenomenaal. Je weet 
niet alleen alles, maar je kunt het ook nog eens helder en op een prettige manier (met veel 
geduld!) uitleggen. Bedankt.   
De ruim 200 logopedisten van de deelnemende instellingen, aan jullie ben ik ook veel 
dank verschuldigd. Of ik nou weer aan de telefoon hing om te vragen of jullie nog nieuwe 
inclusies hadden of om jullie achter de broek aan te zitten zo veel mogelijk therapie te 
geven; jullie deden altijd je best om RATS-3 tot een succes te maken. En dat is ons zeker 
gelukt, gezien het respect wat men (inter-)nationaal toonde voor deze grote studie. In het 
bijzonder wil ik Sylvia Goosen en Gäby van Gils van het Amphia Ziekenhuis in Breda noemen. 
Jullie enthousiasme en scherpte hebben tot een bewonderenswaardig aantal Bredase 
inclusies geleid. Geweldig bedankt! Ook wil ik expliciet Marjolein Zomerdijk, Liset Bergevoet, 
Irma Adbegovic, Nienke Wolthuis en Yvonne Hendrick bedanken voor het scoren van de bijna 
500 ANTATs. Voor het assisteren tijdens de testafnames of het uitwerken van de data dank 
ik mijn studenten: Liset Bergevoet, Leanda Bosschaart, Birgitte Grootscholten, Ryanne van 
Maldegem, Nadia Mighorst, Rosemary Nieuwenhuize, Aniek Perdaen, Karlijn Pols, Evelien 
Tielen, Lokke Walstra, Maike van den Wijngaard, Yvette Crijnen en Nienke Wolthuis.  
Inmiddels heb ik plaats gemaakt op de 22e en ben ik verhuisd naar de derde verdieping 
(helaas zonder dat prachtige uitzicht op de Erasmusbrug). Ik wil de collega’s van de 22e 
bedanken voor de samenwerking. In het bijzonder Esther, Naziha, Dorothée en Eric, voor het 
blussen van menig brandje. Ook mijn nieuwe collega’s van Rijndam Revalidatie RVE Erasmus 
MC wil ik hartelijk bedanken. In het bijzonder mijn buren van de ergotherapie; fijn dat er 
soms een gezicht om de hoek kwam dat vroeg hoe het met me ging als ik weer eens achter 
mijn computer zat te pruttelen.  
Lieve vrienden, ik heb geprobeerd om mijn promotie niet ten koste te laten gaan van tijd 
voor jullie. Ik hoop dat ik daar een beetje in geslaagd ben. Lieve Gang: Air-Thana, Anne, Ebru, 
Linda, Lisa, Simone; we go way back tot de middelbare school. Ik vind het fijn jullie nog 
steeds regelmatig te spreken en zien. Ik ben trots op hoe iedereen zich ontwikkeld heeft. 
Wie had kunnen denken dat dit bij elkaar geraapte zooitje betweterige pubers met eigen 
jargon zo goed terecht zou komen! Merel en Ymke, logopedie partners in crime. Het is altijd 
fijn om met jullie te sparren over het werk, maar ook over het leven. Jullie zijn een veilige 
haven en hebben me altijd gesteund. Ik waardeer onze recente traditie van een weekendje 
samen weg enorm en hoop dat we dit lang zullen voortzetten. Lieve Carolina, we begonnen 
dan wel als collega’s, maar inmiddels ben je zo veel meer dan dat! Je hebt een prachtig gezin 
en een jaloersmakende carrière. Ik mis je erg nu je in Chili zit en ik kijk enorm uit naar de 
momenten dat we elkaar weer in real life zien. Ik bewonder jouw passie voor het leven en 
ben dankbaar voor jouw vriendschap. Maarten, we zijn dit promotietraject soort van samen 
in gegaan en ik ben blij dat je er tot het einde bij betrokken bent geweest. Je hebt een 
prachtige cover gemaakt. Niemand had het beter gekund, thanks! Ook Jan, Anneke, Mijke en 
Loek wil ik bedanken voor de steun en interesse tijdens dit traject. Charl en Faria, a.k.a. 
dierbare buurtjes! Dank voor de never-ending interesse en kopjes thee. Lieve vrienden van 
Ruud, zo noem ik jullie maar even, want jullie zijn met te veel om allemaal bij naam te 
noemen. Sinds ik jullie ken, neemt het aantal hersencellen in hoog tempo af, maar de mooie 
 
 
herinneringen groeien gelukkig net zo snel. Ik ben blij dat ik deel uitmaak van jullie toffe 
groep! In het bijzonder: Coen en Koen, bedankt voor het op peil houden van mijn conditie 
met onze hardloop-eetclub (of is het een eet-hardloopclub?).  
Er zijn natuurlijk nog veel meer mensen die mijn lief en leed hebben gedeeld tijdens dit 
traject. Helaas kan ik niet iedereen hier met naam noemen, maar jullie interesse en steun 
heb ik zeker gewaardeerd; bedankt!   
Nelly, Mariëtte, Laura, Patrick en Remko, ik maak nog niet zo lang deel uit van de familie, 
maar het voelt erg goed. Zoë, Lynn, Sophie en kleine Emma, bedankt dat jullie me zo vaak 
aan het lachen maken, heerlijk!   
Paranimf Djaina, doctor Satoer, ik ben blij dat je als steunpilaar bij mijn promotie 
aanwezig bent. Wat hebben we in de afgelopen tijd veel lief en leed gedeeld! Ik kijk uit naar 
ons boek vol onthullingen over de academische wereld, met sowieso een hoofdstuk over de 
begeleiding van stagiaires! Het was en is erg fijn om met je te kunnen sparren, meestal 
onder het genot van een speciaalbiertje (nog even en ik mag weer meedoen). Je recente 
vaste aanstelling heb je zo dubbel en dwars verdiend met het waardevolle en mooie werk 
dat je doet! Ik hoop dat we in de toekomst kunnen blijven samenwerken aan Rotterdams 
taalonderzoek.   
Natuurlijk is er ook een plaats in dit dankwoord voor jou, Miriam, grote zus. Mir, ik keek 
vroeger altijd al tegen je op en nog steeds. Vroeger vanwege je zelfverzekerdheid en lef. You 
always had my back: als klasgenootjes mij lastig vielen, was jij er om ze stevig aan te 
spreken. Ook nam je me later op sleeptouw en mocht ik als kleine zusje mee gaan stappen. 
De grote stoere zus ben je nog steeds, maar het laatste jaar ben je zo veel zachter geworden 
door die kleine Lis. Je bent echt een super moeder en mijn beste vriendin! Ik vind het 
daarom erg fijn dat je mijn paranimf bent. Michel, als je gaat giechelen, dan gaat het de 
goede kant op. Ik hou van jouw humor en geplaag. Laten we daar vooral nog lang mee 
doorgaan.    
Mama, je zegt altijd dat je het zo knap vindt wat ik doe, maar dat valt wel mee. Het is een 
fractie van wat jij hebt gedaan: twee evenwichtige en gelukkige mensen opvoeden. Ik kan 
me geen lievere en betere moeder wensen. Papa, je staat altijd achter mij, of het nou was 
toen ik met knikkende knieën de hoeven van Buddy moest uitkrabben, of toen ik besloot om 
nog een master en zelfs nog een PhD te doen. Papa en mama, jullie onvoorwaardelijke 
vertrouwen in mij is zo’n fijn en warm gevoel. Wat ik ook weer bedenk te gaan doen, ik weet 
dat jullie mij altijd voor de volle 100% supporten en trots op me zijn. 
Lieve Ruud, je bent de beste anomalie die er is en zoals Moloko zingt: “You’re a breath of 
fresh air to me”. De relativerende woorden ‘Komt goed’ zijn jouw lijfspreuk en … je hebt 
gelijk! Het is goed gekomen. Eindelijk is dit soloproject afgerond en kunnen we nu samen 
aan een nog spannender duoproject beginnen: een gezin. Ik kijk enorm uit naar de komst 
van ons kleintje en weet dat me dit samen met jou ook gaat lukken. Blijf je me altijd aan het 
lachen maken?      
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